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ABSTRACT 
Adequate iodine intake during pregnancy is vital for the developing foetus.  Most of 
the Australian research over the last two decades suggests suboptimal iodine status in 
pregnant women, however, iodine-related behaviours and nutritional indices of iodine 
status of Western Australian pregnant women have not been assessed. 
This study explored iodine intake, knowledge, beliefs, iodine supplement and iodised 
salt use in 425 pregnant women attending WA’s only tertiary women’s and neonatal 
hospital in 2012-13.  In addition, the reliability of an existing food frequency 
questionnaire was assessed and a potential rapid iodine screening tool for use in this 
population was developed. 
Participants completed a self-administered questionnaire (including a 41-item food 
frequency questionnaire).  Median iodine intakes calculated using self-reported dietary 
iodine and total iodine data both met the EAR (160 ug/day).  Median iodine intake 
from food alone (148 ug/day) approached the EAR.  Approximately 66% of subjects 
used iodine-containing supplements during pregnancy and approximately 45% of 
subjects who could recall the type of salt they used were consuming iodised salt.  
Significant factors associated with iodine-containing supplement use during 
pregnancy were gestational stage and gravidity, with education level and ethnic group 
combination identified as significant factors associated with iodised salt use.  
Knowledge regarding food sources of iodine and health problems associated with 
inadequate iodine intake was low. 
Findings indicate that the NHMRC recommendation for all pregnant women to take 
an iodine-containing supplement during pregnancy may not apply to all pregnant 
women in this state.  Further research is needed to assess urinary indicators of iodine 
status of WA pregnant women and to validate the rapid screening tool.  The latter will 
assist with identifying those pregnant women at risk of inadequate iodine intakes. 
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CHAPTER 1 : INTRODUCTION 
1.1 Statement of the problem 
It has been well-documented that severe deficiency of the essential trace element, iodine, 
results in maternal and foetal hypothyroidism.  This, in turn, has been associated with 
a range of poor health outcomes such as stillbirth, miscarriage, birth defects and mental 
retardation of varying severity (World Health Organization United Nations Children's 
Emergency Fund and International Council for the Control of Iodine Deficiency 
Disorders 2007, (WHO/UNICEF/ICCIDD)).  The most devastating, yet preventable, 
consequence of severe iodine deficiency is cretinism (Delange 2007; Hetzel 1983; 
Morreale de Escobar, Obregón, and del Rey 2007).  Evidence of the effect that mild-to-
moderate iodine deficiency during pregnancy has on foetal (and child) outcomes is less 
clear.  Furthermore, evidence from quality randomised controlled trials is limited (Zhou 
et al. 2013) at this point in time. 
The 2003-4 National Iodine Nutrition Survey (NINS) involving the mainland states of 
Australia classified the general Australian population as mildly iodine deficient based 
on a population weighted median urinary iodine concentration of school-aged children 
(Li et al. 2008).  Although pregnant women were not represented in these studies, all 
research conducted on iodine status of pregnant women in Australia and New Zealand 
(NZ) from 1999-2010 reported iodine deficiency in study populations.   
In October 2009, iodine fortification of all non-organic bread and bread products 
available in Australia was mandated.  It was acknowledged that this strategy was not 
likely to meet the needs of pregnant women and breastfeeding women and after further 
review with an expert group, the National Health and Medical Research Council 
(NHMRC) released in 2010 a national blanket recommendation that all women who 
are considering pregnancy, pregnant or breastfeeding take a daily iodine supplement 
of 150 ug (Mackerras and Eastman 2012). 
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Seven to eight years later the results of the 2011-12 National Health Measures Survey 
(NHMS) reported improvements in general adult iodine status with median urinary 
iodine concentration (MUIC) indicating iodine sufficiency (Australian Bureau of 
Statistics 2013a).  This improvement is likely to reflect the 2009 introduction of 
mandatory fortification of all bread and bread products (non-organic) with iodised salt 
and potentially the NHMRC iodine recommendation mentioned above. 
Western Australia (WA) is in a unique position as reflected in the highest MUIC of 
the populations sampled in the NINS and NHMS with results indicating iodine 
sufficiency in 2003-4 and 2011-12.  The reason for this difference in iodine status is 
multifactorial; not only is WA the largest state in Australia with a vast coastline and 
nutrient-rich soils (Australian Bureau of Statistics 2013b), it is also the most culturally 
diverse state with nearly one-third of the population born overseas, a higher proportion 
than any other Australian state or territory (Government of Western Australia 2013).  
The former reason is likely to impact on the native iodine content of local produce and 
water supplies.  The latter is likely to influence dietary intake patterns, health beliefs 
and health behaviours in general (Chaturvedi 2001) and possibly influence the use of 
iodine-containing supplements, iodised salt and knowledge on the topic.  
The review of literature regarding iodine intakes, knowledge and practices has been 
restricted to Australian and New Zealand studies due to the NHMRC recommendation 
referring to this population only.  Up until now, there has been no investigation into 
iodine intakes, knowledge and practices of pregnant women in this state. Furthermore 
the urinary iodine concentrations (UIC) of pregnant women from WA were not 
included in projections used to estimate the national iodine supplementation 
recommendation (as no previous studies have measured UIC of WA pregnant women).  
1.2 Benefits of the study 
This research will be the first to investigate iodine knowledge, beliefs and practices 
(dietary intake, iodised salt use and iodine-containing supplement use) in WA pregnant 
women.  The overall opinion was that mandatory fortification of bread and bread 
products alone was not enough to ensure adequate iodine intake in pregnant women 
(Australian Bureau of Statistics 2013b; Mackerras et al. 2011), hence the 
recommendation in 2010 for iodine supplementation during pregnancy.  
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Whether this applies to pregnant women in WA requires review. Results from this 
study will begin to address this gap in the literature.  In addition to this, pregnancy is 
a time when women are bombarded with nutrition and health related messages and it 
is important to know whether this message is necessary.  This study will also provide 
the opportunity to assess the possibility of pregnant women exceeding the upper level 
of intake (UL) for iodine. 
1.3 Study aims and objectives 
1.3.1 Primary aim and objectives 
To explore the knowledge, beliefs and practices related to iodine nutrition in 
a sample of WA pregnant women. 
 Estimate dietary intake of iodine in pregnant women in WA. 
 Determine consumption of dietary sources of iodine, including iodised 
salt. 
 Quantify the use of iodine supplementation before and during 
pregnancy. 
 Assess knowledge of food sources of iodine and the need for iodine 
during pregnancy, as well as beliefs of pregnant women regarding iodine 
requirements. 
 Identify sources of information regarding iodine that pregnant women 
have used. 
1.3.2 Secondary aim and objectives 
To develop a rapid iodine screening tool for use in WA pregnant women. 
 Assess the reliability of an existing tool used to rank dietary iodine 
intake in WA pregnant women. 
 Identify the key components from the existing tool to be included in a 
rapid iodine screening tool to determine the women whose individual 
usual intakes are not likely to meet the EAR for iodine. 
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CHAPTER 2 : LITERATURE REVIEW 
The first section of this chapter provides an overview of iodine including iodine 
deficiency disorders, assessment of iodine status, adult nutrient reference values and 
iodine homeostasis during pregnancy, as well as a summary of key results from large 
scale nutrition and health surveys conducted in Australia and New Zealand.  The 
second part of this chapter focuses on pregnancy-related iodine nutrition findings 
(including iodine-containing supplement use and iodised salt use) from studies 
conducted in Australia and New Zealand between 1 January 1980 to 24 October 2015 
(date of literature search cessation).  The following electronic databases were searched 
for relevant articles: PubMed, Science Direct, Informit, Medline and Google scholar 
using the key terms “iodine” or “iodine deficiency” and “pregnancy” or “pregnant 
women” and “Australia” or “New Zealand”.  Articles that were from veterinarian 
journals, related to thyroid cancer or referred to iodine use as an antiseptic were 
excluded. 
2.1  Introduction 
Iodine is an essential trace element necessary for the regulation of thyroid gland 
function and for the production of thyroid hormones triiodothyronine (3,5,3’-
triiodothyronine or T3) and thyroxine (3,5,3’,5’-tetraiodothyronine or T4).  
Consequently, a large proportion (70-80%) of the body’s iodine is found in the thyroid 
gland under euthyroid (normal thyroid gland) conditions (Food Standards Australia 
New Zealand 2005; Gibson 2005). 
The thyroid hormones are required for the regulation of the metabolism of the 
macronutrients carbohydrate, fat and protein, as well as vitamin and mineral 
metabolism (World Health Organization and Food and Agriculture Organisation of the 
United Nations 2001).  These hormones are essential for early development of the 
central nervous system and most organs, in particular, the brain of the developing 
foetus during gestation (Hetzel 2012; National Health and Medical Research Council 
and New Zealand Ministry of Health 2006b), infancy and childhood 
(WHO/UNICEF/ICCIDD 2007). 
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The link between iodine and thyroid function began in the early 20th century when 
associations between goitre (an enlarged thyroid gland) and iodine deficiency were 
made.  More importantly, it was discovered that iodine prophylaxis prevented goitre 
and by the 1920s salt iodisation began in Switzerland and the United States to address 
this issue.  Before this discovery goitre was considered to be a cosmetic problem only 
(Zimmermann 2009).  The relationship between iodine, thyroid hormones and brain 
development became apparent in the 1970s when Pharoah and Connolly (1987) 
confirmed that iodine supplementation played a role in the prevention of cretinism 
(Lazarus 2005), defined as; a condition that results in severe mental retardation and 
varying degrees of deaf-mutism, stunted linear growth and spasticity) 
(WHO/UNICEF/ICCIDD 2007).  This became a key trial, providing strong evidence 
that the consequences of iodine deficiency were more widespread than goitre alone 
(Hetzel and Dunn 1989). 
2.1.1 Iodine Deficiency Disorders (IDD) 
In 1983, Hetzel suggested the use of the term “iodine deficiency disorders” (IDD) to 
encompass the spectrum of consequences (Figure 2.1) resulting from iodine deficiency 
that are preventable with adequate iodine intake (Hetzel 1983; 
WHO/UNICEF/ICCIDD 2007).  One of the most serious consequences of iodine 
deficiency is cretinism (Section 2.1).  This draws attention to the importance of 
ensuring adequate iodine intake during pregnancy and early childhood when the brain 
is most vulnerable to the effects of iodine deficiency.  It is, however, worth noting that 
IDD can have negative effects in all life stages (Hetzel 1983; WHO/UNICEF/ICCIDD 
2007). 
Iodine deficiency (and the associated range of preventable disorders) continues to pose 
a major public health problem.  Andersson, Karumbunathan, and Zimmermann (2012) 
estimated that in 2011, 1.88 billion people worldwide, including 240.9 million school-
aged children had inadequate iodine intakes.  It is important to note, however, that 
more recent data reveal that the number of countries with adequate iodine intakes has 
almost doubled in the last decade (from 67 to 111), with Australia being one of these 
countries (Australian Bureau of Statistics 2013a; Pearce, Andersson, and Zimmermann 
2013).    
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This reflects global improvement in iodine status due to the successful implementation 
of universal salt iodisation (USI) in some countries around the globe, and, in the case 
of Australia, due to the 2009 introduction of mandatory fortification of non-organic 
bread and bread products with iodine. 
 
Figure 2.1  Iodine deficiency disorders  
(Iodine Global Network n.d.) (formerly known as ICCIDD) 
2.1.2 Iodine deficiency in Australia and New Zealand 
From an historical viewpoint, recognition of iodine deficiency in Australia and New 
Zealand, as evidenced by endemic goitre, dates back to the early 1900s (Australian 
Population Health Development Principal Committee 2007).  Populations in Tasmania 
(Tas), New South Wales (NSW), Victoria (Vic), Queensland (Qld), Australian Capital 
Territory (ACT), South Australia (SA) and NZ were subject to varying degrees of 
iodine deficiency with intervention strategies employed in different areas of Australia 
such as; the introduction of iodised household salt in the 1920s, iodine tablets in 1947 
in the ACT and Tas and an initial trial of fortification of bread improvers with iodised 
salt between 1953 and the 1980s in both the ACT and Tas (Australian Population 
Health Development Principal Committee 2007; Food Standards Australia New 
Zealand 2008c). 
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In New Zealand, iodisation of table and cooking salt began in the 1920s with limited 
success on goitre rates, hence an increase in the concentration of iodine in table and 
cooking salt was initiated in the late 1930s (Australian Population Health Development 
Principal Committee 2007; Food Standards Australia New Zealand 2008c). The 
overall impact of these strategies in Australia and New Zealand has varied, some 
having limited success on improving iodine status, others being associated with high 
rates of iodine induced hyperthyroidism leading to their cessation (Connolly, Vidor, 
and Stewart 1970; Food Standards Australia New Zealand 2007). 
It is believed that up until the 1990s, the trace contamination of milk (and dairy 
products) with iodine (from iodine-containing sterilising agents) inadvertently 
protected vast parts of the Australian and the New Zealand population from iodine 
deficiency (Li et al. 2006; Zimmermann 2010). The replacement and, or reduction of 
iodine containing sterilising agents in the dairy industry saw a reduction in the iodine 
concentration of milk and dairy products which has been linked to the recurrence of 
iodine deficiency in Australia and NZ reported from the late 1990s (Li et al. 2001).  
The trend towards a decreased consumption of discretionary salt for health related 
reasons and the increased consumption of food prepared outside of the home (iodised 
salt use in commercial food production was not common at the time) (Li et al. 2001), 
together with the abandonment of previous iodine intervention strategies have also 
been proposed as contributing factors (Australian Population Health Development 
Principal Committee 2007). 
Further to this, all studies conducted on pregnant women in Australia between 1998 
and 2009 (prior to the mandatory fortification of non-organic bread and bread products 
with iodised salt) reflected borderline iodine deficiency or mild iodine deficiency in 
NSW (Blumenthal, Byth, and Eastman 2012; Charlton et al. 2010; Gunton et al. 1999; 
Li et al. 2001; McElduff et al. 2002; Travers et al. 2006), Vic (Hamrosi, Wallace, and 
Riley 2005; Rahman et al. 2011), ACT (Nguyen et al. 2010), NT (Mackerras, Singh, 
and Eastman 2011) and Tas (Burgess et al. 2007; Stilwell et al. 2008). 
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The results of the 2011–12 NHMS (post-fortification of bread and bread products) 
show improvements in the overall Australian population iodine status, reflecting a shift 
from mild iodine deficiency in 2004 (based on urinary excretion in school-aged 
children (SAC) (Section 2.4) to iodine sufficiency in 2011-12 (in both SAC and adults) 
(Australian Bureau of Statistics 2013a).  However, approximately 60% of women of 
childbearing age (16-44 years) (Australian Bureau of Statistics 2013a) remain at risk 
of iodine deficiency according to WHO/UNICEF/ICCIDD (2007) criteria for pregnant 
women. 
2.1.3 Ecology and food sources of iodine 
Iodine is found in varying concentrations in oceans, the atmosphere and soil, mainly 
as salts of the iodide ion (I-).  Methyl iodide in the ocean is transformed (as is 
molecular iodine) to gaseous inorganic and particulate forms of iodine.  These forms 
return to soil via precipitation or enter groundwater and surface water directly or via 
leaching (Agency for Toxic Substances and Disease Registry 2004; Zimmermann, 
Jooste, and Pandav 2008). 
Interruptions to this cycle over time can result in iodine-deficient soils, groundwater, 
and crops.  This progression through the food chain results in iodine-deficient animals 
and humans who consume or rely upon the local produce (Australian Population 
Health Development Principal Committee 2007; Zimmermann, Jooste, and Pandav 
2008).  Iodine deficiency was once thought to be a problem mostly affecting those 
living in developing countries and, or, certain geographical areas such as: mountainous 
regions, inland areas and areas that are prone to frequent flooding. (Food Standards 
Australia New Zealand 2008c; WHO/UNICEF/ICCIDD 2007).  It is now known that 
iodine deficiency can and does occur in coastal areas, in developed countries (in this 
case, Australia and New Zealand) and in areas once thought to be iodine sufficient 
(WHO/UNICEF/ICCIDD 2007). 
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Within the ocean environment, bioaccumulation results in seafood and aquatic plants 
becoming concentrated sources of iodine (United States Department of the Interior 
2007).  Other than seafood and aquatic plants, terrestrial plants and animal products 
can be important sources of iodine depending on the local iodide content of the soil 
which can vary immensely (from 1 to 250 ug g -1) (Hess 2013) and the frequency of 
consumption of these products.  In recent years, globalisation of the food supply has 
led to contributions from non-local sources. 
Cow’s milk (and dairy products) in their native forms are not rich sources of iodine, 
however, there has been a general consensus that up until the last twenty years, the 
trace contamination of milk (and dairy products) with iodine (from iodine containing 
sterilising agents) has protected parts of the Australian and NZ populations from iodine 
deficiency (Li et al. 2001; Li et al. 2006; Zimmermann 2010).  Changes within the 
dairy industry as described in Section 2.1.3 have been linked to the recurrence of iodine 
deficiency in Australia and New Zealand (Li et al. 2001). 
The introduction of foods fortified with iodine in Australia and NZ (iodised salt in 
general and non-organic bread and bread products containing iodised salt) are cost-
efficient and feasible strategies currently being used to reintroduce iodine into the food 
chain, with the latter being mandated in October, 2009 in Australia and NZ to improve 
the population’s iodine status (Food Standards Australia New Zealand 2008c; 
Zimmermann 2009).  The Food Standards Australia New Zealand (2009, p.3) 
mandatory fortification definition of bread is: 
“…the product made by baking a yeast-leavened dough prepared from one 
or more cereal flours or meals and water and includes yeast-leavened bread 
made from all cereal flours (i.e. wheat, rye and gluten free bread), bread 
rolls, buns, English muffins, focaccia and fruit bread.” (Food Standards 
Australia New Zealand 2009). 
Yeast-free bread, purpose made breadcrumbs and bread mixes sold for domestic use 
are not required to meet the mandatory iodine fortification standards (Food Standards 
Australia New Zealand 2009). 
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Large scale (or national) nutrition and health surveys over the last 10 years have been 
important investigative and informative tools regarding iodine intake in Australia. 
Dietary intake data from the 1995 National Nutrition Survey (NNS) has been used to 
calculate estimated iodine intakes and to determine the major food contributors of 
iodine within population subgroups (Food Standards Australia New Zealand 2008a).  
The NNS has also been used to assist with the estimation of iodine supplementation 
levels and, in combination with the 2003 cohort of the Australian Longitudinal Study 
on Women’s Health (ALSWH) to project the impact of mandatory iodisation of bread 
on dietary iodine intake of women (Mackerras et al. 2011; Mackerras and Eastman 
2012).  Nutrient data and health measures from more recent national surveys e.g. 
National Children’s Survey (Commonwealth of Australia 2008) and the NHMS 
(Australian Bureau of Statistics 2013a) have provided valuable updated data regarding 
iodine intake and iodine status of Australians, respectively. 
Table 2.1  Approximate iodine content of various foods 
(Food Standards Australia New Zealand 2012). 
Food Iodine content 
(ug/100 g) 
Iodine content 
(ug/serve) 
Serve size 
Oysters 160 144 6 oysters – 90 g 
Sushi (containing 
seaweed) 
92 92 1 sushi roll – 100 g 
Bread (except organic 
bread) 
46 28 2 slices bread -60 g 
Steamed snapper 40 50 1 fillet – 125 g 
Cheddar cheese 23 4 2.5 cm cube – 16 g 
Eggs 22 19 2 eggs – 88 g 
Ice cream 21 10 2 scoops – 48 g 
Regular milk 23 57 1 large glass – 250 ml 
Canned tuna 10 10 1 small tin – 95 g 
Bread, organic 3 2 2 slices – 60 g 
Beef, pork, lamb <1.5 <1.5 2 loin lamb chops 
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2.2 Iodine absorption, metabolism and excretion 
Iodine is typically ingested as iodate (IO3-) or iodide (I-) from iodine containing foods 
and supplements.  The former is reduced to iodide in the gut and is rapidly absorbed 
in the duodenum (Hess, 2013).  Iodide is actively taken up by several tissues in the 
body including the thyroid, lactating mammary gland and the placenta (Cavalieri 1997; 
Hess 2013; Nicola et al. 2009).  The salivary glands and gastric mucosa also have the 
ability to take up iodide from the circulation, and iodide is released into saliva and 
gastric juice, enters the small intestine and is reabsorbed (Nicola et al. 2009). The 
physiological role of this enteric phase remains unclear (Hess 2013; Nicola et al. 
2009). 
Iodide is vital for the regulation of thyroid gland function and for the production of the 
thyroid hormones triiodothyronine (3,5,3’-triiodothyronine, T3) and thyroxine 
(3,5,3’,5’-tetraiodothyronine, T4) (Figure 2.2) which are responsible for the regulation 
of basal metabolic rate and the growth, development and functioning of the central 
nervous system (Hess 2013). Under euthyroid conditions up to 10% of circulating 
iodide is taken up by the thyroid, however during prolonged iodine deficiency this can 
increase to 80% (Gibson 2005; Hess 2013).  Circulating iodide is also cleared by the 
kidneys with approximately 90% of iodide eventually excreted by the kidneys (Gibson 
2005; Zimmermann 2009). 
 
Figure 2.2  Chemical structure of the thyroid hormones 
(Michael and Sabyasachi 2010) 
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The biosynthesis of thyroid hormones is complex and tightly regulated by TSH 
(thyroid stimulating hormone) secreted by the anterior pituitary (Michael and 
Sabyasachi 2010; Obregon, Escobar Del Rey, and Morreale de Escobar 2005).  Iodide 
is actively transported into the thyroid cells across the basolateral membrane via the 
sodium-iodine symporter (NIS) which is driven by the Na+ - K+ ATPase pump 
(Bizhanova and Kopp 2009; Gibson 2005).  It is transported through the cell and across 
the apical membrane into the colloid of the thyroid follicle via pendrin (Bizhanova and 
Kopp 2009; Zimmermann, Jooste, and Pandav 2008).  The next step involves the rapid 
oxidation of iodide by thyroperoxidase (TPO) and hydrogen peroxide on the apical 
surface of the thyroid follicular cell, and is followed by the iodination of tyrosyl 
residues on thyroglobulin (Tg) (a glycoprotein found within the colloid) to produce 
the precursors of thyroid hormone–monoiodotyrosine (MIT) and diiodotyrosine (DIT) 
(Bizhanova and Kopp 2009; Gibson 2005; Zimmermann, Jooste, and Pandav 2008). 
Under the influence of TPO, two residues of DIT are coupled within Tg to form 
thyroxine (T4), or one MIT and one DIT are coupled to form T3 (Gibson 2005; Hess 
2013).  These are stored within the follicular lumen until they are endocytosed and 
fused with lysosomes within the thyroid cell.  Proteases degrade peptide linkages 
within Tg releasing T3 and T4 which then enter the circulation whilst iodide stored in 
MIT and DIT is cleaved and recycled within the thyroid gland (Hess 2013; Michael 
and Sabyasachi 2010) (Figure 2.3). 
 
Figure 2.3  Iodine pathway in the thyroid cell 
(Zimmermann, Jooste, and Pandav 2008) 
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Once in the circulation the majority of T3 and T4 attach to thyroxine-binding globulin 
(TBG), transthyretin and albumin (Hess 2013) and begins the journey to target tissues.  
T3 is the metabolically active form of these thyroid hormones and the deiodination of 
T4 to T3 is an important final step occurring in target tissues (Hess 2013; World Health 
Organization and Food and Agriculture Organisation of the United Nations 2001).  T3 
binds to its nuclear receptor in target tissue cells where the complex controls gene 
transcription and protein synthesis (World Health Organization and Food and 
Agriculture Organisation of the United Nations 2001).  Removed iodide then re-enters 
the plasma iodide pool to return to the thyroid or is excreted by the kidney (more than 
90%), with a small amount excreted in the faeces after entering the gastrointestinal 
tract (Hess 2013; Zimmermann, Jooste, and Pandav 2008). 
There is the potential for dietary factors such as goitrogens (substances that block 
absorption and utilisation of iodine) (Gibson 2005) and deficiencies in other 
micronutrients such as iron, selenium and vitamin A, to interfere with the normal 
processes of absorption and metabolism.  Vegetables from the Brassica family 
(including cabbage, kale, cabbage, broccoli, cauliflower), as well as, cassava, maize, 
sweet potatoes and lima beans contain goitrogenic substances (Hess 2013).  
Deficiencies in iron, selenium and vitamin A can have effects on a range of enzymes 
involved in thyroid hormone and TSH synthesis and, or metabolism (Gibson 2005; 
Hess 2013). 
2.2.1 Changes in iodine homeostasis during pregnancy 
Pregnancy induces physiological changes which bring about a greater demand for 
iodine, hence higher iodine requirements during this life stage.  A rise in oestrogen 
concentration in early pregnancy leads to an increase in liver synthesis of TBG, and 
thus increased serum TBG levels.  Higher serum TBG concentration ensures increased 
total circulating thyroid hormones during pregnancy.  Maternal thyroid hormone 
production increases as a means to maintain adequate free (unbound) T3 (FT3) and T4 
(FT4) concentrations, thereby providing the foetus with adequate maternal T4 for 
neuronal migration and proliferation in the period before the foetal thyroid gland is 
functional (Glinoer 2007; Williams 2008; Zimmermann 2009). 
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After this time, the hypothalamic-pituitary axis develops and the foetus begins 
producing its own thyroid hormone supply from maternal iodide.  The foetus, however, 
remains dependent on maternal thyroid hormones throughout gestation (Morreale de 
Escobar, Obregón, and del Rey 2007; Williams 2008). 
Placental human chorionic gonadotropin (hCG) concentration peaks late in the first 
trimester.  The mild thyrotrophic effect of hCG causes an increase in maternal T4, 
leading to an initial decrease in serum TSH at this gestational stage (Delange 2001; 
Morreale de Escobar, Obregón, and del Rey 2007; Pearce, Andersson, and 
Zimmermann 2013).  Again, this is a process thought to provide adequate T4 to the 
foetus (Morreale de Escobar, Obregón, and del Rey 2007).  An increase in maternal 
TSH occurs at the end of the first trimester and concentrations remain higher during 
the second and third trimesters than in the first trimester (Delange 2001; Stagnaro-
Green et al. 2011).  The onset of foetal thyroid hormone production (foetal TSH) 
commences around the end of the first trimester (Williams 2008), however, the foetus 
remains reliant on maternal thyroid hormones until birth.  During pregnancy there is 
an increase in glomerular filtration rate (GFR) (due to increased renal blood flow) 
which leads to increased iodine excretion.  Whether urinary iodine excretion increases 
or decreases with advancing gestation is still a topic of debate, with many studies 
reporting conflicting results (Fuse et al. 2011; Stilwell et al. 2008).  Maternal FT4 and 
FT3 concentrations progressively decrease in the second trimester onwards as foetal 
hormone production increases (Figure 2.4) (Morreale de Escobar, Obregón, and del 
Rey 2007). 
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Figure 2.4  Maternal FT4 and FT3 concentrations during pregnancy 
(Morreale de Escobar, Obregón, and del Rey 2007) 
2.3 Biochemical and clinical assessment of iodine status in the general 
population 
Four of the most commonly used methods to assess iodine status in various populations 
are as follows; 1) Urinary iodine concentration (ug/L) or 24-h collections (ug/L or 
ug/24 h), 2) Goitre rate assessed by palpation or ultrasound (%), 3) Serum TSH, 4) 
Serum Tg (Li and Eastman 2010; WHO/UNICEF/ICCIDD 2007), together with two 
methods that are not used as frequently 5) Free T4 and 6) Free thyroxine Index (FT4I) 
(Stagnaro-Green et al. 2011). 
2.3.1 Urinary iodine concentration (UIC) 
Approximately 90% of iodine absorbed by the body is eventually cleared by the 
kidneys (Gibson 2005).  For this reason, UIC, indicative of recent dietary iodine intake, 
is a widely used index in population iodine studies (Gibson 2005; Li and Eastman 
2010).  Samples are either casual, also known as spot urine samples, or based on a 24-
hour urine collection.  The former method is more frequently used due to ease of 
collection (WHO/UNICEF/ICCIDD 2007). 
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Assessing the UIC of SAC (≥6 years of age) is currently the recommended method for 
determining the iodine status of populations (Eastman 2012; WHO/UNICEF/ICCIDD 
2007) due to the traditional use of reference ranges in this age group 
(WHO/UNICEF/ICCIDD 2007).  Whilst UIC is the most commonly used, practical 
and universally accepted method to determine iodine status it is not without its 
limitations.  Firstly, the reliability of this biomarker as a population indicator of iodine 
status depends on representative populations or samples and the overall sample size 
(National Health and Medical Research Council 2009; WHO/UNICEF/ICCIDD 
2007).  WHO/UNICEF/ICCIDD (2007) guidelines recommend a minimum of 30 urine 
collections from the sampling group.  Using a casual sample to measure individual 
iodine status, irrespective of life stage, is limited due to diurnal, seasonal and intra-
individual variation (König et al. 2011), including hydration status (Brough et al. 2015; 
Nguyen et al. 2010). 
2.3.2 Goitre assessed by palpation or ultrasound (%) 
The thyroid gland is located in front of the larynx and upper trachea (Gibson 2005).  
Enlargement of the thyroid gland, also known as goitre, has historically been used as 
an indicator of iodine deficiency (WHO/UNICEF/ICCIDD 2007).  Goitre formation 
can be triggered by various conditions.  In the case of iodine deficiency, goitre 
formation in non-pregnant adults occurs due to inadequate iodine intake (usually at 
levels <50 ug/day, however this is variable) and/or significant levels of goitrogens in 
the diet and is potentially exacerbated by selenium, iron or vitamin A deficiencies 
(Gibson 2005; Hess 2013; Zimmermann 2009). 
Iodine intakes less than 100 ug per day can cause a reduction in circulating T4 levels 
(Zimmermann 2009).  Figure 2.5 represents the steps leading to goitre formation.  In 
severe iodine deficiency a marked increase in the secretion of TSH from the pituitary 
occurs.  This causes an increase in both iodine turnover (by acting on NIS gene 
transcription) and glandular uptake of iodide together with proliferation of thyroid 
cells releasing Tg (a thyroid specific protein). These combined effects result in 
increased thyroid volume (TV) and (potential) goitre formation (Gibson 2005; Glinoer 
2007; Zimmermann 2009). 
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Figure 2.5  Thyroid function and goitre formation during pregnancy 
(Glinoer 2007) 
Thyroid size reflects the long-term iodine status of an individual or a population and 
can be measured by palpation (Grade 0, Grade 1 and Grade 2).  A high inter-observer 
variation can lead to misclassification by this method (WHO/UNICEF/ICCIDD 2007).  
A second and more precise method of determining thyroid size is by ultrasonography.  
Gender-specific reference values for the upper limit of normal (p.97) thyroid volume 
of children between 6 and 12 years of age (or using body surface area) are referred to 
in the classification process (WHO/UNICEF/ICCIDD 2007).  The prevalence of 
goitre, total goitre rate (TGR), is one method of determining the iodine status of 
populations in epidemiological studies. TGR is an indicator of long-term iodine status 
but has limited applicability when evaluating current prevalence or current iodine 
status of a population as it can take some months for the size of the thyroid gland to 
normalize following improvements in iodine status.  TGR can still be used as a 
measure of iodine status trends (Andersson et al. 2005; WHO/UNICEF/ICCIDD 
2007). 
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2.3.3  Serum TSH 
In severe iodine deficiency, reduced circulating T4 levels can bring about a marked 
increase in the secretion of TSH from the pituitary (Gibson 2005; Glinoer 2007).  In 
mild-to-moderate iodine deficiency, however, TSH levels are typically within the 
normal range (Gibson 2005; Skeaff 2012).  Measurement of TSH levels in adults and 
school children is not recommended for assessment of iodine status of the adult and 
child populations (WHO/UNICEF/ICCIDD 2007) due to this lack of sensitivity, 
however, improvements in the assays over time have led to some improvements in the 
sensitivity of this measure (Eastman 2012). 
2.3.4 Serum Tg 
The thyroid protein, Tg, can be used as measure of thyroid activity (Eastman 2012; 
Gibson 2005; WHO/UNICEF/ICCIDD 2007).  Stimulation of thyroid cells (which 
occurs when iodine intake is inadequate), can trigger thyroid hyperplasia leading to 
increases in serum Tg concentration (Gibson 2005; Hess 2013).  In contrast to UIC 
which reflect shorter term iodine nutrition and goitre as an indicator of long-term 
iodine status, Tg can be used as a medium to long-term index as it reveals iodine status 
over months or years (Hess 2013). 
2.3.5 Free thyroxine (FT4) 
The majority of thyroxine (T4) in the blood is found bound to serum proteins such as 
TBG and albumin (Stagnaro-Green et al. 2011).  Total serum T4 (TT4) concentration 
can be measured, however TT4 concentration alone does not give an indication of the 
T4 that is free (unbound).  FT4 is a direct measure of the proportion of the serum TT4 
that is unbound and available to be taken up by target tissues (Stagnaro-Green et al. 
2011).  Measuring FT4 concentration using modern techniques is more favourable to 
using indirect measures such as FT4I (described below). 
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2.3.6 Free thyroxine index (FT4I) 
FT4I, historically known as adjusted total thyroxine (Stein and Price 1972), is 
calculated by multiplying TT4 by T3 resin uptake (TT4 x T3 resin uptake) or as a ratio 
of TT4 and TBG (Stagnaro-Green et al. 2011).  FT4I is an indirect measure of free 
circulating T4 and takes into consideration the influence of TBG on FT4 concentration.  
This measure is not commonly used today, due to improvements in the direct analysis 
techniques of measures of free thyroid hormones (Stagnaro-Green et al. 2011). 
2.4 Biochemical and clinical assessment of iodine status in pregnancy 
2.4.1  Urinary iodine concentration 
As mentioned in section 2.3.1 UIC reflects recent iodine intake (over preceding days) 
(WHO/UNICEF/ICCIDD 2007) and therefore is not an appropriate measure of long-
term iodine status (Mackerras, Singh, and Eastman 2011).  The use of a casual urine 
sample to measure individual iodine status, irrespective of life stage, is limited due to 
diurnal, seasonal and intra-individual variation (König et al. 2011).  The latter results 
from variation in recent iodine intake (Andersen et al, 2014) as well as hydration status 
(Brough et al. 2015; Nguyen et al. 2010). 
It  has been recognised that the accuracy of using UIC to determine iodine status during 
pregnancy is impacted by three pregnancy-specific factors;  a) increased GFR (Glinoer 
2007), leading some to suggest that increased iodine excretion during early pregnancy 
may mask iodine deficiency (Mackerras et al. 2011; Stilwell et al. 2008); b) a lack of 
data available on the role of the placenta with regards to iodine storage (Delange 2007), 
as this value cannot be assessed by UIC; and c) UIC does not account for iodine 
transferred to the foetus (Mackerras and Eastman 2012).  Andersen et al. (2014) also 
found that timing of consumption of iodine-containing supplements (if used) in 
relation to timing of urine sampling had a significant effect on the MUIC and UIE of 
a sample of Danish women (n=158).  Furthermore, Skeaff (2012) points out a lack of 
validation relating to the pregnancy-specific cut-off value. 
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Recognition of the major differences between UIC in SAC and pregnant women is 
reflected in the separate recommendations for the interpretation of UIC in pregnant 
women (Andersson et al. 2007).  It is worth noting in Table 2.2 and Table 2.3 that the 
MUIC between 100-199 ug/L is considered adequate in SAC and non-pregnant adults 
whilst the corresponding MUIC for pregnant women is set higher (150-249 ug/L). 
Table 2.2  MUIC criteria for assessing iodine nutrition of  SAC (≥6 years) and adultsa 
(WHO/UNICEF/ICCIDD 2007). 
MUIC (ug/L) Iodine intake Iodine Status 
<20 Insufficient Severe iodine deficiency 
20-49 Insufficient Moderate iodine deficiency 
50-99 Insufficient Mild iodine deficiency 
100-199 Adequate Adequate iodine nutrition 
200-299 Above requirements May pose a slight risk of more 
than adequate intake in overall 
population 
≥300 Excessive Risk of adverse health 
consequencesb 
a Applies to adults but not to pregnant and lactating women. 
b Such as iodine-induced hyperthyroidism, autoimmune thyroid disease. 
 
Table 2.3  MUIC criteria for assessing iodine nutrition of pregnant womena 
(WHO/UNICEF/ICCIDD 2007). 
MUIC (ug/L) Iodine intake 
<150 Insufficient 
150-249 Adequate 
250-499 Above requirements 
≥500 Excessiveb 
a For lactating women and children <2 years of age a MUIC of 100 ug/L can be used to define adequate 
iodine intake, but no other categories of iodine intake are defined. 
b “Excessive” means in excess of the amount required to prevent and control iodine deficiency. 
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The International Council for Control of Iodine Deficiency Disorders (ICCIDD) and 
the Public Health Committee of the American Thyroid Association (PHCATA) have 
since adopted the recommendations for pregnant women (Table 2.3) (Australian 
Population Health Development Principal Committee 2007).  The current criteria do 
not give cut-off values which would allow determination of the severity of iodine 
deficiency, although it has been assumed that a greater degree of deficiency is reflected 
by lower UICs (Pettigrew-Porter et al. 2011). 
A longitudinal study conducted on pregnant women in Sydney between 2007 and 2008 
(n=367) by Blumenthal, Byth, and Eastman (2012) (Table 2.6) found that MUIC 
reflecting mild-to-moderate iodine deficiency did not correlate with abnormal thyroid 
function or abnormal thyroid hormone levels. Similar findings were reported in a New 
Zealand study conducted on 170 pregnant women in 2005 (Pettigrew-Porter et al. 
2011) (Table 2.6).  Up until recently, this cast doubt on whether mild-to-moderate 
iodine deficiency had negative impacts on the neurocognitive development of the 
foetus. 
More evidence is mounting to negate this doubt, with findings from longitudinal 
studies conducted by (Hynes et al. 2013) in Tas and (Bath et al. 2013) in the United 
Kingdom suggesting that mild-to-moderate iodine deficiency during pregnancy 
negatively impacts foetal neurocognition.  Results show impaired cognitive outcomes 
at 8-9 years of age in the children born to mothers with mild-to-moderate iodine 
deficiency during pregnancy using standardized assessment tools such as National 
Assessment Program-Literacy and Numeracy (NAPLAN), Student Assessment and 
Reporting Information System (SARIS) or Child IQ using an abbreviated form of 
Wechsler Intelligence Scale for Children (Bath et al. 2013; Hynes et al. 2013).  
Randomised controlled trials currently being conducted in Thailand and India (the 
MITCH studies) will provide further evidence relating birth outcomes from mild-to-
moderate iodine deficiency in pregnancy (Melse-Boonstra et al. 2012). 
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2.4.2  Goitre assessed by palpation or ultrasound (%) 
Skeaff (2012) acknowledges that the assessment of goitre rates in pregnancy is difficult 
due to a lack of published TV ranges for use in pregnancy, although it can be assumed 
that visible goitre in pregnant women reflects moderate-to-severe iodine deficiency.  
As mentioned previously, measurements of goitre rates or TV (size) are long–term 
measurements of iodine status and have limited applicability when evaluating current 
prevalence or current iodine status.  In pregnancy it is not appropriate to rely on 
measures of TV, especially since other methods described in this section (e.g. UIC and 
TSH) can detect inadequate/insufficient iodine status prior to the sequelae that lead to 
increased TV and, or goitre formation, therefore allowing for earlier detection and 
correction. 
2.4.3 Serum TSH 
To interpret TSH levels during pregnancy, the major metabolic processes that initiate 
changes in the regulation of thyroid hormone production and usage need to be 
acknowledged (Eastman 2012; Morreale de Escobar, Obregón, and del Rey 2007; 
Stagnaro-Green et al. 2011).  In particular, peak hCG levels late in the first trimester 
have a thyrotropic effect, causing an increase in maternal T4 and an initial decrease in 
maternal serum TSH (Gilbert et al. 2008; Morreale de Escobar, Obregón, and del Rey 
2007; Williams 2008).  This is followed by normalisation of levels in most pregnant 
women, as compensatory mechanisms to maintain a euthyroid state are triggered. 
Gilbert et al. (2008), Eastman (2012) and Stagnaro-Green et al. (2011) have proposed 
the use of trimester-specific TSH thresholds to diagnose sub-clinical hypothyroidism 
during pregnancy.  The PHCATA concludes that the maternal TSH reference range 
for pregnancy is lower than in non-pregnant women and (in the absence of laboratory 
trimester specific reference ranges) the upper limit for TSH in the first trimester is 2.5 
mIU/L and 3.0 mIU/L for second and third trimesters (Stagnaro-Green et al. 2011) 
(Table 2.4). 
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The secretion of T4 in neonates is highly sensitive to iodine deficiency in the maternal 
circulation (due to low iodine stores in the neonatal thyroid) and results in increased 
TSH secretion in the neonate (Li and Eastman 2010; WHO/UNICEF/ICCIDD 2007).   
Hence neonatal TSH levels are used as an indirect method for assessing maternal 
iodine status (as well as population iodine status) and directly to screen for congenital 
hypothyroidism (CH) in the neonate (Li and Eastman 2010; Skeaff 2012; 
WHO/UNICEF/ICCIDD 2007).  The WHO/UNICEF/ICCIDD (2007) criterion of an 
iodine sufficient population is one in which there is a < 3% frequency of neonatal TSH 
levels >5 mIU/L. 
The use of neonatal TSH as a population monitoring tool for iodine deficiency has 
been a topic of debate for many years.  Eastman (2012) stresses that the use of neonatal 
TSH for population iodine monitoring should only be used as an additional screening 
method.  There are still many variables affecting the accuracy of neonatal TSH levels 
for example, factors such as stress during labour can increase neonatal TSH levels, as 
can exposure to iodine containing antiseptics during pregnancy and labour (Gibson 
2005; WHO/UNICEF/ICCIDD 2007).  The timing of blood samples (samples taken 
before 72 hours are likely to result in higher values due to the immediate rise in TSH 
in the neonate following birth and up to 72 hours after birth) and the choice of assay 
method used to measure TSH can also affect these values (Li and Eastman 2010; 
WHO/UNICEF/ICCIDD 2007). 
Determination of maternal TSH concentration to assess maternal thyroid function is 
preferable and more logical than awaiting neonatal TSH levels.  This allows for earlier 
detection and correction of thyroid dysfunction, in addition, maternal measures are less 
susceptible to interference by extraneous factors.  However, it has been suggested that 
the use of maternal TSH levels to determine iodine status lacks sensitivity in those 
with mild-to-moderate iodine deficiency (Section 2.3.3) and is best used as an adjunct 
to other measurements of iodine status (e.g. UIC). 
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Table 2.4  Maternal TSH reference ranges (trimester-specific) 
(Stagnaro-Green et al. 2011). 
Trimester Reference range 
(mIU/L)* 
1 0.1-2.5 
2 0.2-3.0 
3 0.3-3.0 
* If laboratory trimester-specific reference ranges are not available 
2.4.4 Serum Tg 
Use of Tg as an indicator of iodine status during pregnancy is currently limited.  
Reference cut-offs are not available for use in pregnancy (Skeaff 2012) and 
determination of these ranges is complicated by studies reporting that increased Tg 
during pregnancy can be due to greater thyroid secretory activity during this life-stage, 
in general (Laurberg et al. 2007).  Ma and Skeaff (2014) suggested that further research 
using larger sample sizes including pregnant women of varying iodine status (adequate 
and inadequate) and studies measuring both Tg and UIC are required to investigate 
this indicator further.  
2.4.5 Free thyroxine (FT4) 
Free thyroxine (FT4) can be used to determine thyroid function in pregnant women 
(albeit as an adjunct to TSH concentration), however limitations do exist.  Earlier 
immunoassay methods were prone to interference as a result of increased TBG and 
decreased serum albumin during pregnancy (Azizi et al. 2013; Stagnaro-Green et al. 
2011).  Issues relating to  time, expense and availability of more advanced methods  
i.e. online solid phase extraction-liquid chromatography/tandem mass spectrometry 
(LC/MS/MS) (Stagnaro-Green et al. 2011), together with the absence of laboratory-
specific reference ranges and gestation-specific reference ranges, have limited the use 
of FT4 alone in determining thyroid function in pregnant women (Eastman 2012). 
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2.4.6  Free thyroxine index (FT4I) 
Improvements in the direct analysis of free thyroid hormones, together with the lack 
of widely accepted reference ranges for FT4I during pregnancy have limited the use 
and applicability of this measure in pregnant women.  Whilst Azizi et al. (2013) 
derived trimester-specific reference ranges for FT4I in a small Iranian study on 152 
healthy iodine sufficient pregnant women, the use of FT4I remains minimal and has 
not been used in any of the Australian or New Zealand studies. 
2.5 Iodine requirements 
Adult Nutrient Reference Values (NRV) for Australia and New Zealand released in 
2006 are stated in Table 2.5. 
The Recommended Dietary Intake (RDI) for iodine represents the daily dietary intake 
of iodine that is sufficient to meet the iodine needs of most (97-98%) healthy 
individuals in a certain gender and life stage group, however this value should not be 
used to assess intakes of groups (Food Standards Australia New Zealand 2008e; 
National Health and Medical Research Council and New Zealand Ministry of Health 
2006b).  The Estimated Average Requirement (EAR) for iodine is the daily level of 
iodine that meets the iodine requirements for half of the healthy individuals in a certain 
gender and life stage (National Health and Medical Research Council and New 
Zealand Ministry of Health 2006b) and it is applied to this research to estimate the 
prevalence of inadequate iodine intakes within the (study) population (Food Standards 
Australia New Zealand 2008e; National Health and Medical Research Council and 
New Zealand Ministry of Health 2006b).  The Upper Level of Intake (UL) is briefly 
referred to in this study and relates to the highest average level of iodine likely not to 
cause adverse health effects to most individuals (National Health and Medical 
Research Council and New Zealand Ministry of Health 2006b).  The potential for 
adverse effects increase as iodine levels increase above the UL and can be used to 
estimate the proportion of the population at risk of excessive iodine intake (National 
Health and Medical Research Council and New Zealand Ministry of Health 2006b). 
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Table 2.5  Iodine NRV for Adults 
(National Health and Medical Research Council and New Zealand Ministry of Health 2006b) 
 EAR  
(ug/day) 
RDI 
 (ug/day) 
UL 
(ug/day) 
Men  
19 - >70 y 
100 150 1100 
Women  
19 - > 70 y 
100 150 1100 
Pregnancy  
14-50 y 
160 220 1100 
Lactation  
14-50 y 
190 270 1100 
 
2.5.1 Adults 
Iodine balance studies have indicated that urinary iodide concentrations of 
approximately 100 ug/L reflect intakes that meet adult physiological needs thus 
providing the background necessary for establishing an Estimated Average 
Requirement (EAR) of 100 ug/day for adults.  A coefficient of variation of 20% was 
added to the EAR to determine the Recommended Dietary Intake (RDI) of 150 ug/day 
(National Health and Medical Research Council and New Zealand Ministry of Health 
2006b) (Table 2.5). 
2.5.2 Pregnancy 
The higher iodine requirements during pregnancy are reflected in the EAR (160 
ug/day) and RDI (220 ug/day) versus EAR (100 ug/day) and RDI (150 ug/day) for 
non-pregnant adults (Table 2.5).  Requirements have been based on iodine thyroid 
content of newborns and iodine balance studies.  A coefficient of variation of 20% was 
added to the EAR to determine the RDI for pregnant women (National Health and 
Medical Research Council and New Zealand Ministry of Health 2006b).  As discussed 
in 2.2.1, these elevated requirements reflect a greater demand for iodine during 
pregnancy due to an increase in maternal thyroid hormone production and an increase 
in GFR leading to increased iodine excretion (Glinoer 2007; Zimmermann 2009). 
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2.6 Iodine status in the Australian and New Zealand population 
Iodine deficiency was reported in the early 1900’s in Tasmania and regions of 
Queensland, NSW, ACT and Victoria (Section 2.1.2)  Various efforts were undertaken 
in some states to rectify the problem (Section 2.1.2) and in the early 1990’s Australia’s 
iodine status was deemed sufficient (Eastman 1993, cited in National Health and 
Medical Research Council 2009). During this time, surveillance and monitoring of the 
population’s iodine status by the Australian Centre for Control of Iodine Deficiency 
Disorders (ACCIDD) was irregular (Eastman 1999), and over the following years the 
results from smaller surveys and studies raised concern about the declining urinary 
iodine excretion (UIE) of the population (Eastman 1999; Li et al. 2006). 
This concerning trend led to the undertaking of a national iodine study of the mainland 
states of Australia.  The results of the NINS conducted in 2004 on 1709 SAC in five 
mainland states of Australia classified the general Australian population as mildly 
iodine deficient as evidenced by a national population weighted median urinary iodine 
concentration (MUIC) of 98 ug/L (Australian Population Health Development 
Principal Committee 2007; Li et al. 2008; Li et al. 2006). 
This confirmed the suggestion at the time that iodine deficiency had re-emerged in 
some parts of Australia.  Western Australia and Qld were the only two states reported 
to have an optimal population iodine status in this study (Australian Population Health 
Development Principal Committee 2007; Li et al. 2008; Li et al. 2006).  Tas, ACT and 
NT were not represented in this study, however, both Tas and ACT had historical 
evidence of inadequate iodine intake in their populations and were the first to 
implement the use of iodine containing bread improvers as a strategy to improve 
population iodine status (in 1966 and 1953, respectively), albeit unsuccessful in the 
initial attempt (Australian Population Health Development Principal Committee 
2007). 
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More recently, the 2011–12 NHMS has shown improvements in the overall iodine 
intake in the Australian adult population 18 months post mandatory fortification of 
bread and bread products with iodine.  Results reveal MUIC of 124.0 ug/L (with 
approximately 13% having MUIC less than 50 ug/L), indicating overall iodine 
sufficiency according to WHO criteria (Australian Bureau of Statistics 2013a; 
WHO/UNICEF/ICCIDD 2007).  As can be seen in Figure 2.6, WA adults still have 
the highest MUIC (157.4 ug/L), followed by the NT, whilst the MUIC of Tasmanian 
adults remains the lowest (108.0 ug/L). This level still indicates iodine sufficiency for 
the general adult population (Australian Bureau of Statistics 2013a; 
WHO/UNICEF/ICCIDD 2007). 
 
Figure 2.6  MUIC of persons aged 18 years and over by state and territory 
(Australian Bureau of Statistics 2013a). 
 A review of the studies conducted on pregnant women in areas of Australia and NZ 
is discussed further in Section 2.9. To date, no studies have been conducted to assess 
MUIC in pregnant women in WA (or Qld) where the iodine status of SAC in 2004 and 
adults in 2012-2013 was considered adequate. 
It has been suggested that MUIC of pregnant women in these states is likely to be 
equivalent to, if not lower, than the MUIC of school age children (Australian 
Population Health Development Principal Committee 2007; Mackerras and Eastman 
2012), therefore reflecting insufficient iodine intake based on 2004 data. 
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MUIC results from the NHMS were obtained for Australian women of childbearing 
years (16-44 years). These women had MUIC of 121.0 ug/L and whilst this reflects 
sufficient iodine intake in non-pregnant adults, this level is considered insufficient for 
pregnant women.  Furthermore, around 18.3% had MUIC less than 50 ug/L, lower 
than the national average and approximately 62% had MUIC less than 150 ug/L, levels 
that would raise some concern for pregnant women according to 
WHO/UNICEF/ICCIDD (2007) criteria (Australian Bureau of Statistics 2013a, 
2013b). 
Whilst the latest NHMS data looks promising with regards to overall improvement in 
iodine status following mandatory iodine fortification of bread and bread products in 
the Australian population, the study did not focus on pregnant women. The overall 
opinion is that mandatory fortification alone is not enough to ensure adequate iodine 
intake in pregnant women (Australian Bureau of Statistics 2013a; Mackerras et al. 
2011), but whether this applies to all states and territories is yet to be fully explored. 
It has been well-documented that NZ soils are low in iodine, with reports of endemic 
goitre dating back to the late 1800s (Thomson 2004).  Many strategies to improve 
iodine status have been implemented over the years commencing with the iodisation 
of table and cooking salt in 1924 (Food Standards Australia New Zealand 2008d), 
followed by an increase in iodine concentration in cooking salt in 1938 that assisted 
with improving the population iodine status between 1960-1980 (adequate or more 
than adequate iodine status) (Australian Population Health Development Principal 
Committee 2007). However, studies in the late 1980s and early 1990s indicated that 
iodine deficiency in the NZ population had re-emerged (Australian Population Health 
Development Principal Committee 2007). 
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Various initiatives have been put in place since then including the mandatory iodine 
fortification of bread and bread products in 2009 and a government subsidised iodine 
supplementation program for all pregnant and breastfeeding women in 2010 (Brough 
et al. 2015).  Authors of studies conducted after the mandatory iodine fortification of 
bread and bread products agree that improvements in UIC have occurred, however a 
level of concern remains regarding suboptimal iodine status of SAC (Skeaff and 
Lonsdale-Cooper 2013) and pregnant and breastfeeding women (Brough et al. 2015; 
Mallard and Houghton 2014).  This has highlighted the need for further research in  
subgroups within the NZ population. 
2.7 Estimation of dietary iodine consumption 
Dietary assessment tools such as dietary records, 24-hour dietary recalls, weighed food 
records, and food frequency questionnaires (FFQ) are used in the field of nutrition as 
a means of estimating dietary intake (short-term to longer-term), as well as dietary 
habits and trends. National nutrition surveys and smaller scale studies often utilise 
FFQ, whereas 24-hour dietary recalls, dietary records, weighed food records, and FFQ 
can be used on an individual basis or for group level analysis (Thompson and Subar 
2013). 
Most of the iodine specific studies that have been conducted in pregnant women in 
Australia have used either 24-hour recalls or FFQ.  These methods are easy to 
administer, of low participant burden and provide information on dietary habits and 
significant food sources of iodine (Biro 2002; Willett 2013).  However, researchers 
rely on the accurate recall of foods consumed by the participants, as well as the correct 
interpretation of quantities, frequency of consumption and motivation of the 
participants to complete the FFQ (Babor 1987).  Furthermore, it is not possible to 
collect information on all aspects of a person’s diet such as all food eaten, contents of 
combination dishes and all cooking methods used (Thompson and Byers 1994).  
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It should be noted that dietary assessment methods such as 24-hour dietary recalls, 
dietary records or food frequency questionnaires  are in general are subject to self-
report bias (if self-administered), including social desirability bias (the subject’s desire 
for approval) (Babor 1987; Subar et al. 2015) thus leading to over or underestimation 
of the key nutrient/s of interest.  In addition to this, length of questionnaire may 
influence over or underestimation. Krebs-Smith et al. (1995) found that a high number 
of questions (related to fruit and vegetable consumption) had a tendency to 
overestimate intakes compared to a summary question.  Some authors suggest FFQs 
overestimate iodine intake (Rasmussen et al. 2001), while others question 
underestimation in their FFQs due to the omission of iodine-rich food sources such as 
iodised salt (Condo et al. 2015).  The act of quantifying the weight of iodised salt itself 
is problematic (often in grams or less), relies on individual accuracy in reporting 
minimal amounts such as “sprinkle”, “shake” or “pinch” (Skeaff 2012) and allowances 
need to be made for cooking losses. 
In addition to this, the calculation of iodine intake is dependent on food composition 
databases, some of which are incomplete (Charrondiere et al. 2011; Skeaff 2012).  An 
element of uncertainty remains for specified values in food composition databases as 
to whether multiple sampling has captured seasonal, soil and natural variability, as 
well as variances in agricultural processes, cleaning procedures and storage (if direct 
methods are used) or whether values have been assigned using indirect methods (from 
literature or imputed data) and the accuracy of this data (Charrondiere et al. 2011). 
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It is recommended that FFQ should be validated against methods such as; duplicate 
portions, biological markers such as UIC and/or thyroid hormones (TSH, T4) or 
dietary records (Skeaff 2012). Each of these methods, however, contributes its 
associated limitations to the estimation.  Tan et al. (2013) validated their short iodine-
specific FFQ using a combination of the two above methods in a sample of older 
Australians living in NSW and results indicated a moderate correlation (r=0.377) 
between the FFQ and three 24-hour dietary recalls.  A significant correlation 
(Spearman’s correlation, r=0.265) was reported between UIC/creatinine ratio and 
estimated iodine intake measured by the FFQ (Tan et al. 2013).  Condo et al. (2015) 
compared an iodine-specific FFQ with 4 day weighed food records of pregnant women 
in SA and assessed the correlation between iodine intake (FFQ) and urinary iodine as 
well as thyroid hormones.  The authors reported a moderate correlation (r=0.349) 
between the iodine-specific FFQ and 4-day weighed food records, this increased when 
iodine-containing supplements were accounted for (r=0.876).  The FFQ was associated 
with 24-hour UIE and 24-hour UIC however no association was found between the 
FFQ and thyroid hormones.  Australian studies which have investigated the use of a 
FFQ to assess intake of this nutrient are generally positive. 
Limitations aside, validated FFQs are considered useful for their ability to categorise 
or rank individuals into levels of intake (Block 1982; Erkkola et al. 2001; Thompson 
and Subar 2013) and for highlighting those who fall within the extremes (Erkkola et 
al. 2001).  They are relatively inexpensive and practical research tools for estimating 
and ranking dietary iodine intake, especially when alternative indices are not available 
(e.g. biochemical, clinical or anthropometric data) (Skeaff 2012).  Additionally, FFQ 
provide essential information relating to complex dietary patterns and behaviours, 
important information that biomarkers alone do not provide (Subar et al. 2015). 
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2.8 Iodine intake in the Australian and New Zealand population 
As mentioned in Section 2.1.3, the richest food sources of iodine are animals and plants 
of marine origin (e.g. fish, shellfish and marine plants such as seaweed) (Gibson 2005).  
Iodine content of other plant and animal food sources varies markedly and is dependent 
on the local iodine content of soil and water, geographical location, agricultural and 
farming practices and seasonality (Gibson 2005; Laurberg et al. 2007).   Other sources 
of dietary iodine, albeit in lesser quantities are; milk and dairy products, bread and 
bread products that have been fortified with iodine, eggs and iodised salt (Gibson 
2005) and tap water (Food Standards Australia New Zealand 2008a). 
Whether a food product is an important source of iodine depends not only on the 
concentration of iodine in that food, but the frequency of consumption of that food 
product.   In order to present an overall picture of iodine intake in Australia and NZ 
over the last two decades, information from two large Australian surveys, together 
with one NZ survey, will be summarised here and briefly compared to relevant iodine 
intake findings of pregnancy-specific iodine studies conducted in these two countries. 
Results from 13,858 participants (2 years of age and over) in the 1995 NNS revealed 
that dairy products contributed significantly to overall iodine intake in Australia with 
eggs, tap water and iodised salt noted as important contributors.  Seafood consumption 
in these participants was low and did not make a significant contribution to iodine 
intake (Food Standards Australia New Zealand 2008a). 
Although a large study, the present day applications of the results from the 1995 NNS 
are somewhat limited.  The sample size of pregnant women (and in this case the 
population of interest), was relatively small (Mackerras et al. 2011). At the time of the 
survey, fortification of bread and bread products with iodine had not been mandated 
and this accounted for bread and bread products not being identified as major 
contributors to overall iodine intake (Food Standards Australia New Zealand 2008a).  
Further to this, Food Standards Australia and New Zealand (FSANZ) cautioned that 
the data obtained for discretionary iodised salt use were likely to be an underestimation 
due to incomplete participant responses (Food Standards Australia New Zealand 
2008a). 
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More recently data from the 2003 cohort of the ALSWH study have provided 
information on dietary iodine intakes of women in Australia, in particular pregnant 
women.  Iodine intake data were obtained via a FFQ developed by The Cancer Council 
of Victoria and contained key iodine-containing foods (Mackerras et al. 2011).  Results 
from 665 pregnant women confirmed that milk and dairy products were major 
contributors to dietary iodine intake in this group, together with bread and bread 
products (adjusted for iodine fortification).  The findings of low seafood consumption 
in the 1995 NNS are reinforced in this study with fish consumption contributing 
minimally to overall iodine intake (Mackerras et al. 2011).   
Findings from the 2009 New Zealand Total Diet Survey (NZTDS) (Vannoort and 
Thomson 2011) suggested that dairy products were significant contributors to dietary 
iodine intake in 25+ year females (encompassing women of childbearing age).  This 
survey was based on simulated diets and did not assess iodised salt use. 
Australian and NZ studies on iodine nutrition and status of pregnant women confirm 
the above findings, namely that milk and dairy products together with bread and bread 
products containing iodised salt are significant contributors to overall iodine intake 
(Charlton et al. 2013; Lucas et al. 2014; Martin, Savige, and Mitchell 2014; Rahman 
et al. 2011), whilst fish and other seafood are consumed infrequently (Charlton et al. 
2013; Lucas et al. 2014; Martin, Savige, and Mitchell 2014; Nguyen et al. 2010; 
Pettigrew-Porter et al. 2011; Rahman et al. 2011). 
A total of 20 studies to measure iodine status and, or intake have been conducted on 
pregnant women in Australia and NZ since 1980 (Table 2.6).  A study conducted by 
Nithiananthan, Carroll, and Krebs (2013) included pregnant women but their results 
cannot be distinguished from non-pregnant women so has been excluded.  One other 
study was excluded due to a small sample size, that conducted by Thomson et al (2001) 
in NZ.  Urinary iodine excretion was measured for a small number of the pregnant 
women supplemented with selenium (n=18) and those not supplemented (n=17). 
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Table 2.6  Studies related to iodine status and, or intakes of pregnant women in Australia and New Zealand (1980 to present) 
Author (Publication Date) 
Date of study 
State or 
Territory 
Sample 
Size (n) 
Gestation 
stage (wk) 
MUIC 
(ug/L) 
K/B/A Diet I  
(ug) 
Supp I 
(% use) 
Salt I TV TSH 
(mIU/L) 
Other 
Gunton et al. (1999) (Public) 
1998-1999 
(overlap with McElduff et al. 2002) 
NSW 
 
81  Approx. 30  104 
 
     Maternal I/Cr ratio 
FT4 
McElduff et al. (2002) (Public) 
1998-1999 
1998-1999 
2000 
NSW 84  (total) 
(1316 Neo) 
(1457 Neo) 
Approx. 30 
 
 
 
     Neo  
Li et al. (2001) (Public) 
1998-1999 
NSW 101 Full term 88 
 
       
Hamrosi et al. (2005) (Public) 
1998-2001 
Vic 802 (total) 
277 (Cauc) 
263 (Viet) 
262 (In/SL) 
  14-20 
 
 
52 
58 
61 
       
Stilwell et al. (2008) (Public) 
1999-2001 
Tas 686 (total) 
18 
178 
171 
54 
48 
63 
134 
20 
19.4 
8.7 
12.6 
17.9 
22.2 
27.8 
32.6 
36.8 
40.7 
75 
124 
94 
74 
55 
62 
76 
76 
69 
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Author (Publication Date) 
Date of study 
State or 
Territory 
Sample 
Size (n) 
Gestation 
stage (wk) 
MUIC 
(ug/L) 
K/B/A Diet I  
(ug) 
Supp I 
(% use) 
Salt I TV TSH 
(mIU/L) 
Other 
Travers et al. (2006) (Public & Private) 
2004 
NSW 815 (total) 
691(public) 
124 (private) 
 ≥ 28  85 
82 
101 
     Neo  
Burgess et al. (2007) (Public) 
2000-2001 pre iodine fort. (RHH) 
2003-2006 post iodine fort*. (PHC) 
2006-2006 post iodine fort*. (RHH) 
Tas 802 (total) 
285 
288 
229 
All 1st  
trimester 
 
109 
76 
81 
86 
       
Mackerras et al. (2011) (Public) 
2005-2008 
NT 24 Not reported 49 
 
       
Pettigrew-Porter et al. (2011) (Various) 
2005 
NZ 170 All 
 
38  48  23   Maternal FT4 
Blumenthal et al. (2012) (Private) 
2007-2009 
NSW 367 7-11 
 
81  132 
Extrapolated 
32.5   Maternal FT4 
Charlton et al. (2010) (Public) 
2008 
NSW 139 
 
All 87.5 
 
  20     
Nguyen et al. (2010) (Public) 
Feb – May 2009 
ACT 100 Not reported 62   34    I/Cr ratio 
 
Rahman et al. (2011) (Public & Private) 
2009 pre iodine fort. 
2009/2010 post iodine fort.  
Vic 86 (total) 
24 
62 
 ≥ 28  96 
96 
95.5 
  51 
54 
50 
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Author (Publication Date) 
Date of study 
State or 
Territory 
Sample 
Size (n) 
Gestation 
stage (wk) 
MUIC 
(ug/L) 
K/B/A Diet I  
(ug) 
Supp I 
(% use) 
Salt I TV TSH 
(mIU/L) 
Other 
Clifton et al. (2013) (Public) 
Jan 2009  and  July 2010 
 
 
 
SA 196 
 
 
12 
18 
30 
36 
82 
73 
68 
84 
118 
  47     
Brough et al. (2015) (Various) 
July 2009 pre iodine fort. 
Jan-Sept 2011 post iodine fort 
NZ 57 (total) 
25 
32 
 > 26  
47 
85 
  
119 
217 
Extrapolated 
70    Br milk 
Tg 
TgAB 
Charlton et al. (2013) (Public) 
2011 
2012 
NSW  
147 
114 
 All  
145.5 
166 
  
176 
160  
 
60 
66 
    
Mallard & Houghton (2014) (Public 
& Private) 
2011 
NZ 723  All**    
 
107  
  (Prior preg) 
179  
     (Preg) 
Baseline 
assignment 
 
 
16 
 
22-39 
 
    
Martin et al. (2014) (Public & Private) 
2011-2012 
Vic 200  ≥ 28    62 
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Author (Publication Date) 
Date of study 
State or 
Territory 
Sample 
Size (n) 
Gestation 
stage (wk) 
MUIC 
(ug/L) 
K/B/A Diet I  
(ug) 
Supp I 
(% use) 
Salt I TV TSH 
(mIU/L) 
Other 
Condo et al. (2015) (Public) 
2011-2012 
SA  96  < 20 178-212 
 
 144 (FFQ) 
160 (4d WR) 
75   Maternal Tg 
FT3 
FT4 
El-Mani et al. (2014) (Various) 
2012-2013 
NSW 152  All    67.7     
Lucas et al. (2014) (Public & Private) 
2012 and 2013 
NSW 142  All   189 70     
 
MUIC = Median urinary iodine concentration TV = Thyroid volume Salt I = Iodised salt use 
K/B/A = Knowledge/Beliefs/Attitudes Br milk = Breast milk iodine content RHH = Royal Hobart Hospital 
Diet I = Dietary Iodine Supp I = Iodine containing supplement use PHC = Primary health care centre 
Salt I = Iodised salt use Fort = Fortification (mandatory) In/SL = Indian/Sri Lankan 
Cauc = Caucasian Viet = Vietnamese 4d WR = 4 day weighed record 
Neo = Neonatal Preg=Pregnancy/pregnant Various = recruitment from a variety of settings 
Public = recruitment from a public 
hospital/antenatal setting 
Private = recruitment from a public 
hospital/antenatal setting  
 
* Fort = Fortification (voluntary) **Women surveyed postpartum  
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2.9 Iodine status of pregnant women in Australia and New Zealand 
2.9.1 Urinary iodine concentration (UIC) 
Iodine deficiency (MUIC <150 ug/L) set by WHO/UNICEF/ICCIDD (2007) was 
reported in 14 out of the 16 studies which included MUIC measurements.  The range 
in MUIC across these studies was 38-212 ug/L. 
Studies conducted pre-fortification of bread and bread products 
The iodine content of soils across Australia and NZ is variable and therefore the 
following results have been divided into states of Australia and NZ.  These arbitrary 
boundaries also assist with reporting iodine status in different regions. 
New South Wales 
The earliest studies were conducted in 1998-1999 (Gunton et al. 1999; Li et al. 2001) 
in women at full-term from Westmead Hospital antenatal clinic and in those at 30 
weeks from Royal North Shore Hospital, respectively (Table 2.6).  The MUIC of both 
of these groups indicated iodine deficiency in the sample population (88 ug/L and 81 
ug/L, respectively).  Iodine deficiency was also reported in third trimester women in 
one of the largest iodine studies conducted on pregnant women in Australia and NZ 
prior to the mandatory iodine fortification of bread and bread products in 2004 
(Travers et al. 2006) (MUIC=85 ug/L), as well as in a sample of first trimester women 
attending a private antenatal clinic in North Western Sydney in 2007-2009 
(Blumenthal, Byth, and Eastman 2012) (MUIC=81 ug/L).  Charlton et al. (2010) also 
reported iodine deficiency in participants attending a public antenatal clinic in the 
Illawarra region of NSW in 2008 (MUIC=87.5 ug/L) (Table 2.6). 
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These MUIC values covered a wide range of gestational ages and were remarkably 
similar. Women from non-English speaking backgrounds (NESB) were excluded from 
the Charlton et al. (2010) study and no other information was provided on ethnicity. 
The study conducted by Blumenthal, Byth, and Eastman (2012) comprised of women 
mainly with Australian backgrounds (79.3%), whilst it is likely that the majority of 
participants in Travers et al. (2006) were English speaking due to the information 
provided on those using the services where the study was conducted. No information 
was provided on ethnicity in the earliest studies NSW studies (Gunton et al. 1999; Li 
et al. 2001). 
Victoria 
Hamrosi, Wallace, and Riley (2005) focused on iodine status (UIC) in three ethnic 
subgroups rather than a random sample of pregnant women.  Eight hundred and two 
pregnant women (14-20 weeks gestation) in Melbourne were recruited during 1998-
2002 (Table 2.6).  The MUIC values were significantly lower than those of the Sydney 
studies. MUIC of 227 Caucasian women was significantly lower (52 ug/L) and 48.4% 
had UIC < 50 ug/L than women from Vietnamese (n = 263; 58 ug/L and 38.4 % < 50 
ug/L) and Indian/ Sri Lankan (n = 262; 61 ug/L and 40.8 % < 50 ug/L) backgrounds.  
It should be noted that the authors of this study found that samples stored for a greater 
length of time (greater than 3 years) had lower UIC than samples stored for less time. 
Inadequate storage of older samples, potential dietary changes over time leading to 
lower iodine intakes (hence lower UIC) in women whose samples were taken earlier 
in the study (and stored for longer), adsorption of iodine into the storage tube material 
or other unexplained loss of iodine over time were potential factors identified by the 
authors.  This was the first study conducted in Australia to highlight that ethnic 
subgroups appeared to have different iodine status than pregnant women with 
Caucasian backgrounds. 
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Tasmania 
The Stilwell et al. (2008) study conducted in 1999-2001 involved 686 women of all 
gestational stages.  The authors stated that the sample was representative of the general 
population using the public health system in terms of socioeconomic status, education 
and ethnicity, however the ethnicity of the pregnant women in the study was not 
reported.  Participants were found to be iodine deficient (MUIC=75 ug/L), as were 
those in a smaller pre-fortification study conducted by Burgess et al. (2007) in 2000-
2001 (MUIC=76 ug/L) (Table 2.6).  Thus the Tasmanian MUIC data were part-way 
between the NSW and Vic data. 
Australian Capital Territory 
Nguyen et al. (2010) investigated a sample of 100 pregnant women across all 
gestational stages attending the antenatal clinic at Canberra Hospital (MUIC=62 ug/L) 
(Table 2.6).  This is the only study to date that has been conducted in ACT, and resulted 
in a MUIC considerably lower than the data from Sydney or even Tasmania. The 
ethnicity of the participants was not reported in this study. 
Northern Territory 
Studies conducted on pregnant women in the NT are limited, however one study 
conducted by Mackerras, Singh, and Eastman (2011) involved a small sample (n=24) 
of Indigenous teenagers in the Darwin Health Region.  The MUIC in this study was 
the second lowest out of all the studies reviewed (49 ug/L) (Table 2.6).  Whilst the 
sample size was small, it highlighted the need for further research into the iodine status 
of both Indigenous pregnant women and adolescents in general. 
It is worth noting that geographical differences between states/territories (e.g. coastal 
versus inland) within Australia are likely to have had an impact on local soil content 
of iodine and therefore the iodine content of the local food supply. In addition, 
differences in ethnic backgrounds and thus food habits of the populations may have 
contributed to the variations in MUIC values observed. 
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New Zealand 
Pettigrew-Porter et al. (2011) reported the lowest MUIC out of all of the studies (38 
ug/L). Their study included 170 pregnant women, predominantly of New Zealand 
European and Other backgrounds, across all gestational stages residing in the North 
and South Island (Table 2.6).  This was the only study to use a proportionate to 
population sampling method. The difference in geographical location with NZ 
traditionally having a lower iodine content of soil (Thomson et al. 2001) and therefore 
less iodine in the local food supply (Brough et al. 2015) was likely to have been a 
major contributing factor to the low MUIC reported in this study. 
In the states and territories involved (NSW, Vic, Tas, ACT, NT) and in NZ, the overall 
finding was that the pregnant subjects were iodine deficient based on MUIC (prior to 
the mandatory fortification of bread and bread products with iodine).  Hamrosi, 
Wallace, and Riley (2005) (Vic), Stilwell et al. (2008) (Tas), Burgess et al. (2007) 
(Tas), Nguyen et al. (2010) (ACT), Mackerras, Singh, and Eastman (2011) (NT) and 
Pettigrew-Porter et al. (2011) (NZ) all reported MUIC at less than half of the 
WHO/UNICEF/ICCIDD (2007) cut-off point for sufficiency in pregnant women  
(> 150 ug/L). 
Studies conducted post-fortification of bread and bread products 
Six studies in four Australian states and in NZ have investigated UIC since the 
fortification of bread and bread products.  Two of the five studies that had pre-and 
post-fortification comparison groups reported that differences in MUIC in pregnant 
women pre- and post-iodine fortification were not significantly different (Burgess et 
al. 2007) (Tas) and (Rahman et al. 2011) (Vic), whilst (Brough et al. 2015) (NZ), 
(Charlton et al. 2013) (NSW) and (Clifton et al. 2013) (SA) reported some significant 
differences in iodine status between pre- and post-fortification groups. 
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Tasmania 
Tasmania stood alone with regards to the early initiation of iodine fortification of bread 
and bread products.  The Tasmanian government addressed iodine deficiency in the 
state’s population by adopting a voluntary iodine fortification program in October 
2001 whilst awaiting fortification on a national scale (implemented in October 2009).  
Burgess et al. (2007) recruited 517 Tasmanian pregnant women across two settings in 
2003-2006 to compare with the MUIC data from the 2000-2001 sample. The 
participants who attended the Royal Hobart Hospital (RHH) antenatal clinic were of 
all gestational stages (as were 2000-2001 subjects); details on ethnicity were not 
provided. The increase in post-fortification MUIC was not significant (76 ug/L vs. 86 
ug/L, p=0.237). The second subgroup (n=288) was recruited on the first trimester visit 
to a primary health care centre (PHC) in 2006. Again the MUIC was not significantly 
different (76 ug/L vs. 81 ug/L, p=0.809), indicating iodine insufficiency. 
Supplement use and iodised salt use were not reported in the above study, however, it 
is unlikely that the majority of pregnancy multivitamin supplements contained iodine 
at the time.  In addition, the contribution of iodine obtained from iodised salt was likely 
to have been low around this time, with Li et al. (2007) reporting that only 11% of 
Australian households purchased iodised salt (based on SALT Market Overview 
Homescan Data to July 2003). AZTEC data capturing iodised salt purchases between 
2003-2006 indicated a 29% increase in iodised salt purchased by Australian 
households, potentially influenced by media coverage at the time (Li et al. 2007).  
Overall iodised salt use, however, was still likely to be low in 2006 (post-fortification 
subgroup), with less than 50% of Australian households purchasing iodised salt. 
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Victoria 
The second study to report no significant difference in MUIC pre- and post-
fortification of bread and bread products was a cross-sectional study conducted from 
January 2009 to February 2010 in regional Vic (Rahman et al. 2011) (Table 2.6).  All 
women (at or over 28 weeks gestation) attending major antenatal clinics in all six local 
government areas in Gippsland were invited to participate in the study.  The majority 
of women were of Caucasian backgrounds (93.5%) (Rahman et al. 2011).  The MUIC 
of the participants pre-fortification was similar to the MUIC post-fortification (96.0 
ug/L vs. 95.5 ug/L), indicating iodine insufficiency.  Approximately half of the 
participants were consuming iodine containing supplements post-fortification 
although it should be noted that the sample sizes both pre- and post-fortification were 
relatively small (n=24 and n=62, respectively) and response rate was low (29%). 
New South Wales 
In contrast, the Illawarra (NSW) post-fortification study conducted by Charlton et al. 
(2013) was the only study (with a pre-and post-fortification comparison group) to 
report MUIC > 150 ug/L (MUIC=166 ug/L in the overall sample in 2012) (Table 2.6).  
MUIC indicated sufficiency in 2011 and 2012 in the women using iodine-containing 
supplements, whilst MUIC remained insufficient in post-fortification years in those 
not taking iodine containing supplements (2011:178 ug/L; 2012:202 µg/L versus 2011: 
109 ug/L; 2012: 124 µg/L p<0.05), respectively.  It should be noted that the (pre-
fortification) iodine status of women in studies conducted in NSW was not as low as 
women in other states, territories and in NZ. This, together with higher reported iodine-
containing supplement use (60-66%) than half of the studies that reported this data 
likely explains why a subset of these participants achieved iodine sufficiency (post-
fortification). 
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The post-fortification study above was conducted more than 4 years after the 
Tasmanian post-fortification study (Burgess et al. 2007) and during a period of 
mandatory iodine fortification (versus voluntary fortification, as was the case in the 
Tasmanian study).  Furthermore, time differences in the pre- and post-fortification 
findings between the Illawarra study and earlier studies will have impacted the results.  
Additional contributing factors over this time period include; a) the 2010 release of 
NHMRC recommendations stating that women who are pregnant, considering 
pregnancy or breastfeeding take an iodine supplement of 150 ug daily (National Health 
and Medical Research Council 2010) and b) reformulation of some pregnancy 
multivitamin preparations to include or increase iodine content.  The possible flow-on 
effect of these factors needs to be considered when comparing more recent studies with 
studies conducted prior to 2010. 
Although a smaller study, the factors mentioned above will have had an impact on the 
findings of the 2009-2010 Victorian study (Rahman et al. 2011) with 60% (2011) and 
66% (2012) of participants in the Illawarra study (Charlton et al. 2013) having 
consumed iodine containing supplements compared to 51% in the earlier Gippsland 
study (Rahman et al. 2011). 
South Australia 
For the first time, the Adelaide study by Clifton et al. (2013) revealed a significant 
increase in the MUIC in participants not using iodine supplements pre- (n=84) and 
post-fortification (n=94) (68 ug/L vs. 84 ug/L, p=0.01), suggesting that bread 
fortification had a positive impact on iodine status in these pregnant women.  
Participants in this study however, remained iodine deficient with an overall 
MUIC=82 ug/L (Table 2.6). 
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Results from a second Adelaide study by Condo et al. (2015) (n=96) (post-fortification 
only) reported MUIC ranging from 178-212 ug/L indicating iodine sufficiency in 
pregnant women attending antenatal clinics in 2011-2012.  The MUIC was the highest 
out of all of the studies and more than double the concentration of the previous 
Adelaide study.  This difference, again, was likely to be due to the positive influence 
of bread fortification, however, this trend also coincided with the highest reported 
iodine containing supplement use (75%) amongst all studies. It is worth noting that 
sampling bias was likely in this population as women in the study were participants in 
another study regarding iodine and pregnancy. 
New Zealand 
Findings from the Palmerston North area of NZ (Brough et al. 2015) confirm a 
significant increase in the MUIC of pregnant women from pre- (n=25) to post-
fortification (n=32)             (47 ug/L vs.52 ug/L, p <0.001), with 70% taking iodine 
supplements in 2011 (post-fortification).  Despite this high prevalence of iodine 
supplement use, the overall study population remained iodine deficient post-
fortification whereas the MUIC of pregnant women in the 2011 and 2012 subset in the 
Illawarra study (Charlton et al. 2013) with slightly lower percentages (60-66% iodine 
supplement use, respectively) indicated borderline sufficiency and sufficiency 
(MUIC=145.5 ug/L in 2011 and 166 ug/L in 2012) (Table 2.6).  The pre-fortification 
iodine status of the Illawarra study population was not as low as that of the NZ 
participants and, as mentioned previously, is likely to be a contributing factor to this 
difference. 
The small sample size of the NZ study (n=59), with subjects mostly of a Caucasian 
background, needs to be acknowledged, as well as the impact that differences in 
geographical location are likely to have on iodine status between participants in the 
Illawarra region of NSW and Palmerston North in NZ.  Not only are there distinct 
differences in the iodine content of soil and the local food supply but government 
initiatives in NZ differ to those in Australia (Section 2.7).  In addition, the health care 
system (including antenatal and postnatal care), population demographics, iodine 
content of iodine supplements, as well as prior knowledge of the general public on 
iodine nutrition topics are not similar. 
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Four out of five studies that had pre-and post-fortification comparison groups raise 
concern of ongoing inadequate iodine status for pregnant women in Tas, Vic, SA and 
NZ despite the implementation of iodine fortification strategies. The findings reinforce 
the importance of the NHMRC recommendations for pregnant women to take an 
iodine-containing supplement of 150 ug daily in the states, territories and countries 
where MUIC reflected inadequate iodine status. 
Two of the more recent Australian studies (Charlton et al. 2013) (Illawarra) and 
(Clifton et al. 2013) (Adelaide) reveal a different trend to the majority of studies with 
iodine sufficiency reported in study subsets using iodine-containing supplements.  The 
findings from the Illawarra study indicated borderline sufficiency in those taking 
iodine-containing supplements in 2011 and in 2012 (Table 2.6).  Clifton et al. (2013) 
reported that a significant number of women taking iodine-containing supplements at 
two time points in the 3rd trimester (30 and 36 weeks) had UIC >150 ug/L when 
compared to those who were not taking iodine supplements (p=0.022 and p=0.038, 
respectively) at any gestational stage.  In contrast, Condo et al. (2015) (Adelaide) 
reported MUIC indicating iodine sufficiency (178 (24 h UIC)-212 (spot MUIC) ug/L) 
with no significant difference in spot MUIC reported between iodine-containing 
supplement users or non-users. 
The above findings differ to those of the smaller NZ and Gippsland studies (Brough et 
al. 2015; Rahman et al. 2011). The reason for this difference is multifactorial and can 
be explained, in part, by the higher baseline MUIC reported in subgroups within the 
Illawarra (Charlton et al. 2013) and Adelaide (Clifton et al. 2013) studies.  Further 
explanations can be found, as indicated below. 
Some clarification of the role of iodine supplementation in closing the gap between 
iodine deficiency and iodine sufficiency in pregnant women has been provided.  In the 
studies that did not find significant changes in iodine status after the introduction of 
mandatory fortification of bread and bread products, iodine supplementation ranged 
from 50-70% (Table 2.6).  Iodine status, post-fortification, was similar in the 
Gippsland study (Rahman et al. 2011) and improved in Palmerston North subjects 
(Brough et al. 2015), however, as mentioned previously, sample sizes in both studies 
were small. 
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One of the limitations of most of the studies in Table 2.6 was that they were cross-
sectional and conducted on pregnant women during various stages of pregnancy.  This 
is problematic from a comparison point of view due to variances in MUIC at different 
stages (Section 2.4.1).  Two longitudinal studies have been conducted (Clifton et al. 
2013; Stilwell et al. 2008) with Stilwell et al. (2008) reporting that GFR and iodine 
excretion in Hobart participants was higher in early gestation (prior to 22 weeks).  This 
raised questions as to whether the current criterion for assessing UIC overestimated 
the adequacy of iodine nutrition, particularly before 22 weeks of gestation (Stilwell et 
al. 2008). It should be noted that information regarding iodine supplement use was not 
reported in this study, although use of iodine supplements was unlikely to be high in 
this era. 
Clifton et al. (2013) (Adelaide) reported a significant increase in UIC with advancing 
gestation in the total sample despite an overall decrease in the number of women using 
iodine supplements as gestation progressed beyond 30 weeks (Table 2.6).  This lack 
of adherence to iodine supplementation as pregnancy progressed, as well as the lack 
of consistency with the use of iodine supplementation at reported time points, limits 
the interpretation of the value of iodine supplementation. These factors are likely to 
have had an impact on all studies that investigated iodine supplement use. 
The lack of clarity regarding changes in UIC with advancing pregnancy is a gap in the 
literature and highlights the need for further research to determine and standardise 
gestation-specific UIC reference intervals.  Furthermore, sample size, socioeconomic 
and cultural differences of participants, study methodologies, prior iodine knowledge 
of participants, sampling bias and varied settings place limitations on comparisons 
between states/territories and between Australia and NZ.  As mentioned previously, 
variance in local iodine content of soil and produce, government initiatives, health care 
and iodine content in popular pregnancy multivitamin preparations are additional 
factors that confound comparisons between these two countries. 
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2.9.2 Goitre and thyroid volume as indicators of iodine status 
Studies conducted pre-fortification of bread and bread products 
Only one study (Pettigrew-Porter et al. 2011) (Table 2.6) reported TV (measured by 
ultrasonography) in pregnant participants (n=170) in both the North and South Island 
of NZ.   The majority were classified as iodine deficient based on MUIC (38 ug/L) but 
only 7% of the participants were classified as having goitre (TV>18 ml).  It is 
important to mention that most participants had normal TSH and FT4 levels with only 
2.6% classified as hypothyroidic based on maternal TSH and 15% with FT4 < 10.3 
pmol/L. The limitations of using TV/goitre rates are described in Section 2.4.2, and 
apply when interpreting the results of this study. The sequelae of goitre formation only 
partially concur with the overall pattern shown in this study and therefore earlier 
detection of iodine deficiency using UIC in combination with TSH and FT4 to make a 
subclinical diagnosis is preferable given the limitations of using TV/goitre rates. 
Given that 5 years have passed since the implementation of mandatory fortification, it 
would be appropriate to conduct a study to reassess all of these indicators in a similar 
population. 
2.9.3   Serum TSH 
As mentioned in Section 2.4.3, an iodine sufficient population is one in which there is  
<3% frequency of neonatal TSH levels >5 mIU/L (WHO/UNICEF/ICCIDD 2007). 
More recent research has led to the proposal of trimester-specific maternal TSH 
thresholds to diagnose subclinical hypothyroidism during pregnancy (Eastman 2012; 
Gilbert et al. 2008; Stagnaro-Green et al. 2011).  In the absence of laboratory trimester-
specific TSH thresholds, the recommendation for the upper limit for maternal TSH in 
the first trimester is 2.5 mIU/L, and 3.0 mIU/L for second and third trimesters 
(Stagnaro-Green et al. 2011) (Table 2.4). 
Studies conducted pre-fortification of bread and bread products–maternal TSH 
Four studies across two states and NZ investigated maternal TSH levels as an indicator 
of thyroid function in pregnant participants prior to iodine fortification of bread and 
bread products. 
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Maternal TSH levels of 70 consecutive participants (approximately 30 weeks 
gestation) in Northern Sydney (Gunton et al. 1999) were determined and compared to 
those who were classified as having normal iodine status, mild deficiency or moderate-
to-severe deficiency based on WHO 1994 urinary excretion reference ranges.  TSH 
levels across all iodine status subgroups in the pregnant participants did not exceed 
1.67 ± 0.9 μIU/ml, were within the reference ranges recommended in the Guidelines 
of the ATA (Stagnaro-Green et al. 2011) and indicated that thyroid function (based on 
TSH) did not appear to be affected despite urinary measures suggesting iodine 
deficiency (of varying degrees) in the participants.  This highlighted the insensitive 
nature of maternal serum TSH levels in determining iodine status of pregnant women 
as described in Sections 2.3.3 and 2.4.3. 
A second Sydney study (North Western Sydney) conducted almost a decade later 
(Blumenthal, Byth, and Eastman 2012) (Table 2.6) found that 6.5% of the 367 first 
trimester participants had serum TSH > 2.5 mIU/L indicating gestational subclinical 
hypothyroidism in the first trimester according to the Guidelines of the ATA 
(Stagnaro-Green et al. 2011).  The influence of time on the differing results needs to 
be acknowledged.  It has been documented that the population iodine status in 
Australia changed from iodine sufficient in 1992 (Li et al. 2008) to mildly deficient by 
2007-2009.  The larger sample size in the second study and difference in gestational 
stage of the participants also needs to be taken into consideration. 
A lower percentage (2.6%, n=4) of the 154 NZ participants (Pettigrew-Porter et al. 
2011) were similarly hypothyroidic as assessed by TSH. It should be noted that the 
sample size of this study was smaller than the Sydney studies, women across all 
trimesters were sampled (Table 2.6) and the previously explained differences between 
Australian and NZ make comparisons difficult to interpret. 
Although the aim of a 2006 WA study by Gilbert et al. (2008) was not specifically to 
study the iodine status of 2159 first trimester pregnant women, the results are worth 
noting given the paucity of information relating to the iodine status of pregnant women 
in this state.  The reference group (n=1817) used to derive a first trimester reference 
range consisted of consecutive pregnant women from both regional and metropolitan 
areas (excluding those with thyroid autoimmunity) who attended their first trimester 
screening in Western Diagnostic pathology laboratories over a two month period. 
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The reported-derived reference range for maternal TSH in eligible women (n=1817) 
in their first trimester of pregnancy was 0.02-2.15 mIU/L, within the reference range 
of 5 out of 6 studies assessed in the Guidelines of the ATA (Stagnaro-Green et al. 
2011) and the recommendation of first trimester reference range of 0.1-2.5 mIU/mL in 
the absence of laboratory specific values (Table 2.4).  The median TSH concentration 
was 0.78 (0.03, 2.78) and within the reference range proposed by the ATA (Stagnaro-
Green et al. 2011) indicating adequate iodine status (based on TSH) for first trimester 
pregnant women in WA compared to the findings from the Sydney study indicating 
subclinical hypothyroidism in their study population (Blumenthal, Byth, and Eastman 
2012). 
Studies conducted post-fortification of bread and bread products–maternal 
TSH 
Condo et al. (2015) measured maternal TSH following the fortification of bread with 
iodine in 96 subjects at 28 weeks gestation in a SA study conducted in 2011-2012.  
Mean maternal TSH level was 1.53 (± 0.10) mIU/L , within the manufacturer’s non-
pregnant reference ranges as well as the third trimester-specific reference range of 0.3-
3 mIU/L (Stagnaro-Green et al. 2011).  These findings indicated adequate iodine status 
in participants (based on mean TSH level). 
Studies conducted pre-fortification of bread and bread products–neonatal TSH 
McElduff et al. (2002) reported a prevalence of 8.1% (n=1316) and 5.4 % (n=1457) of 
neonates with TSH >5 mIU/L in two population samples in Northern Sydney during 
1998 and 1999, indicative of an iodine deficient population. A different conclusion 
was drawn from a 2004 study conducted by Travers et al. (2006) in the Central coast 
area of NSW that found that only 2.2% of neonates (n=824) had TSH levels >5 mIU/L.  
Differences in sample size, study methodology, year of study, sample demographics, 
time of heel-prick samples and assay methods in neonates is likely to account for at 
least some of the differences in findings between these NSW studies. 
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Private or public hospital status of neonates born to mothers attending Royal North 
Shore hospital in Sydney was not reported in the study conducted by McElduff et al. 
(2002).  The authors acknowledged that although some neonatal blood samples were 
drawn on day 3, this could have been before 72 hours in some babies born in the 
morning, hence overestimating neonatal TSH levels.  Travers et al. (2006) sampled 
neonates born to mothers attending both public and private antenatal clinics (including 
NESB women) and similarly, timing of neonatal blood samples was problematic. Time 
of birth was only ascertained for neonates born in the public hospital and most of those 
samples were collected before 72 hours of birth. 
All of the studies investigating neonatal and maternal TSH levels were conducted prior 
to the mandatory fortification of bread and bread products with iodine.  The findings 
from the McElduff et al. (2002) (Sydney) show >3% frequency of neonatal TSH levels 
>5 mIU/L, indicating iodine insufficiency in the study population, whilst a study 
conducted in the NSW central coast area 5-6 years later reflected iodine sufficiency 
(<3% frequency of neonatal TSH levels >5 mIU/L) (Travers et al. 2006).  Possible 
reasons for the differing results are mentioned above, in addition, these studies 
highlight that iodine status of populations within regions of the same state (two coastal 
regions) can vary. 
It is interesting to note that the maternal TSH levels of participants at approximately 
30 weeks gestation in the Gunton et al. (1999) study did not reflect iodine insufficiency 
of the group (MUIC reflected iodine deficiency) whilst neonatal TSH levels over a 
similar time period, in the same location (Northern Sydney), indicated iodine 
insufficiency. Moreover, an unexpected weak positive relationship (r=0.26, p=0.02) 
was reported by McElduff et al. (2002) when neonatal TSH levels of 84 participants 
were correlated to the maternal UIC (paired) from the study conducted by Gunton et 
al. (1999).  Given the sample size and the problems associated with using UIC as an 
individual marker of iodine status, the correlation remains questionable until 
reproduced on a larger sample. 
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Studies assessing maternal TSH levels showed mixed results with 6.5% of the 
participants in the 2007-2009 North Western Sydney study (Blumenthal, Byth, and 
Eastman 2012) and 2.6% of pregnant women in the 2005 New Zealand study 
(Pettigrew-Porter et al. 2011) diagnosed with gestational subclinical hypothyroidism.  
The findings from two Northern Sydney studies (Gunton et al. 1999; McElduff et al. 
2002) reported maternal TSH levels within normal ranges, despite UIC and neonatal 
TSH indicating iodine deficiency. 
Maternal TSH results from a WA study (Gilbert et al. 2008) suggested that participants 
in this study were iodine sufficient (in the absence of UIC).  Further studies assessing 
neonatal and maternal TSH following the mandatory fortification of bread with iodine 
would assist with population and regional monitoring and comparisons (pre- and post-
fortification), given that all current studies assessing these measures were conducted 
pre-fortification. 
2.9.4 Serum Tg 
Studies conducted post-fortification of bread and bread products 
Only two studies measured serum Tg (and anti-thyroglobulin antibodies), both were 
post-fortification.  Brough et al. (2015) measured serum Tg (and anti-thyroglobulin 
antibodies) in a self-selecting sample of pregnant and breastfeeding women living in 
Palmerston North (NZ) (Table 2.6).  A small sample of pregnant women post-
fortification (n=34) had a median Tg of 15.9 ug/L, however similar levels were 
reported in euthyroid women in the United States (Mitchell et al cited in Brough et al. 
2015) with no correlation between Tg concentration and UIC or iodine supplement 
use.  Condo et al. (2015) reported mean serum Tg within non-pregnant reference 
ranges for pregnant women in a 2011-2012 SA study (17.9 ± 1.4 ng/ml) (reference 
range=0-59 ng/ml).  The use of serum Tg as a sole indicator of iodine status, as 
mentioned previously, is limited, as described in Section 2.4.4. 
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2.9.5  Free thyroxine (FT4) 
Five studies conducted in NSW, WA, SA and NZ measured FT4 concentrations. 
Studies conducted pre-fortification of bread and bread products 
Gunton et al. (1999) (Northern Sydney) reported TSH and FT4 concentrations in 70 
pregnant women classified by iodine status subgroup according to urinary excretion.  
Those with severe-to-moderate iodine deficiency had the lowest FT4 concentration 
(12.9 ± 3.70 pmol/L) compared to the mildly iodine deficient group (12.5 ± 3.00 
pmol/L) and those with normal iodine status (12.1 ± 2.25 pmol/L) (Table 2.6) although 
the findings were not significant. 
Similarly, a North Western Sydney study (Blumenthal, Byth, and Eastman 2012) 
found no significant association between FT4 and UIC in their sample of first trimester 
pregnant women, even when those with UIC < 50 ug/L were compared with 
participants who had UIC > 100 ug/L.  TSH concentration and FT4 levels were found 
to be inversely associated (r=-0.490, p < 0.001) which is to be expected given the 
thyrotropic effect of high concentrations of hCG in the first trimester (leading to an 
increase in maternal FT4) that, in turn, leads to a transient depression of maternal TSH 
(Morreale de Escobar, Obregón, and del Rey 2007; Skeaff 2011). The mean FT4 
concentration reported in this study was 15.4 (± 2.7) pmol/L and was well within the 
trimester-specific references range for the first trimester (7.4-18.9 pmol/L) (Soldin 
2006). 
Pettigrew-Porter et al. (2011) (NZ) reported a median FT4 concentration of 14.2 
pmol/L (within the normal reference range).  It is worth noting that 15% of women in 
their third trimester were reported to have low FT4 concentration (<10.3 pmol/L) when 
kit-specific reference ranges were applied. The authors acknowledged the limitations 
of FT4 and the likelihood of overestimation of low FT4 concentrations of those in their 
second and third trimesters. 
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In the WA study conducted by Gilbert et al. (2008), reference ranges were derived for 
thyroid hormones in pregnant women in their first trimester.  The mean FT4 
concentration was 13.5 pmol/L (2.1) which was part-way between the NSW and NZ 
concentrations reported in studies by Gunton et al. (1999) (NSW), Blumenthal, Byth, 
and Eastman (2012) (NSW) and Pettigrew-Porter et al. (2011) (NZ).  The reference 
range (10.4-17.8 pmol/L) ascertained in this WA study did not differ substantially from 
the laboratory-specific reference range of 9-19 pmol/L. 
Studies conducted post-fortification of bread and bread products 
One study assessed FT4 concentration in a sample of 96 pregnant women in SA 
(Condo et al. 2015). The mean FT4 concentration at 28 weeks gestation (11.95 ± 0.14 
pmol/L) was within non-pregnant normal reference ranges reported in the study.  The 
mean FT4 value was also within the reference range for third trimester (8.3–15.6 
pmol/L) (Soldin 2006), which was not unexpected given that the MUIC was the 
highest out of all of the studies. 
In summary, FT4 was not used as a single measure of thyroid function in any of the 
studies above, presumably due to the limitations described in Section 2.4.5.  The use 
of different reference ranges (i.e. kit-specific or laboratory) makes it difficult to 
compare the above studies, as does differing assay methods, sample sizes and 
gestational stages of participants. 
Comparing the results to Soldin’s reference ranges; 3.7–23.4 pmol/L for the first 
trimester, 7.4–18.9 pmol/L for the second trimester, 8.3–15.6 pmol/L for the third 
trimester, it is unlikely that even those with moderate-to-severe iodine deficiency 
(assessed by UIC) in the above studies would have been identified as being at risk of 
iodine deficiency based on abnormal FT4 levels alone.  This reinforces the fact that 
FT4 is not a reliable indicator of iodine status in isolation. 
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2.10 Maternal iodine knowledge and beliefs 
Little is known about the iodine related knowledge and beliefs of pregnant women 
living in Australia and NZ, with only 8 studies identified between 1980 and 2014 
(Brough et al. 2015; Charlton et al. 2012; Charlton et al. 2010; El-mani, Charlton, et 
al. 2014; Lucas et al. 2014; Mallard and Houghton 2014; Martin, Savige, and Mitchell 
2014; Rahman et al. 2011). 
2.10.1 Knowledge of iodine-related topics 
Australia 
A pre-fortification study conducted in the Illawarra region of NSW in 2008 (Charlton 
et al. 2010) provided useful insight into the knowledge of pregnant women across all 
trimesters with regards to iodine.  Less than a third of the participants (n=139) 
attending a public antenatal clinic were able to identify the correct health effects as a 
result of insufficient iodine.  Comparative results from the post-fortification study, 
conducted on 147 pregnant participants attending a public antenatal clinic in the same 
region in 2011-2012 (Charlton et al. 2012) found that the majority of correct responses 
on the same topics decreased or remained the same, indicating that overall, there was 
no significant increase in knowledge relating to iodine and pregnancy adverse effects 
in women before and after fortification. Factors such as age, number of pregnancies 
and education did not significantly affect iodine knowledge in the pre-fortification 
study (Charlton et al. 2010). 
El-mani, Charlton, et al. (2014) (Table 2.6) conducted a study in the same region 
(including women attending private obstetrician’s clinics) and reported similar results 
with less than a third of the participants able to select the correct answers regarding 
health effects and iodine deficiency.  Unlike the previous studies, the authors found 
that those with higher education levels and with greater household incomes had better 
knowledge (relating to the question).  More recently, Lucas et al. (2014) also reported 
poor iodine knowledge in pregnant women in the Illawarra region (Table 2.6) despite 
a higher percentage who were able to identify malformations in pregnancy (46%), 
goitre (39 %) and impaired physical development (32%) (approximately), when 
compared to the pre-fortification study (Charlton et al. 2010). 
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A Victorian cross-sectional study of 200 women in their third trimester also indicated 
limited knowledge (Martin, Savige, and Mitchell 2014).  Approximately 45% of 
women were unaware of the need for increasing their intake of iodine and one-third 
(32.5%) of subjects were unaware of good food sources of iodine. 
The 2008 and 2011-2012 Illawarra studies (Charlton et al. 2012; Charlton et al. 2010), 
2012-2013 study (El-mani, Charlton, et al. 2014), 2012-2013 study (Lucas et al. 2014) 
and 2011-2012 study (Martin, Savige, and Mitchell 2014) were the only studies that 
investigated the participants’ knowledge of iodine-rich food sources, which was found 
to be inadequate pre- and post-fortification.  Whilst fish and seafood are considered to 
be rich sources of iodine, only around 26-60% of participants in these studies correctly 
identified these foods.  Half of the participants in the Illawarra studies (51%) pre- and 
post-fortification identified salt as a good source of iodine (Charlton et al. 2012; 
Charlton et al. 2010), similar percentages were reported in studies conducted by Lucas 
et al. (2014) and Martin, Savige, and Mitchell (2014).  Approximately one quarter of 
participants (pre- and post-fortification) selected milk as a good source of iodine 
(Charlton et al. 2012; Charlton et al. 2010), comparable to the latest study by (Lucas 
et al. 2014).  Eggs were correctly identified by between 23%-31% (Charlton et al. 
2012; Charlton et al. 2010; El-mani, Charlton, et al. 2014; Lucas et al. 2014). 
Charlton et al. (2012), Lucas et al. (2014) and El-mani, Charlton, et al. (2014) reported 
that less than a third of participants identified bread in their post-fortification studies. 
Furthermore, approximately 16% of subjects in the SA study (Martin, Savige, and 
Mitchell 2014) were aware of the mandatory iodine fortification of bread, followed by 
11.5% in NSW (El-mani, Charlton, et al. 2014) and 5% of the participants in the NSW 
study by Charlton et al. (2012). 
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New Zealand 
Brough et al. (2015) reported low knowledge of iodine deficiency and 
recommendations for iodine supplement use in their NZ (Palmerston North) study of 
breastfeeding and pregnant women of ≥28 weeks gestation- pre-fortification (2009) 
and post-fortification (2011) (Table 2.6).  Sixty eight percent of the 2009 sample 
identified that iodine deficiency was a problem compared to 41% in 2011.  The 
awareness of NZ government initiatives to address iodine deficiency (the mandatory 
iodine fortification of bread in 2009 and a government subsidised iodine supplement 
program for pregnant and breastfeeding women from July 2010) was low. 
Approximately half of the pregnant women in 2011 were aware of the subsidised 
iodine supplement initiative, whilst 5 pregnant women (15%) in the post fortification 
sample were aware of the mandatory bread fortification (Brough et al. 2015). 
One of the major limitations of this study relates to the small sample sizes of pregnant 
women in both 2009 and 2011.  Comparisons between studies from Australia and NZ 
need to be made with caution due to various geographical factors (as described in 
Section 2.9.1) that are likely to contribute to differing knowledge, beliefs and status of 
participants in these countries.  Despite this, the overall findings of low knowledge in 
this NZ study concur with the results of other Australian studies (Charlton et al. 2012; 
Charlton et al. 2010; El-mani, Charlton, et al. 2014; Lucas et al. 2014; Martin, Savige, 
and Mitchell 2014; Rahman et al. 2011). 
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2.10.2  Beliefs and sources of information regarding iodine-related topics 
Australia 
Only 17% of women in the 2008 pre-fortification study (Charlton et al. 2010) believed 
that they had received enough information to make informed decisions regarding 
iodine versus 80% for iron and 72% for folate.  A significant improvement occurred 
post-fortification whereby 34 and 32% of the participants in the 2011 and 2012 post-
fortification studies believed that they had received enough information regarding 
iodine (Charlton et al. 2013).  Interestingly, the percentage who felt that they had 
received enough information almost doubled (61.1%) in another NSW study post-
fortification study (El-mani, Charlton, et al. 2014), three-fold the pre-fortification 
results in the study conducted by Charlton et al. (2013), suggesting an improvement in 
the participant’s perception of having obtained enough information despite overall 
poor knowledge on the topic. 
Approximately 49% of women in the 2011-2012 Illawarra studies (Charlton et al. 
2012) reported that they had received information on iodine related topics.  Similarly, 
unpublished results from the study conducted by Lucas et al. (2014) suggest that 46% 
of women had received information on iodine related topics. 
These results raise three immediate concerns;  1) an ongoing lack of awareness by 
health professionals of the need to educate women on the importance of iodine during 
pregnancy, as well as 2) an ongoing lack of public health education (Charlton et al. 
2013) in areas where iodine deficiency during pregnancy has been shown to be 
prevalent, and 3) the discordance between women receiving information on iodine 
related topics and their belief that they have received enough information to make 
informed decisions regarding iodine.  These three factors are likely to influence iodine 
related behaviours (e.g. use of iodine-containing supplements, iodised salt use and 
intake of iodine-rich foods). 
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Of the women participating in the 2008 Illawarra study, approximately 16% obtained 
written nutrition information regarding iodine from a healthcare professional, with 
approximately 7% obtaining information verbally (Charlton et al. 2010). 
Approximately 12% of participants in the 2011 Illawarra study obtained nutrition 
information regarding iodine via written communication from a healthcare 
professional versus approximately 37% who received this information verbally from a 
health professional (Charlton et al. 2012).  Possible explanations for the increasing 
trend in verbal communication on iodine related topics could be due to; increased 
knowledge of health professionals with regards to the importance of iodine in 
pregnancy and, or improvements in opportunities to provide verbal education. 
Most participants (74%) in the Charlton et al. (2010) pre-fortification study did not 
know if their diet provided enough iodine.  In the 2012 post-fortification study it was 
reported that 74% of participants did not know if their diet provided enough iodine for 
their own needs and 80% did not know if their diet provided enough iodine for their 
unborn child’s needs (Charlton et al. 2013).  The percentage of women who did not 
know if their diet provided enough iodine for their own needs (53%), or for their 
unborn child’s needs (58%) decreased in the study conducted by Lucas et al. (2014).  
Again, suggesting an improvement in the participant’s perception (of meeting their 
iodine requirements). 
These studies were cross-sectional convenience samples and women from NESB were 
excluded. The studies were region specific, limiting the generalizability of the results 
to other states or other regions within the same state.  The validated survey instrument 
was kept consistent between studies (Charlton et al. 2012; Charlton et al. 2013; Lucas 
et al. 2014), however, as with all self-reported questionnaires, participant responses 
were subject to self-report bias (Charlton et al. 2012). This knowledge and awareness 
perspective requires further investigation in other states, preferably in studies with 
larger sample sizes and the inclusion of NESB participants. 
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A smaller Victorian post fortification study (Rahman et al. 2011) (Table 2.6) found 
that only a third of pregnant women reported hearing about the importance of iodine 
and a similar number of participants had received advice from doctors about taking 
iodine containing supplements.  This study, also a cross-sectional study, had the 
advantage of including both hospital antenatal clinic participants and those from 
private obstetrician clinics in Gippsland.  It should be noted that all participants were 
≥28 weeks gestation, therefore the majority of these women had proceeded to their 
third trimester without knowing about the importance of iodine, and without any 
formal communication regarding iodine supplementation from a doctor. 
A cross-sectional study conducted in Gippsland (Martin, Savige, and Mitchell 2014) 
on 200 pregnant women in their third trimester reported that around 40% of 
participants did not believe it necessary to take an iodine-containing supplement if they 
had a healthy diet during pregnancy.  A similar percentage (34.3%) had received iodine 
information from a medical practitioner, with the media, midwives, family and friends 
named as other common sources of information. 
There is a clear consensus from the authors of the studies conducted in regions of NSW 
(Charlton et al. 2012; Charlton et al. 2010; Charlton et al. 2013; El-mani, Charlton, et 
al. 2014; Lucas et al. 2014); Vic (Martin, Savige, and Mitchell 2014; Rahman et al. 
2011) and NZ (Brough et al. 2015) that knowledge and awareness of the importance 
of iodine during pregnancy and of the initiatives to address the problem of iodine 
deficiency is lacking in pregnant women.  Whilst some improvements have occurred 
post-fortification, it is apparent that these improvements do not translate to better 
overall knowledge especially when compared to other nutrition-related topics 
(Charlton et al. 2012) such as iron and folate.  More recent publications (El-mani, 
Charlton, et al. 2014; Lucas et al. 2014) have focused on the lack of awareness of 
health professionals and the importance of their role in the provision of education and 
advice on iodine related topics to women as part of their antenatal care.  These findings 
highlight that consideration of the complexities of addressing improvements in 
knowledge are not only needed for pregnant women. 
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2.11 Dietary iodine consumption and iodised salt use 
2.11.1  Dietary iodine consumption 
Australia 
Ten studies assessed dietary iodine intake (Blumenthal, Byth, and Eastman 2012; 
Brough et al. 2015; Charlton et al. 2012; Charlton et al. 2013; Condo et al. 2015; Lucas 
et al. 2014; Mallard and Houghton 2014; Martin, Savige, and Mitchell 2014; Nguyen 
et al. 2010; Pettigrew-Porter et al. 2011; Rahman et al. 2011) with seven of these 
studies estimating participant daily iodine intake (ug) (Blumenthal, Byth, and Eastman 
2012; Brough et al. 2015; Charlton et al. 2013; Condo et al. 2015; Lucas et al. 2014; 
Mallard and Houghton 2014; Pettigrew-Porter et al. 2011) (Table 2.7). 
Blumenthal, Byth, and Eastman (2012) (NSW) estimated the mean daily iodine intake 
of pregnant women (n=367) (pre-fortification) using a method of extrapolation from 
UIE.  The derived estimate of daily iodine intake was 132 ug/day, which was below 
the EAR for pregnant women (160 ug/day).  This study also utilised a FFQ, limited to 
milk, dairy and fish consumption to determine associations between the consumption 
of these three iodine food sources and UIC. Out of these food sources, only milk was 
reported to significantly increase UIC (p=0.035) when UIC subgroups were tested for 
homogeneity across categorical milk consumption data. 
Two to three years post-fortification in another NSW study (Illawarra), Charlton et al. 
(2013) reported mean daily iodine intake of 176 (92) ug/day (2011) and 160 (80) 
ug/day (2012) using an iodine-specific, validated, self-administered FFQ to calculate 
mean dietary intake.  Estimated intakes after additional adjustments were made for the 
inclusion of iodine in bread were 211 (98) ug/day (2011) and 193 (86) ug/day (2012).  
The results were in accordance with the 2003 ALSWH food frequency data projected 
onto the 1995 NNS for total iodine intake for pregnant women (167 ug/day) 
(Mackerras et al. 2011).  Major contributors to iodine intake in the 2012 NSW study 
(Charlton et al. 2013) were milk and dairy foods (58%), cereals including bread (20%), 
tap water (8%), with seafood and eggs only contributing 3% to estimated daily iodine 
intake. 
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Table 2.7  Studies reporting dietary iodine intakes of pregnant women in Australia and New 
Zealand (1980 to present) 
Author (Date of publication) 
Date of study 
State or 
Territory 
Sample 
Size (n) 
Gestational 
stage (wk) 
Diet I (ug) 
Pettigrew-Porter et al. (2011) 
2005 
NZ 170 All 
 
 
48 (FFQ)  
Blumenthal et al. (2012) 
2007-2009 
NSW 367 7-11 
 
 
132 
Extrapolated 
Brough et al. (2013) 
July 2009 pre iodine fort. 
Jan-Sept 2011 post iodine fort 
NZ 57 
25 
32 
> 26  
119 
217 
Extrapolated 
Charlton et al. (2013) 
2011 
2012 
NSW  
147 
114 
All  
211 (FFQ) 
193 (FFQ) 
Mallard & Houghton (2013) 
2011 
NZ 723 All  
107 (Prior preg) 
179 (Preg) 
Baseline assignment 
Condo et al. (2015) 
2011-2012 
SA  96 < 20  
144 (FFQ) 
160 (4d WR) 
Lucas et al. (2014) 
2012 and 2013 
NSW 142 All  
189 (FFQ) 
 
Lucas et al. (2014) (Table 2.7) used the same iodine-specific, validated, self-
administered FFQ to calculate median dietary intake of participants in the Illawarra 
region.  They reported the highest estimated dietary iodine of 189 (129-260) ug/day, 
however 38% of participants did not meet the EAR.  Dairy foods and bread and cereals 
contributed the most to overall iodine intake of the participants (52% and 18%), 
respectively, with minimal contribution from fish and seafood (7%). 
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In 2011-2012 (Condo et al. 2015) assessed iodine intake of study participants using a 
validated iodine-specific FFQ (at two time points) and a four day weighed food record. 
The mean iodine intakes were 144 (52) ug/day and 160 (54) ug/day, respectively, 
indicating borderline sufficiency/adequacy.  It should be noted that iodine from iodised 
salt was not quantified and therefore not included in these figures. 
The two remaining Australian studies did not quantify daily iodine intake but reported 
on the consumption of various iodine food sources.  Rahman et al. (2011) found that 
95% of participants in the Gippsland study reported consuming milk, milk products 
and bread fortified with iodine regularly.  Seafood, seaweed, sushi contributed minimal 
amounts to overall dietary iodine intake with only 9% of participants consuming these 
foods.  The second study conducted in Canberra gave limited information relating to 
dietary intake, however findings from previous studies were confirmed with regards 
to the low dietary intake of fish and sushi (Nguyen et al. 2010). 
New Zealand 
A study conducted in NZ in 2005 on 170 pregnant women (pre-fortification) 
(Pettigrew-Porter et al. 2011) (Table 2.7) assessed dietary intake via an iodine-specific, 
semi-quantitative, self-administered FFQ.  The reported mean daily iodine intake was 
48 (23) ug/day, well below the EAR for pregnant women (160 ug/day). Fish and 
seafood consumption was low with only 38% of participants consuming fish once a 
week and 77% never consuming other types of seafood. 
Mallard and Houghton (2014) reported findings from a postpartum survey conducted 
across eleven maternity wards and hospitals in NZ in 2011 (n=723).  Unlike other 
studies, iodine from food was determined by the baseline assignment of 60 ug/day 
(based on 2003-2004 NZTDS) to all subjects, with a further 48 ug/day of iodine 
assigned to those who used iodised salt. The mean iodine intake prior to pregnancy 
was estimated to be 107 ug/day and 179 ug/day during pregnancy, figures that were 
well above the 2005 NZ study (Pettigrew-Porter et al. 2011) and indicated adequate 
iodine intake during pregnancy in this population.  The results for pregnant women 
(post-fortification) were part-way between the 2005 NZ study and findings from the 
study conducted by Brough et al. (2015). 
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Brough et al. (2015) (Palmerston North) reported that the mean estimated daily iodine 
intake based on extrapolation from 24-h urinary excretion was below the EAR in 2009 
(pre-fortification) in their 2011 study.  The majority of women (73%) achieved the 
EAR post-fortification (2009: 119 ug/day (77) vs. 2011: 217 ug/day (87)), a 
significantly higher value than the pre-fortification estimated iodine intake (p<0.001).  
The pre-fortification result was higher than the estimated iodine intake reported in the 
2005 NZ study (Pettigrew-Porter et al. 2011), possibly due to sample size differences 
(Table 2.7), different methods of estimating iodine intake (estimation from FFQ versus 
extrapolation from urinary excretion), timing of studies, location within NZ and socio-
demographic variances, in addition to possible increases in non-local food supply 
between 2005-2009 and changing dietary trends. 
2.11.2  Iodised salt use 
Eleven studies reported the percentage of iodised salt use in pregnant women 
(Blumenthal, Byth, and Eastman 2012; Brough et al. 2015; Charlton et al. 2012; 
Charlton et al. 2010; Charlton et al. 2013; Condo et al. 2015; El-mani, Charlton, et al. 
2014; Lucas et al. 2014; Martin, Savige, and Mitchell 2014; Nguyen et al. 2010; 
Pettigrew-Porter et al. 2011; Rahman et al. 2011) (Table 2.6). 
Data capturing iodised salt sales in Australia indicated that 11% of households 
purchased iodised salt in 2003, followed by a 29% increase between 2003 and 2006 
(Li et al. 2007) due to media coverage.  The majority of studies that investigated 
iodised salt use confirmed that 50% or less of the participants consumed iodised salt; 
21% pre-fortification (Blumenthal, Byth, and Eastman 2012) (NSW), 40% pre-
fortification vs. 49% post-fortification (Charlton et al. 2012; Charlton et al. 2010) 
(NSW), <34% pre-fortification (Nguyen et al. 2010) (ACT), 50% pre-fortification vs. 
32% post-fortification (Rahman et al. 2011) (Vic), 38% post-fortification (Brough et 
al. 2015) (NZ), 47% post-fortification (Condo et al. 2015) (SA); 19.5% post-
fortification (Martin, Savige, and Mitchell 2014) (Vic) 45.6% post-fortification (El-
mani, Charlton, et al. 2014) (NSW) and 50% post-fortification (Lucas et al. 2014) 
(NSW). It was difficult to establish if the percentages reported related to daily iodised 
salt use, which limits further interpretation. 
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A NZ study (Pettigrew-Porter et al. 2011) provided further detail, reporting  iodised 
salt consumption at the table (60%) and in cooking (73%) separately, however only a 
quarter of participants used iodised salt at least once a day. The most recent study from 
the Palmerston North, NZ (Brough et al. 2015) found that although 88% and 79% of 
participants had access to iodised salt at home (pre- and post-fortification, 
respectively), only 38% exclusively used iodised salt. These findings highlighted that 
iodised salt use amongst this population can be sporadic and not exclusive, even when 
readily available. 
Many factors influence the accuracy of these results and limit comparisons between 
studies.  The depth of questioning on the topic varied (i.e. frequency of consumption, 
general use, discretionary use, use in cooking, quantities and exclusive use). Equally 
as important to acknowledge is that iodised salt use will naturally vary between 
countries and states (and within states) due to differences in geographical location, 
public education strategies, traditions, iodised salt availability, individual perceived 
risk, education levels and other socioeconomic factors. 
Summary of estimates of iodine intake 
The method used to estimate intake (i.e. extrapolation based on UIE, baseline 
assignment of iodine or values obtained from food frequency data) limits the 
generalisability of these findings to other populations.  In addition, the FFQ used 
varied between most of these studies, with the exception of  Charlton et al. (2012); 
Charlton et al. (2013); Lucas et al. (2014).  Despite being based on the same nutrient, 
(i.e. iodine), differing food lists and quantities places limitations on comparisons 
between populations (i.e. states in Australia and NZ). 
In summary, the estimated mean daily iodine intake was found to be inadequate (based 
on EAR for pregnant women=160 ug/day) in 2 pre-fortification studies (Pettigrew-
Porter et al. 2011) (North and South Island, NZ), (Blumenthal, Byth, and Eastman 
2012) (North Western Sydney, NSW), in the pre-fortification subset in the study 
conducted by Brough et al. (2015) (Palmerston North, NZ) and in the value determined 
via FFQ only in the post-fortification study by Condo et al. (2015) (Adelaide, SA). 
The majority of post-fortification estimated daily iodine intake results indicated 
adequacy (Table 2.7). 
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Whilst it is difficult to establish whether these improvements were due to mandatory 
fortification of bread and bread products, increased iodine supplement use, iodised salt 
use or a combination of factors, there is a general shift from insufficient iodine intake 
toward adequate iodine intake in NSW, NZ and SA.  Dietary consumption of iodine-
containing foods and iodised salt use has not been reported in pregnant women in 
recent years in Tas or NT and to the author’s knowledge, not reported at all in pregnant 
women in Qld or WA.  Further investigation in these states would prove useful from 
a monitoring and surveillance perspective (and to provide initial data regarding dietary 
intake and iodised salt use in Qld and WA, the two states that have traditionally been 
reported as iodine sufficient). 
2.12 Iodine-containing supplement use 
The 2010 NHMRC recommendation that women who are pregnant, considering 
pregnancy or breastfeeding take an iodine supplement of 150 ug daily (National Health 
and Medical Research Council 2010) was based on national studies conducted on 
pregnant women in south eastern Australia, results of the 2004 NINS, FSANZ 1995 
Total Diet Survey results and international findings (Food Standards Australia New 
Zealand 2008c).  Similar recommendations by WHO, ICCIDD and ATA were already 
established in other countries around the world. 
Consistent with the recommendation, use of dietary modelling by Mackerras and 
Eastman (2012) estimated a gap of 100-150 ug iodine intake in Australian women aged 
19-44 years, even after the introduction of mandatory fortification of bread and bread 
products with iodine.  It should be noted that pregnant women in WA and Qld were 
not represented (Mackerras and Eastman 2012) in one of two phases of dietary 
modelling due to a lack of studies on iodine status in pregnant women in these states 
at the time. 
Iodine-containing supplement use in pregnant women was investigated in 13 out of 20 
of the studies (Table 2.6). Iodine supplement use in these studies (conducted during 
2005-2013) ranged from 20% to 75%. 
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Four of these studies (Blumenthal, Byth, and Eastman 2012; Charlton et al. 2010; 
Nguyen et al. 2010; Pettigrew-Porter et al. 2011) were conducted prior to the 
mandatory fortification of bread and bread products with iodised salt and prior to the 
release of the NHMRC recommendation for Iodine Supplementation During 
Pregnancy in Australia. These studies reflected a lower percentage of iodine 
supplement use in their participants (32.5%, 20%, 34% and 23%, respectively) than in 
the more recent post-fortification studies conducted by Brough et al. (2015), Charlton 
et al. (2013), Clifton et al. (2013), Condo et al. (2015); El-mani, Charlton, et al. (2014); 
Lucas et al. (2014); Mallard and Houghton (2014); Martin, Savige, and Mitchell 
(2014); and (Rahman et al. 2011) (70%, 60-66%, 47%, 75%, 67.7%, 70%, 22-39%; 
62% and 51-54%), respectively. 
Studies conducted pre-fortification of bread and bread products 
The NSW study conducted by Blumenthal, Byth, and Eastman (2012) had the largest 
sample size (n=367), however had limited generalisability due to the recruitment of 
the sample from one private obstetric clinic in North Western Sydney.  Nearly half 
(48%) of the women taking part in the study had a tertiary education, thus it was 
assumed that most were well-educated and able to afford private obstetric care 
(Blumenthal, Byth, and Eastman 2012). 
Approximately 72% of the subjects were taking a pregnancy vitamin supplement, 
however only 32.5% of these supplements contained iodine.  The findings suggest 
firstly, that most pregnancy vitamin supplements at the time did not contain iodine and 
secondly, that pregnant women with a tertiary education and those likely able to afford 
daily iodine supplements were unaware of the importance of taking iodine containing 
supplements during pregnancy.  This lack of awareness was to be expected, given that 
these studies were conducted prior to the mandatory fortification of bread and bread 
products with iodine and the release of the NHMRC recommendation for iodine 
supplementation. 
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The pre-fortification study conducted in NZ in 2005 (n=170) reflected a similar trend.  
The majority of women (79%) had either tertiary or postgraduate qualifications and 
74% of responding subjects had a total household income > $50 000 (New Zealand 
Dollars) however, only 23% used an iodine supplement during pregnancy (Pettigrew-
Porter et al. 2011). The overall generalisability of these findings was limited due to the 
underrepresentation of women with lower education levels, lower incomes and 
Maori/Pacific Island ethnic backgrounds.  The study was also prone to self-selection 
bias due to the recruitment strategy used. 
Two of the remaining pre-fortification studies (Charlton et al. 2010; Nguyen et al. 
2010) were on smaller samples sizes than the previous studies.  Nguyen et al. (2010) 
reported that 34% of pregnant women in the study (n=100) (Canberra) consumed 
iodine supplements.  Broader application of these findings is limited due to the small 
sample size.  The Illawarra study conducted on 139 pregnant women attending a public 
antenatal clinic (Charlton et al. 2010) reported the lowest iodine supplement use out 
of all pre-fortification studies (20%) (Table 2.6). 
Overall, iodine supplement use amongst participants in the pre-fortification studies 
(attending both private and public health care facilities) was low (<50%).  Charlton et 
al. (2010) provided some evidence for higher supplement use among those with 
tertiary education (p=0.049) and in those who were pregnant for the first time 
(p<0.005). 
Studies conducted post-fortification of bread and bread products 
Iodine supplement use (post-fortification) was reported in 9 out of 20 studies (Brough 
et al. 2015; Charlton et al. 2012; Clifton et al. 2013; Condo et al. 2015; El-mani, 
Charlton, et al. 2014; Lucas et al. 2014; Mallard and Houghton 2014; Martin, Savige, 
and Mitchell 2014; Rahman et al. 2011).  Iodine supplement use was only reported in 
both pre-fortification and post-fortification groups by Rahman et al. (2011) and 
Charlton et al. (2013). 
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The study conducted in the Illawarra region of NSW in 2011-2012 (Charlton et al. 
2013) (n=130) revealed an increase in iodine supplement use from 20% pre-
fortification (in 2008) to 60% (in 2011) and 66% (in 2012).  This study reported the 
second highest iodine supplement use out of all studies in this review and was one of 
two studies to report a MUIC > 150 ug/L (MUIC=166 ug/L for pregnant women 
sampled in 2012, n=95), indicating iodine sufficiency in the participants using iodine 
supplements post-fortification (2012 subset). 
Findings from a later Illawarra study (El-mani, Charlton, et al. 2014) reflect that the 
majority of the participants were using supplements containing both iodine and folate 
(67.7%).  The use of iodine supplements was very similar to the 2012 subset in the 
Charlton et al. (2013) study (66%).  It should be noted that women attending private 
obstetrician’s clinics and various other locations in the region were invited to 
participate in the study conducted by El-mani, Charlton, et al. (2014) whereas those in 
the Charlton et al. (2013) study were recruited from a single public antenatal clinic, 
suggesting similarities in iodine supplement use in participants regardless of the 
utilisation of public or private antenatal services, at least in this region. 
The most recent NSW study in the same region as those above (Lucas et al. 2014) 
reported the joint second highest percentages of iodine supplement use (70%). The 
majority of participants were recruited from a public antenatal facility.  Lucas et al. 
(2014) declared that this figure may have been over-reported due to the assumptions 
made when assigning iodine contents to supplements for which brand names were not 
specified by the participants. In contrast to the pre- versus post-fortification trend 
reported by Charlton et al. (2013), Rahman et al. (2011) found lower iodine 
supplement use in 62 Gippsland participants post-fortification (50%) versus pre-
fortification (54%). The small sample size and the fact that this study was conducted 
in the 9 months leading up to fortification (January-September 2009) and immediately 
post-fortification (October 2009–February 2010) needs to be taken into consideration 
when interpreting these results.  Results from a 2011-2012 study conducted in the same 
region on 200 pregnant women (Martin, Savige, and Mitchell 2014) indicated higher 
iodine-containing supplement use (62%). 
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Forty seven percent of pregnant women in an Adelaide study (Clifton et al. 2013) used 
iodine supplements, however it was not possible to differentiate between supplement 
use pre- and post-fortification.  A second Adelaide study (Condo et al. 2015) reported 
the highest percentage of iodine supplement use (75%) however supplement use may 
have been influenced by the recruitment of women already involved in a study related 
to iodine. 
Brough et al. (2015) reported that 70% of participants used iodine-containing 
supplements in 2011 (Table 2.6).  Recruitment was via local newspapers, flyers, 
posters and a university website therefore the study was prone to self-selection bias, 
and therefore interpretation of the results needs to be made with caution, especially in 
light of lower reports in the NZ study conducted in the same year (22-39%) across 12 
sites (Mallard and Houghton 2014). 
At the present time, studies on iodine supplement use during pregnancy in women 
residing in WA and Qld (where the population iodine status is considered optimal) are 
limited. In 2002-2004 it was reported that none of the lactating participants in the Perth 
Infant Feeding Study II (n=587) reported taking iodine-containing supplements during 
pregnancy (Lee et al. 2012).  It is worth noting that this study was designed for 
endpoints other than the assessment of iodine supplement use in pregnant women.  
Data collection occurred post-partum, with participants answering questions regarding 
iodine supplement use (during pregnancy) in retrospect during an era when iodine was 
not topical (and presumably not easily recalled).  It can, however, be assumed that 
adequate iodine supplementation during pregnancy in this study population (pre-
fortification) was minimal as pregnancy multivitamin supplements would not have 
contained the recommended amounts of iodine (Lee et al. 2012), if any iodine at all. 
It is difficult to ascertain when iodine inclusion in pregnancy multivitamin 
supplements began.  Gallego, Goodall, and Eastman (2010) reported that in July 2009 
there were 18 pregnancy multivitamin preparations, of which 85% contained iodine of 
varying concentrations (38–250 ug/day).  More recently with the results of their audit 
of five Australian based online pharmacies in early 2013,  El-mani, Mullan, et al. 
(2014) discovered that only 18 out of 23 pregnancy specific multivitamin preparations 
contained iodine.  Iodine content varied across the brands, ranging from 25-299 ug per 
capsule, tablet or vita gummy. 
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With the release of the 2010 NHMRC recommendation for iodine supplementation 
(150 ug/day) for women who are pregnant, planning a pregnancy or breastfeeding, it 
is likely that most manufacturers have, or plan to increase the iodine content of their 
pregnancy multivitamins to align with this recommendation.  This is a feasible 
explanation for the increase in iodine-containing supplement use reported in the post-
fortification studies, especially as the knowledge and awareness of the importance of 
iodine during pregnancy remains minimal amongst pregnant women in Australia and 
NZ. 
As mentioned previously, three of the more recent Australian studies reporting iodine 
sufficiency in study subgroups (based on MUIC) (Charlton et al. 2013; Clifton et al. 
2013; Condo et al. 2015) also report higher iodine containing supplement use.  It is 
likely that this trend reflects a shift in pharmaceutical manufacturers including iodine 
or increasing the iodine content of their pregnancy formulations and for the latter study 
may have also been due to sampling bias as mentioned in Section 2.9.1. 
Gallego, Goodall, and Eastman (2010) highlighted factors such as the cost of 
supplements together with a lack of understanding of the importance of iodine during 
pregnancy as barriers to their use. Whilst not related specifically to iodine 
supplementation, it is worth noting that Barbour et al. (2012) (United Kingdom) 
identified factors such as supplement associated with morning sickness, forgetting to 
take the supplement, less perceived risk due to previous normal pregnancy, other 
health priorities and scepticism of the benefits of supplements as reasons for non-
compliance with folic acid supplementation. A large Norwegian study based on the 
Norwegian Mother and Child Cohort Study (MoBa) found that pregnant dietary 
supplement users were more likely to be older, primigravid, non-smokers, of normal 
body weight and those with higher education levels (Haugen et al. 2008).  It is not 
unreasonable to expect that these factors may also apply to iodine supplementation use 
(or non-use).  
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El-mani, Charlton, et al. (2014) reported a higher percentage iodine (and folate) 
supplement use in women with the highest household income versus the lowest 
(p=0.001) and although Mallard and Houghton (2014) did not confirm the specific 
sociodemographic indictors used, they reported that women who were less likely to 
take supplements as recommended were those who were the least advantaged.  Results 
from the study conducted by Charlton et al. (2010) suggested significantly higher 
supplement use among those with tertiary education (p=0.049), as well as in women 
during their first pregnancy (p<0.005).  Predictors of iodine supplement use reported 
by Martin, Savige, and Mitchell (2014) were twofold; general supplement use and 
knowledge (those who did not think that they consumed adequate iodine in their diet).  
Comparing the Australian results to a recent Danish study in which a higher level of 
maternal education was identified as a significant predictor of iodine-containing 
supplement use (Andersen et al. 2013) together with the results from the Norwegian 
MoBa study confirms similarities between Australian and some of the Nordic 
countries.   
Whilst it appears that the use of iodine supplements has improved in NSW, Vic, SA 
and NZ, pre-fortification data is limited and little attempt has been made to obtain post-
fortification data in other states. The post-fortification studies suggest that at least 50–
75% of participants used iodine supplements, however, only three studies reported 
MUIC >150 ug/L in subgroups of their populations (Charlton et al. 2013; Clifton et al. 
2013; Condo et al. 2015).  Brough et al. (2015) (NZ), Condo et al. (2015) (SA) and 
Lucas et al. (2014) (NSW) reported the highest iodine supplement use out of the 
Australian studies, with Condo et al. (2015) reflecting the highest MUIC out of all of 
the studies. 
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2.13 Summary 
Studies conducted in Australia and NZ over the last 15 years confirm that iodine 
deficiency in pregnant women is prevalent in regions of NT, ACT (pre-fortification of 
bread and bread products with iodine and the introduction of recommendations for 
iodine supplementation for pregnant and breastfeeding women and those planning a 
pregnancy) and in NSW, Vic, Tas, SA and NZ after the commencement of these 
initiatives. Only three authors reported iodine sufficiency (MUIC >150 ug/L) in 
women using iodine-containing supplements in their study samples (Charlton et al. 
2013; Clifton et al. 2013; Condo et al. 2015). 
Studies investigating iodine intake, knowledge and beliefs of pregnant women in 
Australia and NZ are limited in quantity, by number of participants and by incomplete 
coverage of all states and territories of Australia and areas of NZ. Eight studies have 
investigated iodine knowledge and beliefs of the study participants, and knowledge of 
iodine nutrition issues was found to be minimal (Brough et al. 2015; Charlton et al. 
2012; Charlton et al. 2010; El-mani, Charlton, et al. 2014; Lucas et al. 2014; Mallard 
and Houghton 2014; Martin, Savige, and Mitchell 2014; Rahman et al. 2011). 
The use of iodine-containing supplements varied substantially in the studies reviewed 
(20% to 75%).  Minimal iodine supplement use during pregnancy is of concern in 
states with evidence of ongoing iodine deficiency in pregnant populations despite the 
introduction of bread and bread product fortification.  Currently, it is not known if 
iodine supplementation is required by pregnant women living in WA and Qld (where 
the population iodine status is considered optimal). 
It is clear from the literature that there is a paucity of research on iodine status, iodine 
intake, iodine-containing supplement use and iodine nutrition knowledge and beliefs 
of pregnant women in WA and Qld.  This research project aims to begin to address 
this gap in the literature in pregnant women in WA. 
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CHAPTER 3 : METHODS 
3.1 Overview of aims of the study 
The primary aims of this study were to determine the knowledge of iodine nutrition 
(health effects, iodine-rich food sources); beliefs regarding iodine nutrition 
(participant-perceived consumption); use of an iodine-containing supplement (prior to 
and during pregnancy) and iodised salt use; as well as to estimate dietary intake of 
iodine of pregnant women in WA. 
The secondary aims were to assess the reliability of an existing tool used to rank dietary 
iodine intake in pregnant women and to identify the potential of developing a rapid 
iodine screening tool to determine the women whose individual usual intakes are not 
likely to meet the EAR for iodine. 
3.2  Study design 
The study’s aforementioned aims were addressed through the use of an observational, 
cross-sectional study design which involved subjects completing a 68-item self-
administered paper-based questionnaire which included a 49-item FFQ (Section 3.4).  
A retest subgroup from the original sample repeated the FFQ section of the 
questionnaire (on a separate occasion) in order to address the reliability of the existing 
tool. 
The study was approved by Curtin University Human Research Ethics Committee 
(Approval number HR125/2012) and the Women and Newborn Health Service Human 
Research Ethics Committee (Registration number 2048/EW). 
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3.3  Subjects 
3.3.1 Recruitment of subjects 
The recruitment of subjects was conducted by TH in King Edward Memorial Hospital 
(KEMH) East Wing Clinic (EWC) from 29 December 2012 to 16 July 2013.  The 
antenatal clinics sampled were weekly medical-run clinics servicing WA women with 
medium to high risk pregnancies (referred by their General Practitioner (GP)) and 
included  women attending a weekly Childbirth and Mental Illness clinic (women were 
referred by their GPs and other health organisations). 
 A pilot study to assess administration methods and time taken to complete the 
questionnaire was conducted in the EWC on 18 December 2012.  Twenty eight 
questionnaires were returned during the 4-hour clinic and most subjects took less than 
10 minutes to complete. Response rate was difficult to ascertain as the planned 
recruitment method (every woman receiving a questionnaire when checking in at the 
clinic desk) did not occur and therefore quantifying the number of women who 
declined or did not pick up a questionnaire was not possible.  It was determined from 
this pilot that the recruitment strategy would be refined so that only TH would 
disseminate questionnaires and approach as many women as possible during the clinic 
(see process below). 
Pregnant women attending the EWC from 29 December 2012 to 16 July 2013 were 
approached via face-to-face introduction and explanation of the research by TH. 
Information regarding the study (Appendix A) was provided to all women who were 
approached and they were given time to read the information, ask questions and sign 
the consent form if they agreed to participate (Appendix A).  It was explained that 
participation was voluntary and subjects could withdraw from the study at any time. 
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Pregnant women at any gestational stage over the age of 18, of any nationality and/or 
linguistic background were eligible for inclusion in the study.  Interpreters, translators 
or family members were asked to explain the study and to complete the questionnaire 
in consultation with consenting non-English speaking subjects.  Food flashcard images 
from the Food for New Arrivals program (Association for Services to Torture and 
Trauma Survivors Incorportated n.d.) were adapted and available for use by TH and 
interpreters, translators and family members to help women identify foods that may 
not be recognised or commonly used in their culture. 
Initially women who had diabetes (or history of diabetes/gestational diabetes) or active 
thyroid disease (or history of thyroid disease) were excluded.  This was based on 
exclusion criteria of similar studies conducted in Australia (Clifton et al. 2013; Tan et 
al. 2013).  However, despite screening questions being asked prior to questionnaire 
administration, some women answered yes to “Have you ever been told by a doctor 
that you have thyroid disease/diabetes?” in the questionnaire.  After discussion with 
supervisors, it was decided that only those women who had active thyroid disease 
(taking medication for the disease) were to be excluded from the present study. 
Subjects completing the initial questionnaire (FFQ1) (Appendix B) were asked if they 
would be willing to participate in the retest questionnaire (FFQ section only) (FFQ2) 
(Appendix C) at a different antenatal visit.  Those who agreed were given a card stating 
their study identification number and the date and this card was presented at their next 
appointment for administration of the retest questionnaire. Women who did not have 
time to finish the questionnaire in the clinic were given a pre-paid envelope to return 
the completed questionnaire via post. 
A resource entitled “Iodine in Pregnancy” prepared by KEMH Dietitians was provided 
on completion of the questionnaire to any women who had any concerns or questions 
regarding iodine. 
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3.3.2 Sample size 
The final sample size for the initial administration of the questionnaire was determined 
primarily to provide sufficient statistical power to undertake test-retest analysis of the 
tool.  The sample size for determining the number of test-retest subjects was estimated 
to be 46-86 to detect the difference between test and retest intraclass correlation 
coefficient (ICC) by 10-20% at a 5% significance level with 80% power. Recruitment 
was stopped when 69 subjects had completed the test-retest questionnaire because of 
time constraints for recruitment. 
Sixty nine subjects completed the FFQ section of the questionnaire twice (retest 
group).  Subjects agreeing to undertake the retest questionnaire approached TH with 
their study card (containing ID number and date of first questionnaire administration) 
and were given the retest questionnaire to complete. Three subjects were willing to 
complete the retest questionnaire but had lost their study cards, therefore they provided 
their date of birth and date of their last appointment to allow the matching up of birth 
dates and initial questionnaire to the retest questionnaire.  Subjects could indicate on 
the retest questionnaire whether they thought that their intake had changed since they 
last completed the questionnaire and if so, they were requested to specify the reason 
for the change. 
3.4 Data collection tool 
This study utilised a 68-item questionnaire comprising of a 41-item iodine-specific 
FFQ (adapted from a tool validated by Tan et al. (2013) in the elderly).  The 
questionnaire was a combination of work developed and used previously by Charlton 
et al. (2013) (NSW) and Edmonds (2013) (NZ) and was based on foods considered to 
have a relatively high level of iodine per 100g (using the NZ food composition 
database) or foods that had been previously identified as good sources of iodine in the 
NZ diet. The FFQ was tailored for the purpose of the study aims and the study 
population (see Table 3.1 for full documentation of adaptations and justification).  
Additions that improved the accuracy of reporting in this study were the options “I do 
not know” and “I do not know what iodine is” (Table 3.1). 
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The data collection tool was used to estimate dietary iodine intake (including iodised 
salt use), to identify frequency of consumption of important sources of iodine 
including cow’s milk, bread and bread products, eggs, fish, shellfish and iodised salt 
over the previous two months, to assess iodine knowledge and iodine-containing 
supplement use (before and during pregnancy). Versions of this questionnaire have 
been used in iodine studies on pregnant women in NZ and NSW (Charlton et al. 2013; 
Edmonds 2013; Lucas et al. 2014). 
Table 3.1  Modifications to original questionnaire from Charlton et al. (2013) and Edmonds 
(2013) for Perth Iodine and Pregnancy Study (PIPS) 
Original item Modification for  
present study  
Justification 
Are you planning on 
breastfeeding? 
Item deleted Not a primary aim of the study 
How often in the last 2 months 
have you had fruit (fresh, 
canned or dried)?  
Item deleted Not a major source of iodine 
Do you feel that your own diet 
provides enough iodine for 
your body’s needs (i.e. when 
you are not pregnant)? 
Addition of the option “I do 
not know what iodine is” 
To encourage accurate reporting 
for those who did not know 
what iodine was 
Do you feel that your own diet 
provides enough iodine for 
your body’s needs (i.e. when 
you are pregnant)? 
Addition of the option “I do 
not know what iodine is” 
To encourage accurate reporting 
for those who did not know 
what iodine was 
What type of salt do you 
mostly use at home? 
Addition of the option “I do 
not know” 
To encourage accurate reporting 
for those who did not know 
How often do you add iodised 
salt during cooking? 
Addition of the option “I do 
not know” 
To encourage accurate reporting 
for those who did not know and 
to acknowledge that not all 
women would be responsible 
for cooking/ additions to 
cooking 
How often in the last 2 months 
have you had a snack bar 
(muesli or fruit bar)? 
Term “snack bar” replaced 
with the term “muesli or 
protein bar” 
Muesli or protein bar likely to 
be a term that is more widely 
recognised in this population 
If you eat chocolate, what is 
your usual serving size (i.e. 
compared to a Moro bar)? 
“Moro bar” replaced with 
“Mars bar” 
Mars bar likely to be a term that 
is more widely recognised in 
this population 
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Original item Modification for  
present study  
Justification 
What ethnic group do you 
belong to?  European, 
Chinese, Indian, Other (Dutch, 
Japanese, Tokelauan) 
Main ethnic groups changed 
to Australian, Australian 
Aboriginal, Torres Strait 
Islander, Indian, Chinese, 
British 
To reflect the Australian 
Standard Classification of 
Cultural and Ethnic Groups * 
None Addition of the item “Are 
there any foods that you have 
given up or stopped eating 
since you became pregnant?” 
Investigation of the omission of 
rich iodine sources (e.g. fish and 
seafood) 
None Addition of the item “How 
often in the last 2 months have 
you eaten a dish or meal that 
has used packaged 
breadcrumbs”? 
+ 
“If you add packaged 
breadcrumbs what would be 
the usual amount added per 
serve of the meal?” 
To capture some data on 
breadcrumb consumption 
(potentially influenced by 
mandatory fortification of 
breadcrumbs manufactured 
from returned bread) 
*(Australian Bureau of Statistics 2011) 
The FFQ consisted of eight consumption options per food item: 
 Never 
 Less than one a month 
 1-3 times a month 
 Once a week 
 2-4 times per week 
 5-6 times per week 
 Once a day 
 2 or more times a day 
Serve sizes were specific to each food item and generally, three options were allocated 
per food (e.g. 1 small egg, 1 medium egg, 1 large egg or ¼ cup, ½ cup, ¾ cup).  In the 
instance that women ticked a serve size that was not an option (in-between, “more” or 
“less” than amounts allocated) an additional code was used to record the quantity (e.g. 
if women stated “less than” the minimum serve size a code was assigned that related 
to half of the minimum serve of that particular food item). 
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Items relating to age, obstetric history, current breastfeeding status, income, education 
level and health status regarding diabetes and thyroid function formed part of the 
questionnaire.  In addition, women were asked to list current medications so as to 
identify and exclude women with active thyroid disease using thyroid medications 
such as thyroxine, or any other medications containing iodine. 
3.5 Data entry and calculations 
Questionnaire items were coded and data were entered into Statistical Package for the 
Social Sciences (SPSS) (IBM Corporation 2013) for data analysis.  Information 
obtained from the FFQs was entered into FoodWorks (Xyris Software Pty Ltd 2009) 
based on AUSNUT 2007 (Food Standards Australia New Zealand 2008b), the 
Australian food reference database containing the most complete iodine data at the 
time.  Each subject’s estimated daily iodine intake (ug) was calculated separately, as 
described below: 
 Gram weights per day were calculated per food item consumed (based on 
corresponding serve size multiplied by frequency of consumption per day) (Table 
3.2) 
 The resulting amount (in grams) was entered into FoodWorks for each subject per 
food item consumed and iodine values based on AUSNUT 2007 were automatically 
assigned 
 Estimated food iodine intake (ug) was automatically summated in FoodWorks and 
was manually entered into SPSS 
 Users of iodised salt, either in cooking or added at the table were distinguished from 
those who didn’t use iodised salt or any type of salt and women who didn’t know if 
the salt they used was iodised or not (Figure 4.3).   
 Gram weights (for iodised salt use) per day were calculated based on the 
corresponding serve size multiplied by frequency of consumption per day. 
 Estimated iodine values from iodised salt were entered into FoodWorks and amounts 
were separated when the subject used iodised salt both in cooking and at the table 
 Iodine values from discretionary iodised salt use were entered as a combined value 
(iodine from food alone + discretionary iodised salt = dietary iodine intake) and as a 
separate value (discretionary iodised salt only) in SPSS (for iodised salt users) 
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 Iodine contribution from non-iodised or regular salt is minimal (0.2 ug/g) therefore 
salt was not entered unless it was iodised (approx. 44 ug per/g) 
 A manual recipe for “Bread fortified with iodine” was established in FoodWorks 
using values automatically assigned for “bread, fresh, nfs (no further specifications)” 
combined with a manual override entry of 46 ug iodine per 100 g, as per FSANZ 
information for fortified bread (Food Standards Australia New Zealand 2012).  This 
manual recipe was used to calculate the iodine content of all bread and bread 
products listed in question 41 (except for organic bread).  One slice of bread (one 
small roll, one small pita) was equivalent to 32 g in weight (as per assigned weight 
in FoodWorks for one slice of “bread, fresh, nfs”. 
 The recipe calculation for “Bread fortified with iodine” was used to correct for iodine 
content for the women who consumed the greatest quantity of breadcrumbs (n=8).  
Grams of breadcrumbs were considered equivalent to grams of bread. 
 Dietary supplements were further categorised into those containing iodine (based on 
the subject consuming at least one brand of supplement containing iodine), whilst 
the remainder of subjects were categorised as not using iodine-containing 
supplements (prior to and during pregnancy) 
 Iodine contribution from supplements was added to daily dietary iodine intake (ug) 
under a new variable and will be referred to as total iodine intake.  This applied to 
subjects who had entered enough information for the daily iodine value of the 
supplement to be ascertained (e.g. brand name, dose + term “daily” or used the term 
“once’ if supplement was a once daily formulation) 
 Women who stated that they took supplements regularly (more than once a week) 
formed part of the subgroup above, with the assumption being that these women 
took the supplement daily 
 Dosage amounts were confirmed on manufacturer’s websites in October and 
November 2014 and cross checked with a recent publication reporting on iodine 
supplementation (El-mani, Mullan, et al. 2014) 
 Estimated iodine intakes were not normally distributed, therefore median (IQR) 
values have been reported and non-parametric tests have been used to conduct 
analyses.  Mean (SD) values have also been reported in some instances to allow 
comparison with other studies 
 FoodWorks data were later imported into Excel spreadsheets 
 85 
Table 3.2  Conversion of frequency options (into daily amount) 
Frequency option Conversion 
2 or more times a day Multiply by 3 
Once a day Multiply by 1 
5-6 times per week Multiply by (5.5/7=0.785) 
2-4 times per week Multiply by (3/7=0.428) 
Once a week  Multiply by (1/7=0.143) 
1-3 times a month Divide by 14 
Less than one a month Divide by 35 
 
Table 3.3  Food descriptions from FoodWorks used for data entry 
(Food Standards Australia New Zealand 2012) 
Food  
Milk,cow,fluid,regular fat (~3.5%)  
Cheese,colby style   
Ice cream,regular fat,vanilla & other non-chocolate flavours   
Sausage,beef,grilled   
Chicken,breast,lean,baked   
Beef,blade steak,lean,grilled   
Tofu (soy bean curd),firm,as purchased   
Egg,chicken,whole,cooked,nfs   
Fish,finfish,raw,nfs   
Oyster,raw   
Sushi,California roll,restaurant style   
Bread fortified iodine   
Spinach,English,boiled,drained   
Breadcrumbs,white,commercial   
Cake,plain/buttercake,uniced,homemade from basic ingredients   
Muffin,cake/American style,plain,homemade   
Bar,muesli,with added nuts   
Nuts,mixed (peanut,cashew,hazelnut,brazil nut)   
Chocolate,milk & white chocolate (e.g. Top Deck)   
Salt,table,iodised   
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Percentage contribution to dietary iodine intake (cow’s milk and bread) 
Studies conducted in Australia and NZ have identified that cow’s milk and bread 
products are significant contributors to the iodine intake of women of child-bearing 
age and pregnant women. In the present study, the contribution of these food sources 
were determined by dividing each subject’s estimated daily iodine intake from each 
source by her total estimated daily dietary iodine intake for all food items expressed 
as a percentage. 
Iodised salt users as 3 separate subgroups 
Only some subjects knew if they used iodised salt.  The above calculation was used to 
estimate the percentage contribution of discretionary iodised salt for all subjects 
(assigning 0% for those who did not use iodised salt or did not know what type of salt 
they used) and for women who only answered yes or no to the iodised salt questions 
(excluding the subjects who did not know what type of salt they used) (Table 4.5).  The 
differences in percentage contribution of iodised salt for iodised salt users only was 
also determined (Table 4.6). 
For those who used iodised salt, the iodised salt contribution to dietary iodine intake 
(ug/d) was factored into the numerator and denominator as below: 
 1: Estimated iodine (ug) from iodised salt calculated using FoodWorks (based on 
subject’s estimation of iodised salt use). 
 2: Estimated iodine (ug) from iodised salt calculated by correcting (halving) 
iodised salt used in cooking for primigravid women.  This was based on the 
assumption that the majority of subjects who were pregnant for the first time were 
cooking for two people (subject and partner). 
 3: Estimated iodine (ug) from iodised salt calculated using an adjusted standard 
figure of 48 ug (approximately equivalent to 1 g of iodised salt) (Charlton et al. 
2013; Mallard and Houghton 2014). 
Example for 1: Iodised salt contribution to dietary iodine intake (ug/d) (ID 005): 
1: Estimated iodine (ug) from iodised salt calculated using FoodWorks 
(based on subject’s estimation of iodised salt use)/total estimated daily 
dietary iodine intake * 100 = 66.4/401.8*100 = 16.5% 
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This above approach was also applied to cow’s milk and bread percentage contribution 
calculations (iodised salt included in the denominator for users of iodised salt).  The 
difference in percentage iodine contribution of cow’s milk and bread for those who 
did not use iodised salt was also determined (Table 4.5). 
3.6 Data preparation 
It was necessary to recode a number of variables into categorical variables to assist 
with data analysis (Table 3.4) 
Table 3.4  Categorisation of variables used in the analyses 
Variable Definition and categorisation 
Age (y) Subject’s age categorised into three levels (18-24, 25-34, 35-44) 
Estimated food iodine 
intake (ug) 
Subject’s estimated food iodine intake categorised into two levels 
(Meets EAR, Does not meet EAR) 
Estimated food iodine 
intake (ug) 
Subject’s estimated food iodine intake categorised into three levels 
(tertiles-for subjects completing FFQ1 and FFQ2) 
Ethnic group Subject’s categorisation of her ethnic group collapsed into three 
combinations of ethnic groupings (Australian/Australian 
Aboriginal/TSI, New Zealand/Polynesian, Asian/African/Other) 
Iodised salt use Subject’s use of iodised salt initially categorised into three groups 
(yes, no, I do not know), then into two levels (yes, no-omitting those 
who did not know). 
Estimated iodine intake 
from cow’s milk (ug) 
Subject’s estimated intake from cow’s milk categorised into three 
levels (tertiles-for subjects completing FFQ1 and FFQ2) 
Estimated iodine intake 
from bread and bread 
products (ug) 
Subject’s estimated intake from bread and bread products categorised 
into three levels (tertiles-for subjects completing FFQ1 and FFQ2) 
Consumption frequency 
(bread and bread 
products) 
The lowest levels of consumption (1-3 times a month, < once a 
month and never) were categorised into a new group (< once a week) 
Dietary supplement use Subject’s use of dietary supplements categorised into two groups 
(iodine-containing or non-iodine containing) 
Foods no longer 
consumed 
Subject’s descriptions of foods avoided during pregnancy categorised 
into seven groups (fish/shellfish/seafood, soft cheese and 
unpasteurised dairy, deli meat/pre-prepared and reheated foods, raw 
fish/raw seafood/raw meat, eggs, soft drinks/sugary foods, other) 
Foods required by law to 
have iodine added to 
them 
Subject’s responses categorised into seven groups (bread, salt, 
breakfast cereal/cereal, food that is too salty, chips, seafood, 
milk/dairy) 
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New variables were created to record iodine content (ug) of reported supplement use 
for those who gave enough information to be able to quantify a daily iodine dose 
amount.  It was assumed that non-specific descriptions of multivitamins that were 
preparations for “women” or “pregnancy” formulations contained iodine thus were 
coded as iodine-containing.  Additional variables were created to record estimated 
iodine content (ug) of reported iodised salt use (separate from food intake in the FFQ).  
All p values < 0.05 were considered statistically significant. 
Data analysis 
Data were entered and analysed using IBM SPSS Statistics for Windows, version 23.  
Descriptive statistics were obtained for variables of interest.  For continuous variables, 
median (interquartile range (IQR) were used for skewed data, mean ± standard 
deviation (SD) were used to allow for comparisons with other studies. Frequencies and 
relative percentages were obtained for categorical variables and chi-square tests were 
conducted to assess associations between two categorical variables of interest (e.g. 
iodine supplement use and level of education, income, ethnicity and previous 
pregnancies). 
Test-retest reliability 
Test-retest reliability between FFQ1 and FFQ2 was assessed using ICC for continuous 
variables and Cohen’s kappa for categorical variables.  For sound reliability, an ICC of 
>0.6 and kappa values of >0.7 are recommended (Table 3.6 and Table 3.7).  More 
specifically, two-way random effects model (ICC) of food iodine intake (ug) from FFQ1 
and FFQ2 based on two-way random effects model was calculated for assessing the 
agreement between the questionnaires, as well as between items contributing the most to 
overall food iodine intake (ug) of the study population (cow’s milk and bread products). 
Table 3.5  Statistical tests to determine reliability for continuous data 
Variable Statistical test Application 
Food iodine intake (ug) 
FFQ1 & FFQ2 
(ICC agreement) To determine inter-rater reliability 
Cow’s milk (iodine content ug) 
FFQ1 & FFQ2 
(ICC agreement) To determine inter-rater reliability 
Bread products (iodine content ug) 
FFQ1 & FFQ2 
(ICC agreement) To determine inter-rater reliability 
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Table 3.6  Strength of agreement relating to ICC value 
ICC valuea Strength of agreement 
0.41-0.60 Moderate agreement 
0.61-0.80 Good agreement 
>0.80 Very good agreement 
a (Altman 1999, cited inSchneider 2007) 
In recognition of the fact that the iodine quantities (ug) were derived from the FFQ, 
food iodine intake (ug) data from FFQ1 and FFQ2 were further categorised into tertiles 
to investigate the ranking ability of the questionnaire upon repeated administrations.  
The kappa statistic and the percentage of observed agreement were computed 
(Appendix D).  
Tertile values for food iodine intake (ug/d) data from FFQ1 and FFQ2 were 
categorised as follows: 
 Tertile 1= lowest intake (0 through 104.96 ug/d) 
 Tertile 2= medium intake (104.97 through 196.71 ug/d)* 
*  The EAR for iodine (160 ug/d) is correctly captured in tertile 2 
 Tertile 3= highest intake (196.72 through highest amount) 
Table 3.7  Interpretation of Kappa 
Kappa value Strength of 
agreement 
Interpretation 1a 
Kappa value Strength of 
agreement 
Interpretation 2b 
  <0 Poor agreement 
  0.01-0.20 Slight agreement 
  0.21-0.40 Fair agreement 
0.41-0.60 Moderate agreement 0.41-0.60 Moderate agreement 
0.61-0.80 Good agreement 0.61-0.80 Substantial agreement 
>0.80 Very good agreement 0.81-0.99 Almost perfect 
agreement 
a (Altman 1999, cited inSchneider 2007) 
b (Viera and Garrett 2005) 
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Additionally, Wilcoxon signed rank test was applied to assess the difference in mean 
between two repeated variables (test and retest) from FFQ1 and FFQ2.  Marginal 
homogeneity test was also used to assess the marginal homogeneity between two 
categorised variables of interest (Appendix D). 
Separate analyses were carried out excluding the group who had reported that they 
thought their dietary intake had changed between FFQ administrations given the 
potential for changes in iodine intake.  Analyses were run firstly with, and secondly, 
without these subjects. This process was also followed for women who were provided 
with the KEMH iodine brochure after completion of their first questionnaire due to the 
questions they asked regarding iodine upon initial administration, women who 
completed FFQ2 within 14 days or after 14 days and for women in two different stages 
of pregnancy (≤28 weeks gestation and ≥29 weeks gestation) 
Development of a rapid screening tool 
The development of a rapid screening tool to assess pregnant women’s likelihood of 
meeting the EAR for iodine involved the reduction of the 41-item iodine-specific FFQ 
to five key questions (Section 4.7). 
The purpose of the first question was to identify women with thyroid disease and to 
recommend that iodine requirements are discussed with their Doctor/Obstetrician.  The 
remaining questions were based on the major contributors to iodine intake in this 
population (Figure 4.9): 
 iodine-containing supplements 
 iodised salt 
 cow’s milk 
 bread and bread products (mandatory fortification vehicle) 
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The rapid screening tool associates the consumption of the above-mentioned items to 
the percentage likelihood of meeting the EAR using the total iodine data for the iodine-
containing supplement question, the dietary iodine data for the question relating to 
iodised salt consumption and the food iodine data for the cow’s milk and bread and 
bread products questions (Section 3.5).  Chi-square tests were conducted to ascertain 
these percentages and to assess significant association between the consumption of 
major contributors to iodine in the study population and attainment of  the EAR. 
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CHAPTER 4 : RESULTS 
4.1 Subjects 
Pregnant women were recruited from antenatal clinics operating from Western 
Australia’s only tertiary women’s and neonatal hospital (29 December 2012 to 16 July 
2013).  Sixty five women screened via the introductory questions were not recruited 
to the study due to thyroid disease, history of thyroid disease, diabetes and history of 
diabetes or suspicion of diabetes (awaiting results of their oral glucose tolerance test).  
One hundred and twenty women declined to participate in the study including four 
women who would have required an interpreter.  Data were collected and analysed for 
425 subjects, with 455 questionnaires disseminated and 433 questionnaires returned 
(Figure 4.1). Eight questionnaires were excluded: three due to subjects’ age <18 years, 
three due to incomplete responses (>1/2 of the questionnaires were incomplete) and 
two because of active thyroid disease.  Six women completed the questionnaire with 
translation and interpretation from a family member and one woman had the assistance 
of a translator/interpreter within the clinic.  The overall response rate of those eligible 
was 71%. 
 
Figure 4.1  Recruitment for PIPS 
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4.1.1 Demographic characteristics   
The demographic information of the subjects is summarised in Table 4.1.  The mean 
age was 29.4 (5.5) years (range 18-44 years), with more than a third of these women 
(38%) in their first pregnancy.  Over half (58%) were ≥ 29 weeks gestation, and 42% 
of subjects were 13-28 weeks pregnant.  Only 3 women were less than 13 weeks 
pregnant (<1%).   
Due to low subject numbers in some groups, ethnicity was recoded into three 
combinations of ethnic groups (see Appendix E for all ethnic groups indicated by 
subjects), with over half (53%) from Australian/Australian Aboriginal/Torres Strait 
Islander (TSI) backgrounds, of which a low number were Australian Aboriginal and 
TSI women (n=10 and n=0), respectively.  Approximately 40% of subjects were of 
Asian/African/Other ethnicities.  New Zealand/Polynesian subjects made up less than 
10% of the total sample.  The largest subgroup based on education had tertiary or 
professional qualifications (42%), followed by women who had completed secondary 
school only (33%) and women with a diploma, trade or technical certificate (25%).   
Due to the sensitive nature of income related questions, women were given the option 
not to answer the question on self-reported individual income in the twelve months 
prior to completing the questionnaire, and 17% chose not to.  Of those who answered, 
over half of the subjects (54%) earned less than $50 000, almost one quarter (24%) 
earned $50 000-$100 000 and 5% earned more than $100 000.   
Despite the screening questions designed to exclude those with diabetes/gestational 
diabetes, history of diabetes or thyroid disease, 9 women (2%) reported a history of 
thyroid disease (diagnosed by a doctor) and 18 women (4%) had been told by a doctor 
that they have/had diabetes.  Seven women (2%) were breastfeeding at the time of 
administration of the first questionnaire.  Based on exclusion criteria, a further two 
questionnaires indicating active thyroid disease were excluded.  
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Table 4.1  Subject characteristics 
Subject  
Variable 
n % 
Age (y) (n=422)  
Mean (SD) 
Range 
Missing data  
 
29.4 (5.5) 
18-44 
3 
 
 
Age (group) (n=422) 
18-24 
25-34 
35-44 
Excluded <18 
 
89 
253 
80 
3 
 
21 
60 
19 
Gravidity (n=425) 
Primigravid 
Multigravid 
 
163 
262 
 
38 
62 
Gestation (wk) (n=425) 
<13  
13-28 (inclusive)  
≥29  
 
3 
177 
245 
 
<1 
42 
58 
Combinations of ethnic groups (n=424) 
Australian/Australian  
Aboriginal/TSI  
New Zealand/Polynesian 
Asian/African/Other 
Missing data 
 
223 
 
33 
168 
1 
 
53 
 
8 
39 
Highest level of education (n=420) 
Tertiary or professional qualification 
Diploma, trade or technical certificate 
Secondary school qualification 
Missing data 
 
176 
106 
138 
5 
 
42 
25 
33 
Individual reported income ($) (n=417) 
<$50 000 
$50 000-100 000 
>$100 000 
Do not wish to answer  
Missing data 
 
227 
99 
19 
72 
8 
 
54 
24 
5 
17 
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4.2 Iodine-containing supplement use 
4.2.1 Prior to pregnancy 
Two hundred and fifty three subjects reported that they did not use any dietary 
supplements in the year prior to becoming pregnant whilst a total of 169 selected either 
yes (occasionally, less than once a week) (n=34), yes (regularly, more than once a 
week) (n=132) or yes (without further description) (n=3).  Three subjects did not 
answer this question.   
In total, 78 different brands, and/or dosages of brands of dietary supplements were 
identified and these ranged from pregnancy-specific multivitamin preparations, folate, 
calcium ± vitamin D and iron, to weight loss and “detox” products.  The highest 
percentage use per subject was iron (all brands) (21%), followed by Elevit (19.2%) 
(contains 220 ug iodine) and folate (all brands) (19.2%). 
The results in Figure 4.2 demonstrate that approximately one-quarter of subjects 
(n=102) used an iodine-containing supplement in the year prior to pregnancy, the 
majority of women did not.  Age was significantly associated with iodine-containing 
supplement use in the year before pregnancy (𝜒2=10.855, df=2, p=0.004) (Table 4.2).  
A higher proportion of women in the highest age category (35-44 years) used iodine-
containing supplements in the year before pregnancy (36.7%) compared to 24.2% in 
the 25-34 year age category and 14.8% in the youngest age category (18-24 years) 
(Appendix F).  
There was a significant association between iodine-containing supplement use and 
gestational stage groups (𝜒2=5.376, df=1, p=0.020).  A greater proportion of women 
in the earlier stage of pregnancy at the time the questionnaire was completed (up to 
and including 28 weeks) (30.1%) reported using an iodine-containing supplement in 
the year before pregnancy compared to those who were in the later stage of pregnancy 
(29 weeks or more) (20.2%)  (Table 4.2) (Appendix F). 
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Income category was significantly associated with iodine-containing supplement use 
in the year prior to pregnancy (𝜒2=6.923, df=2, p=0.031).  A higher proportion of 
women from the highest income category (52.6%, n=10) reported using iodine-
containing supplements in the year prior to pregnancy, followed by 26.5% (n=26) in 
the middle income category and 24.8% (n=55) in the lowest income category  (Table 
4.2) (Appendix F).  Education level, however, was not significantly associated with 
iodine-containing supplement use prior to pregnancy (Appendix F). 
4.2.2 During pregnancy 
More than twice the number of subjects reported using dietary supplements during 
pregnancy compared to pre-pregnancy (n=362, n=169), respectively.  Only sixty 
subjects reported that they did not use any dietary supplements whilst the majority of 
subjects used dietary supplements.  A total of 362 women stated either yes 
(occasionally, less than once a week) (n=34), yes (regularly, more than once a week) 
(n=301) or yes (without further description) (n=27). Three subject responses to this 
question were missing.   
Subject responses revealed that 82 different brands, and/or dosages of brands of dietary 
supplements were used during pregnancy.  The same types of products were used 
before and after pregnancy apart from weight loss or “detox” products.  The highest 
percentage use per subject was Elevit (43.4%) (contains 220 ug iodine), followed by 
iron (all brands) (31.8%), vitamin D (all brands) (19.4%) and folate (all brands) 
(19.2%). 
Figure 4.2 illustrates that more than half of the subjects (65.7%) used an iodine-
containing supplement during pregnancy.  Three women did not respond to the 
question and eight women did not give enough information to ascertain whether the 
supplement contained iodine or not therefore were excluded from the percentage 
calculation. 
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Only three subjects (3.2%) taking quantifiable iodine-containing supplements did not 
meet the EAR cut-off of 160 ug/day.  The most likely explanation for this relates to 
supplement dosing assumptions with all three women taking a pregnancy supplement 
that required a dose of two capsules per day.  Two women did not specify that they 
took two capsules as a dose and therefore it was assumed that they only consumed one 
capsule daily, with the third woman specifying consumption of the supplement three 
times a week.  In addition, these women only consumed cow’s milk a maximum 2-4 
times a week and were not iodised salt users. 
 
Figure 4.2  Percentage of subjects using iodine-containing supplements 
Versus either no supplements or non-iodine containing supplements prior to pregnancy (n=418) and 
during pregnancy (n=414).   
As mentioned in Section 3.5 iodine content in supplements was quantified for 95 
subjects.  The mean iodine content of these supplements was approximately 186 ug 
(median=220 ug) (range 38 ug to 500 ug).  Over half of these subjects (n=49) (52%) 
consumed a supplement containing 220 ug iodine (above the NHMRC 
recommendation of 150 ug), with 17 women (18%) taking a supplement that contained 
less iodine than the NHMRC recommendation.  
Gestational stage was significantly associated with iodine-containing supplement use 
during pregnancy (𝜒2=11.279, df=1, p=0.001).  A higher proportion of women who 
were in the earlier stage of pregnancy (at or before 28 weeks gestation) at the time of 
completing the questionnaire reported using iodine-containing supplements (74.9%, 
n=131) compared to women in the later stage of pregnancy (29 weeks or more) (59%, 
n=141) (Table 4.2) (Appendix F). 
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A higher proportion of women who were pregnant for the first time reported using 
iodine-containing supplements (73.8%, n=118) compared to 60.6% (n=154) of women 
who had been pregnant previously (𝜒2=7.498, df=1, p=0.006) (Table 4.2) (Appendix 
F).  Unlike the findings prior to pregnancy, age and income were not significantly 
associated with the use of iodine-containing supplements during pregnancy.  Similar 
to the results prior to pregnancy, education level was not significantly associated with 
iodine-containing supplement use (Appendix F). 
Table 4.2  Demographic comparison – iodine-containing supplement use 
 Prior to pregnancy During pregnancy 
Subject  
Characteristics 
n (%) P value 
Chi-square 
n (%) P value 
Chi-square 
Age (group)  
n 
18-24 
25-34 
35-44 
 
102 
13 (14.8) 
60 (24.2) 
29 (36.7)  
 
p=0.004 
 
271 
52 (59.1) 
163 (66.5) 
56 (71.8) 
 
p=0.216 
First pregnancy 
n 
Yes 
No 
 
102 
38 (23.8)  
64 (24.8) 
 
p=0.807 
 
272 
118 (73.8) 
154 (60.6) 
 
p=0.006 
Gestation (wk) 
n 
Up to-28 (inclusive)  
≥29  
 
102 
53 (30.1) 
49 (20.2) 
 
p=0.020 
 
272 
131 (74.9) 
141 (59.0) 
 
P=0.001 
Individual income  
n 
<$50 000 
$50 000-100 000 
>$100 000   
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 55 (24.8) 
26 (26.5) 
10 (52.6) 
 
p=0.031 
 
230 
145 (65.9) 
71 (71.7) 
14 (73.7) 
 
p=0.508 
 
4.3 Estimated iodine intake (ug/d) 
Estimated daily iodine intake was determined from the subjects’ selected serve sizes 
and frequencies of consumption of the food items within the FFQ (Section 3.5).  Users 
of iodised salt, either in cooking or added at the table were distinguished from those 
who didn’t use iodised salt or any type of salt and women who didn’t know if the salt 
they used was iodised or not (Figure 4.3). 
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Figure 4.3  Categorisation of subjects’ use of iodised salt 
Estimates of iodine intake are reported via three different methods: 
1. Food iodine (n=425) (iodine intake from food alone) 
2. Dietary iodine (n=425) (iodine intake from + iodised salt for those who used 
iodised salt) 
3. Total iodine (n=95) (iodine intake from food + iodised salt for those who used 
iodised salt + iodine in supplement for those who provided brand and dosage 
amounts) (Table 4.3).   
The median iodine intake estimated from food was 148 ug/day, slightly less than the 
EAR for pregnancy (160 ug/day).  Median iodine intakes calculated with the dietary 
iodine data and with the total iodine data were 196 ug/day and 358 ug/day, 
respectively, meeting the EAR for pregnancy (Table 4.3).  Although the intake data 
were not normally distributed, the means have been calculated for comparison with 
other studies and are also included in Table 4.3.  
Table 4.3  Estimated iodine intake according to three different methods. 
Iodine intake Mean 
(ug/day) 
Median 
(IQR) 
(ug/day) 
Min-Max  
(ug/day) 
Meets EAR 
(≥160 ug/day) 
FOOD IODINE 
(food alone) 
n=425 
170 
±98.6 
148 
(100.2-228.0) 
8.3-669.9 
 
Yes (Mean) 
No (Median) 
DIETARY IODINE 
(food ± iodised salt) 
n=425 
234 
±172.1 
196 
(120.3-298.2) 
8.3-1163.9 
 
Yes (Mean) 
Yes (Median) 
TOTAL IODINE 
(food ± iodised salt  
+ iodine supplements) * 
n=95 
415 
±211.7 
358 
(292.8-485.7) 
109.9-1383.9 
 
Yes (Mean) 
Yes (Median) 
* The subjects who used iodine containing supplements and provided brand and dosage allowing for 
quantification. 
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Approximately 3% and 8% of the subjects who consumed quantifiable iodine 
supplements (n=95) did not achieve the EAR and RDI for pregnant women, 
respectively (Figure 4.4) (Table 4.4).  This is compared to over one-third (39.3%) of 
the subjects in the dietary iodine group who did not meet the EAR, whilst more than 
half (53.4%) did not achieve the EAR in the food iodine group.  Less than 5% of those 
in the total iodine group did not meet the EAR (Table 4.4).  
Table 4.4  Proportion of women who did not achieve the EAR, who met the EAR, met the RDI 
and who exceeded the UL for iodine. 
* The subjects who used iodine containing supplements and provided brand and dosage allowing for 
quantification. 
Nearly 40% of the sample were primigravid.  There was a significant association 
between meeting the EAR and gravidity (𝜒2=6.695, df=1, p=0.010) when assessing 
food iodine data.  A higher proportion (51.5%, n=135) of women who had been 
pregnant previously achieved the EAR compared to those who were primigravid 
(38.7%, n=63).  A similar trend was apparent when comparing EAR and gravidity 
using food + iodised salt data for women who had been pregnant previously (63.7%, 
n=167) compared to primigravid women (55.8% n=91), however this association was 
not statistically significant (𝜒2=2.637, df=1, p=0.104).  
Iodine intake Did not meet 
EAR  
(<160 ug/day) 
(%) 
Meets EAR 
(≥160 ug/day) 
 
(%) 
Meets RDI 
(≥220 ug/day) 
 
(%) 
Exceeds UL 
(>1100 ug/day) 
 
(%) 
FOOD IODINE 
(food alone) 
n=425 
53.4 46.6 27.5 0 
DIETARY IODINE 
(food ± iodised salt) 
n=425 
39.3 60.7 42.6 0.2 
TOTAL IODINE 
(food ± iodised salt  
+ iodine supplements) * 
n=95 
3.2 96.8 91.6 3.1 
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Figure 4.4  Percentage of subjects achieving the EAR for iodine 
According to food iodine (iodine intake from food alone), dietary iodine (iodine intake from + iodised 
salt for those who used iodised salt) and total iodine (iodine intake from food + iodised salt for those 
who used iodised salt + iodine in supplement for those who provided brand and dosage amounts).   
4.3.1 Important contributors to dietary iodine intake 
The mean percentage contributions of the three major sources of dietary iodine intake 
for the study subjects was calculated as described in Section 3.5 and are summarised 
in Table 4.5 and Figure 4.5.  The contribution of discretionary iodised salt was 
calculated by; 
1. Estimated iodine from iodised salt calculated using FoodWorks (based on subject’s 
estimation of iodised salt use)  
2. Estimated iodine (ug) from iodised salt calculated by correcting (halving) iodised 
salt used in cooking for primigravid women (subject and partner) 
3. Estimated iodine (ug) from iodised salt calculated using an adjusted standard figure 
of 48 ug (approximately equivalent to 1 g of iodised salt). 
In addition, the percentage iodine contribution from cow’s milk and bread and bread 
products for those who did not use iodised salt was calculated.  Over one-third (38-
41%) of dietary iodine intake came from cow’s milk across these calculations with the 
contribution to those who were not using discretionary iodised salt (n=265) being 
closer to half (45%).  Bread products (fortified with iodine) provided approximately 
18-20% of total iodine.  Iodised salt contributed 10-16% of the total or 12-19% when 
those subjects who did not know what type of salt they used were removed (n=70).  In 
women who provided an estimate of serve size of iodised salt (n=156), contributions 
ranged from 27-44% (Table 4.5).  The differences in percentage contribution of iodised 
salt for iodised salt users only are reported in Table 4.6. 
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Table 4.5  Mean percentage contribution of bread and bread products, cow’s milk and iodised 
salt  
 Bread Cow’s milk Iodised salt  
Iodised salt  
(only yes or no 
responses) 
 
All subjects  
FoodWorks1 
18.5 
n=425 
38.4 
n=424* 
16.1 
n=425 
19.3 
n=355 
 
All subjects 
Corrected2  
18.8 
n=425 
39.1 
n=424* 
14.7 
n=425 
17.6 
n=355 
 
All subjects 
Adjusted 48 ug3 
19.9 
n=425 
41.3 
n=424* 
10.0 
n=425 
12.0 
n=355 
 
Subjects NOT 
using iodised salt 
21.5 
n=265 
45.0 
n=265 
  
*1 subject response missing 
1Total iodine intake of iodised salt users calculated using FoodWorks (based on subject’s estimation of 
iodised salt)  
2Total iodine intake of iodised salt users calculated by correcting (halving) iodised salt (cooking) for 
primigravid pregnant women 
3Total iodine intake of iodised salt users calculated using an adjusted standard figure of 48 ug for iodised 
salt in all iodised salt users 
Table 4.6  Mean percentage contribution of iodised salt (iodised salt users only) 
 Iodised salt 
 
Iodised salt users 
FoodWorks1 
43.6 
n=156 
 
Iodised salt users 
Corrected2  
40.1 
n=156 
 
Iodised salt users 
Adjusted 48 ug3 
27.3 
n=156 
1Total iodine intake of iodised salt users calculated using FoodWorks (based on subjects estimation of 
iodised salt) 
2Total iodine intake of iodised salt users calculated by correcting (halving) iodised salt (table) for 
primigravid pregnant women 
3Total iodine intake of iodised salt users calculated using an adjusted standard figure of 48 ug for iodised 
salt in all iodised salt users 
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Figure 4.5 Comparison of the mean percentage contribution 
Food items contributing the most to iodine intake of subjects using Iodine (ug) from iodised salt 
estimate 1 (calculated using FoodWorks (based on subject’s estimation of iodised salt use)), estimate 
2 (calculated by correcting (halving) iodised salt used in cooking for primigravid women) and 
estimate 3 (calculated using an adjusted standard figure of 48 ug (approximately equivalent to 1 g of 
iodised salt)).  
4.3.2 Frequency of consumption 
All but two women responded to the cow’s milk questions in FFQ1, with 19 women 
indicating that they had not consumed cow’s milk in the last two months.  In addition, 
one subject indicated “nil” relating to serve size and another subject’s serve size was 
missing. Frequency of consumption of cow’s milk was found to be significantly 
associated with achieving the EAR (𝜒2=205.865, df=7, p<0.001) using food iodine 
data.  Of those who consumed cow’s milk two or more times a day, the majority 
(91.2%, n=145) achieved the EAR.  In comparison, only 23.3% (n=35) in the adjacent 
consumption category (once a day) and 15.8% (n=3) of those who never consumed 
cow’s milk met the EAR (Table 4.7).  
The relationship between the frequency of consuming cow’s milk and meeting the 
EAR was also evident when analysing the dietary iodine data for the extreme 
categories (two or more times a day and never) (91.8%, n=146 and 15.8%, n=3) 
(𝜒2=118.005, df=7, p<0.001).   
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Table 4.7  Proportions of women meeting the EAR in each cow’s milk consumption category 
(using food iodine intake and dietary iodine intake) 
 
n 
(within consumption 
category) 
% meeting EAR 
(within consumption category) 
Consumption  
frequency 
 
Food iodine intake 
(Food alone) 
 Dietary iodine 
intake (Food ± 
iodised salt) 
≥2 times a day 159 91.2 (n=145) 91.8 (n=146) 
Once a day  150 23.3 (n=35) 51.3 (n=77) 
5-6 times a week 23 30.4 (n=7) 43.5 (n=10) 
2-4 times a week 37 10.8 (n=4) 35.1 (n=13) 
Once a week 11 9.1 (n=1) 18.2 (n=2) 
1-3 times a month 19 10.5 (n=2) 31.6 (n=6) 
<once a month 5 20.0 (n=1) 20.0 (n=1) 
Never 19 15.8 (n=3) 15.8 (n=3) 
Missing 2   
P value (Chi-square)  <0.001 <0.001 
 
Two women did not respond to the bread and bread products questions in FFQ1 with 
four subjects reporting that they had not consumed any bread or bread products in the 
last two months.  Due to low subject numbers the lowest three categories were 
collapsed into a single category “less than once a week” to assist with statistical 
analysis. Frequency of consumption of bread products fortified with iodine (collapsed 
into 6 categories) was also significantly associated with achieving the EAR 
(𝜒2=85.309, df=5, p<0.001) based on food iodine data (method 1).  Of the women who 
consumed bread products two or more times a day, more than three-quarters (82.8%, 
n=77) achieved the EAR (based on food iodine data), compared to 48.4% (n=78) of 
subjects who consumed bread products once a day (n=161).  There were no subjects 
who reported never consuming these items in the group who met the EAR.  
Based on the dietary iodine estimation (method 2), the association remained significant 
(𝜒2=65.447, df=5, p<0.001).  Of those who had eaten bread products two or more 
times a day, the majority (91.4%, n=85) achieved the EAR compared to those who 
consumed bread products once a day (62.1%, n=100) or did not have bread products 
(25%, n=1) (Table 4.8).  
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Table 4.8  Proportions of women meeting the EAR in each bread consumption category - 
original categories 
(using food iodine intake and dietary iodine intake) 
 
n 
(within consumption 
category) 
% meeting EAR 
(within consumption category) 
Consumption  
frequency 
 
Food iodine intake 
(Food alone) 
 Dietary iodine 
intake (Food ± 
iodised salt) 
≥2 times a day 93 82.8 (n=77) 91.4 (n=85) 
Once a day  161 48.4 (n=78) 62.1 (n=100) 
5-6 times a week 47 14.9 (n=7) 34.0 (n=16) 
2-4 times a week 76 25.0 (n=19) 42.1 (n=32) 
Once a week 22 45.5 (n=10) 59.1 (n=13) 
1-3 times a month 9 33.3 (n=3) 44.4 (n=4) 
<once a month 11 36.4 (n=4) 45.5 (n=5) 
Never 4 0.0 25.0 (n=1) 
Missing 2   
P value (Chi-square)  <0.001 <0.001 
 
Limitations of the FFQ: 
1. Whilst not part of the bread and bread products question, 8 subjects in this study 
consumed breadcrumbs more than once a week. The maximum estimated quantity 
consumed by 5 of these women was approximately 26 g of breadcrumbs per day 
(approximately 12 ug of iodine when corrected for increased iodine due to 
fortification).  This was determined by applying the “Bread fortified with iodine” 
calculation (46 ug iodine per 100g).  These corrections did not have an impact on 
whether subjects did or did not meet the EAR for iodine.  
2. One subject reported using rock salt with a strip of nori (edible seaweed) added to 
the salt grinder. Estimation of iodine quantity for this item was difficult based on 
limitations in measuring minimal amounts. The subject reported the quantity as “a 
sprinkle a day” and based on a FoodWorks estimation of 1 strip = 8.92 ug iodine, 
the amount of iodine would be negligible (e.g. 100 days to use up the strip weighing 
0.5 g in total equates to 0.005 g of nori per day = 0.089 ug iodine). 
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4.4 Iodised salt use 
The use of iodised salt in cooking and use at the table were two separate questions with 
different serve sizes allocated for each (1/4 teaspoon, 1/2 teaspoon, 1 teaspoon for 
addition to cooking and just a sprinkle, 1/8 teaspoon, 1/4 teaspoon for addition at the 
table) (see Appendix B).   
The frequency categories for iodised salt use were; never, less than one a month, 1-3 
times a month, once a week, 2-4 times per week, 5-6 times per week, once a day and 
2 or more times a day, with the option of I don’t know.  
The initial analysis of iodised salt use categorised respondents as; yes (uses iodised 
salt, either in cooking or at the table), no (does not use iodised salt, either in cooking 
or at the table), or I do not know (for those who were uncertain of the type of salt they 
used).  As shown in Figure 4.6, just under half of the subjects (45.9%) (n=195) did not 
use iodised salt, followed by 37.6% who reported using iodised salt (n=160).  
Approximately 16% (n=70) of the women did not know what type of salt they used.   
 
Figure 4.6  Iodised salt use in cooking and/or at the table 
When those who didn’t know whether they used iodised salt or not were excluded 
(n=70) 54.9% reported that they did not use iodised salt and 45.1% of subjects reported 
using iodised salt. Further analysis to determine the percentage of subjects who met 
the EAR and demographic characteristics associated with iodised salt use only used 
these binary data. 
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Over half of those who responded to the question relating to iodised salt use in cooking 
(n=158) used it at least once a day (62%, n=98) (Table 4.9).  Comparative figures for 
iodised salt use at the table were much lower, with 39.2% (n=62) consuming iodised 
salt at the table at least once a day (Table 4.9). 
Cross-tabulation and chi-square analysis indicated a significant association between 
iodised salt use and achievement of the EAR (𝜒2=47.089, df=1, p<0.001).  The 
majority of those who used iodised salt attained the EAR (82.5%, n=132) whilst only 
47.2% of those who did not use iodised salt achieved the EAR (Appendix F).  
There was a significant association between iodised salt use (for subjects who knew what 
type of salt they used) (n=352) and education level (𝜒2=7.522, df=1, p=0.023).  A greater 
proportion of women who had tertiary or professional qualifications (53.7%) reported 
using iodised salt compared to 39.8% of those who had secondary school qualifications 
and 38.5% of those with a diploma, trade or technical certificate (Appendix F).   
Combination of ethnic group was also significantly associated with iodised salt use 
(𝜒2=18.056, df=2, p<0.001).  The highest proportion of women from 
Asian/African/Other ethnic groups backgrounds (59.1%) used iodised salt, compared 
to 46.7% of women from New Zealand/Polynesian backgrounds.  The lowest 
proportion of women using iodised salt were those of Australian/Australian 
Aboriginal/TSI backgrounds (35.2%) (Appendix F).  
Table 4.9  Frequency and percentage of iodised salt use in cooking and at the table. 
 Use in cooking Use at the table 
Consumption frequency Frequency (n) Percent Frequency (n) Percent 
2 or more times a day 42 26.6 13 8.2 
Once a day 56 35.4 49 31.0 
5-6 times per week 15 9.5 4 2.5 
2-4 Times per week 19 12.0 16 10.1 
Once a week 11 7.0 18 11.4 
1-3 times a month 5 3.2 9 5.7 
Less than once a month 3 1.9 13 8.2 
Never 4 2.5 36 22.8 
I do not know 3 1.9 0 0.0 
Total 158 100.0 158 100.0 
Missing 2  2  
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4.5 Knowledge and beliefs-food sources, health problems associated with 
inadequate iodine intakes and iodine information sources 
4.5.1 Food sources 
Salt was selected as a good source of iodine in the Australian diet by 46.9% of subjects 
(Question 13).  Less than half of the subjects correctly selected seafood, eggs and 
bread.  Over one-quarter of subjects incorrectly identified meat and vegetables as a 
good source of iodine, with 12.6% incorrectly selected fruit.  Approximately one-
quarter of women selected “I do not know” when asked to nominate which of the eight 
food items were good sources of iodine in the Australian diet (subjects could select as 
many food items as they wanted) (Table 4.10).  Five subjects did not answer this 
question. 
Table 4.10  Percentage of pregnant women nominating specific foods as being good sources of 
iodine. 
Food source % of subjects  
(n=420) 
% of responses  
(Responses=986) 
Salta* 46.9 20.0 
Seafooda 35.2 15.0 
Eggsa 19.8 8.4 
Milka 17.4 7.4 
Breada*  15.5 6.6 
Vegetables 34.3 14.6 
Meat 26.2 11.2 
Fruit 12.6 5.4 
I do not know 26.9 11.5 
aCorrect answer 
a*Correct answer – only if iodised. 
Education level was significantly associated with the selection of the option “I do not 
know” for the above question (𝜒2=9.188, df=2, p=0.010).  A lower proportion of those 
with tertiary or professional qualifications selected “I do not know” (18.8%) compared 
to 32.1% and 31.9% of those with a diploma, trade or technical certificate and 
secondary education, respectively (Appendix F).  
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Upon assessment of demographic variables and the number of correct responses from 
women for the food items seafood (n=148), eggs (n=83) milk (n=73) and bread (n=65), 
it was found that education was significantly associated with the correct selection of 
seafood as a good source of iodine (𝜒2=13.380, df=2, p=0.001).  Proportionally more 
women who had tertiary or professional qualifications correctly selected seafood 
(43.8%), followed by 34.9% with a diploma, trade or technical certificate and 23.9% of 
those with secondary school qualifications (Appendix F). All other demographic factors 
were not significantly associated with correct responses for this question.  Salt was not 
included in this assessment due to the assumptions surrounding its selection, namely that 
it was assumed that those who selected this option were referring to iodised salt. 
In response to the question “Do you know if there are any foods in Australia that are 
required by law to have iodine added to them?” the majority of women did not know 
(74.7%), 17.3% stated “no”, whilst 8% responded “yes” to the question.  The second part 
of the question was open ended allowing women to specify the food if they nominated “yes”. 
The responses were categorised as follows; bread, salt, breakfast cereal/cereal, any 
food that is too salty, chips, seafood, milk and dairy.  Only 20 women correctly 
identified bread as the mandatory fortification vehicle (4.7% of total sample). 
4.5.2 Health problems 
Over half of the study subjects (55.8%) selected “I do not know” in relation to the list 
of health problems which may or may not be associated with a lack of iodine in the 
diet (Question 14).  Approximately one-quarter of subjects selected the correct 
responses goitre and mental retardation (combined) (Table 4.11). 
Table 4.11  Selected answers for health problems associated with a lack of iodine intake.  
Health Problem % of subjects  
(n=414) 
% of responses  
(Responses=591) 
Goitrea 17.1 12.0 
Mental retardationa 8.9 6.3 
Tiredness 21.3 14.9 
Neural tube defects 15.9 11.2 
Weak bones and teeth  9.2 6.4 
Depression 7.5 5.2 
Arthritis 3.6 2.5 
Blindness 3.4 2.4 
I do not know 55.8 39.1 
aCorrect answer 
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Demographic characteristics indicating significant associations are presented in Table 
4.12.  Age was significantly associated with the correct selection of the health problem 
goitre (𝜒2=6.017, df=2, p=0.049).  A higher proportion of women in the 35-44 year 
age group (25%, n=20) correctly selected goitre, followed by 14.6% (n=37) of those 
in the 25-34 year age group and 12.4% (n=11) of those in the 18-24 year age category.  
While only 36 women correctly selected mental retardation, the same trend occurred 
with the greatest proportion of correct responses (18.8%, n=15) from those in the 
highest age group, 6.3% (n=16) of those in the middle age group and 5.6% (n=5) in 
the 18-24 year age category (Table 4.12) (Appendix F).  
Education level was significantly associated with the selection of the option “I do not 
know” regarding the health problems associated with poor iodine intake (𝜒2=12.022, 
df=2, p=0.002).  A lower proportion of those with tertiary or professional 
qualifications selected “I do not know” (44.9%, n=79) compared to 58.5% (n=62) and 
63.8% (n=88) of those with a diploma, trade or technical certificate and secondary 
education, respectively (Appendix F).  Education level was also significantly 
associated with the correct selection of goitre as an adverse health outcome due to poor 
iodine intake (𝜒2=32.308, df=2, p<0.001) with the greatest proportion of women 
responding affirmatively being those in the higher education group (28.4%, n=50) 
compared to subsequent categories.  A similar trend was evident between education 
category and the correct selection of mental retardation (𝜒2=7.603, df=2, p=0.022) 
(Appendix F).  
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Combination of ethnic groups was significantly associated with the selection of “I do 
not know” (𝜒2=9.732, df=2, p=0.008).  The highest proportion of women from New 
Zealand/Polynesian backgrounds selected this response (63.6%, n=21), followed by 
60.1% (n=134) of those from the Australian/Australian Aboriginal/TSI ethnic 
combination group (Appendix F).  Proportionally more women from 
Asian/African/Other backgrounds (29.2%, n=49) correctly selected goitre, followed 
by 9.1% (n=3) from the New Zealand/Polynesian group and 8.5% (n=19) of those from 
the Australian/Australian Aboriginal/TSI ethnic combination group (𝜒2=30.801, df=2, 
p<0.001).  Similarly, the greatest proportion of women from Asian/African/Other 
backgrounds correctly selected mental retardation as an adverse health outcome 
(13.1%, n=22), followed by 6.3% (n=14)  of those from the Australian/Australian 
Aboriginal/TSI ethnic combination group and 3% (n=1) from the New 
Zealand/Polynesian group (𝜒2=7.048, df=2, p=0.029) (Table 4.12) (Appendix F). 
Stage of pregnancy was significantly associated with the correct selection of goitre 
(𝜒2=6.828, df=1, p=0.009).  A higher proportion of women in the earlier stage of 
pregnancy (up to and including 28 weeks) (22.2%, n=40) selected goitre compared to 
12.7% (n=31) of those in the later stage of pregnancy. 
Table 4.12  Demographic characteristics for selected answers for health problems associated 
with a lack of iodine intake. 
 I do not know Goitre Mental retardation 
Subject  
Characteristics 
n (%) P value 
Chi-square 
n (%) P-value 
Chi-square 
n (%) P value 
Chi square 
Age (group) 
n 
18-24 
25-34 
35-44 
 
231  
50 (56.2)  
143 (56.5) 
38 (47.5)  
 
p=0.351 
 
68  
11 (12.4) 
37 (14.6) 
20 (25.0) 
 
P=0.049 
 
36  
5 (5.6) 
16 (6.3) 
15 (18.8) 
 
p=0.001 
Combinations of ethnic groups 
n 
Aust/Australian  
Aboriginal/TSI  
NZ/ Polynesian 
Asian/Afr/Other 
 
231  
 
134 (60.1) 
21 (63.6) 
76 (45.2) 
 
p=0.008 
 
71 
 
19 (8.5) 
3 (9.1) 
49 (29.2) 
 
P<0.001 
 
37  
 
14 (6.3) 
1 (3.0) 
22 (13.1) 
 
p=0.029 
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 I do not know Goitre Mental retardation 
Gestation (wk) 
n 
Up to-28 (inclusive)  
≥29  
 
231 
90 (50.0) 
141 (57.6) 
 
p=0.123 
 
71 
40 (22.2) 
31 (12.7) 
 
p=0.009 
 
37 
21 (11.7) 
16 (6.5) 
 
P=0.063 
Highest level of education 
n 
Tertiary or professional 
Diploma, trade or technical  
Secondary school  
 
229  
79 (44.9) 
62 (58.5) 
88 (63.8) 
 
p=0.002 
 
70  
50 (28.4) 
13 (12.3) 
7 (5.1) 
 
P<0.001 
 
37  
23 (13.1) 
8 (7.5) 
6 (4.3) 
 
p=0.022 
 
4.5.3 Sources of dietary information  
Exploration of the sources of dietary information for the study subjects revealed that 
more than half of the women received their dietary information from a doctor, followed 
by a midwife and the internet.  Women could select as many options as applied to 
them.  It can be concluded from Figure 4.7 that women received less information on 
iodine and other topics compared to folate and iron. In addition, more women were 
unsure if they received information on iodine, or from who they received this 
information, than the other dietary topics.  
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Figure 4.7  Comparison of sources of dietary information 
.
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In response to the question “If you needed, do you feel that you can receive enough 
dietary information to make informed decisions about the following topics during 
pregnancy?” the majority of subjects felt that they could obtain enough dietary 
information to make informed decisions on iron, calcium, folate, vitamin D, listeria 
and healthy eating during pregnancy (Figure 4.8).  More women stated they could not 
receive enough information on iodine than any of these other dietary topics (Figure 
4.8). 
Over 10% of women reported that they did not know what iodine was (in relation to 
whether they felt that their diet provided enough iodine for their body’s needs when 
pregnant, and when not pregnant). More than half of the subjects did not know if their 
diet provided enough iodine when pregnant and when not pregnant (58.2% and 
57.5%), respectively. Approximately one-quarter were confident that their diet 
provided enough iodine when pregnant (25.9%) and when not pregnant (23.5%).  Less 
than eight percent (7.4%) did not believe that their diets contained adequate iodine for 
pregnancy, whilst 4.8% thought their diets contained inadequate iodine (when not 
pregnant). 
There was a significant association between the subjects’ belief that their diet met their 
iodine needs and consumption of iodine-containing supplements (𝜒2=16.817, df=3, 
p=0.001).  A high proportion of women in all response categories for the question “Do 
you feel that your own diet provides enough iodine for your body’s needs i.e. when you 
are pregnant?” reported taking iodine-containing supplements (at least 64%) except 
for those choosing “I do not know what iodine is” (40%, n=18).  A higher proportion 
of women who selected “No, I do not think my diet provides enough iodine” reported 
using iodine-containing supplements (72.4%, n=21), compared to 70.9% (n=168) of 
those who did not know if their diets provided enough iodine.  Women who were 
confident that their diets provided enough iodine reported lower iodine-containing 
supplement use than the aforementioned categories (63.6%, n=63) (Appendix F).  
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There was also a significant association between the subjects’ belief that their diet met 
their iodine needs and consumption of iodised salt (𝜒2=7.955, df=3, p=0.047).  A 
higher proportion of women who were confident that their diet provided enough iodine 
reported using iodised salt (54.5%, n=48) compared to those who chose the option 
“No, I do not think my diet provides enough iodine” or “I do not know if my diet 
provides enough iodine” (44.8%, n=13 and 44.5%, n=89, respectively).  Only 26.5% 
(n=9) of women who did not know what iodine was used iodised salt (Appendix F).   
 
Figure 4.8  Responses regarding availability of dietary information during pregnancy 
Comparison of responses from women who felt they could obtain dietary information on various 
nutrition related topics during pregnancy. 
When asked “Are there any foods that you have given up or stopped eating since you 
became pregnant?” approximately 63% (n=267) of subjects stated “yes”.  More than 
one-quarter of responses indicated that subjects had given up deli meat, pre-prepared 
and reheated foods totalling the highest response (26.7%), followed by soft cheeses, 
unpasteurised dairy (24.9%) (Table 4.13).  This relates to the high percentage of 
women who reported they felt they could obtain enough information on listeria (80%) 
(Figure 4.8).  The category “Other” included foods such as; mushrooms, acidic foods, 
onion, red meat, alcohol, artificial sweetener, milk and yoghurt.   
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Table 4.13  Foods no longer consumed once pregnant 
Foods avoided once pregnant Number  
of responses* 
%  
of responses 
Deli meat, pre-prepared and reheated foods 194 26.7 
Soft cheeses, unpasteurised dairy 181 24.9 
Fish, shellfish (seafood) 56 7.7 
Raw fish, raw seafood, raw meat 121 16.7 
Soft drinks, sugary foods 29  4.0 
Eggs 23  3.2 
Other 123 16.9 
*Total responses = 727 
In response to the question relating to how often the subjects chose low or reduced salt 
food items, more than half (61.5%) stated “rarely or never”, 32.4% selected the option 
“sometimes” whilst 26.2% either stated “often or always”. 
4.6 Reliability of the FFQ 
Overall the FFQ exhibited moderate reliability based on the results presented in Table 
4.14 through to Table 4.18. 
Median values of the estimated food iodine intakes for the 69 subjects who completed 
the first FFQ (FFQ1) and the retest FFQ (FFQ2) were 152 ug/day and 144 ug/day, 
respectively.  The difference between the population medians assessed by Wilcoxon 
signed rank tests was not significant (p=0.979) (Table 4.14).  
Table 4.14  Comparison of means (SD) and medians (IQR) for FFQ1 and FFQ2  
 
 
Mean ± SD 
(ug/day) 
Median (IQR) 
(ug/day) 
Estimated food iodine  
FFQ1 
n=69 
160 
±85.5 
152 
(95.0-231.1) 
Estimated food iodine  
FFQ2  
n=69 
161 
±89.0 
144 
(85.34-224.2) 
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ICC were calculated and ranged from 0.48 for bread (moderate agreement), to 0.60 
(substantial agreement) for cow’s milk and 0.67 (substantial agreement) for estimated 
food iodine intake (ug) between FFQ1 and FFQ 2 (See Table 4.15). 
Additionally, Wilcoxon signed ranks test revealed that the differences in median 
values between each pair of test and retest variables (food iodine intake, bread and 
bread products and cow’s milk) as well as all subgroups were not statistically 
significant.  Food iodine intake, bread and bread products and cow’s milk were further 
recoded into tertiles for both test and retest observations.  Kappa statistic was then used 
to assess the reliability between FFQ1 and FFQ2.  The kappa value (κ=0.48) indicated 
moderate agreement for food iodine intake of the subjects.  Cow’s milk (ranked into 
tertiles) also showed a moderate agreement between administrations of the FFQ 
(κ=0.58), with bread and bread products (fortified) achieving a kappa value of 0.38 
(fair agreement) (Table 4.16).  More than half of the subjects were correctly classified 
into the same tertile upon repeat administration of the FFQ (Table 4.16). 
Table 4.15  Intraclass correlation coefficients for FFQ1 and FFQ2 
Food iodine intake (ug), cow’s milk (ug) and bread and bread products (ug).   
Comparisons with different subgroups. 
 ICC 
 
Intake 
change 
YES*a 
Intake 
change NO*a 
≤ 28 wks 
(inclusive) 
gestation*b 
> 29 wks 
gestation*c 
≤14 days*d >14 days*e Excluding 
n=4 
(pamphlet)*f 
Food iodine 
intake  
FFQ1 and 
FFQ2 (ug) 
0.67 0.62 0.72 0.68 0.79 0.83 0.62 0.71 
Bread and 
bread 
products  
FFQ1 and 
FFQ2 (ug) 
0.48 0.66 0.37 0.49 0.34 0.11 0.63 0.48 
Cow’s milk  
FFQ1 and 
FFQ2 (ug) 
0.60 0.57 0.63 0.61 0.76 0.78 0.55 0.68 
aSubjects stated that their dietary intake had/had not changed since first administration of the FFQ 
(FFQ1) 
bSubjects who completed FFQ1 up to 28 weeks (inclusive) gestation 
cSubjects who completed FFQ1 from 29 weeks gestation 
d FFQ2 completed ≤14 days from FFQ1 
e FFQ2 completed >14 days from FFQ1 
f Analysis run excluding 4 subjects who received iodine brochure upon completion of FFQ1 
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In addition to this, marginal homogeneity tests indicated there was no significant 
difference in marginal proportions between each pair of test and retest variable of 
interest (food iodine intake, bread and bread products and cow’s milk), suggesting 
agreement between FFQ1 and FFQ2. 
Kappa was also determined for individual food items (as ordered categorical variables 
relating to frequencies of consumption only) for FFQ1 and FFQ2.  Results for food 
items with kappa  > 0.5 (and bread/bread products) are given in Table 4.18.  Although 
tofu, shellfish and sushi had kappa values ranging from 0.39 to 0.76 (fair to substantial 
agreement) for some subgroups, these food items were not consumed frequently by 
the majority of subjects and were not considered major contributors to iodine intake.   
The kappa statistics for cow’s milk, one of the top contributors to iodine intake, across 
the subgroups was consistently above 0.40 (up to 0.66), indicating moderate to 
substantial agreement.  Bread and bread products demonstrated fair agreement 
(κ=0.20-0.38). 
Differences in ICC/kappa associated with the subjects’ perceived change of intake 
between administrations of FFQ1 and FFQ2 was investigated.  Some of the reasons 
for reported change of dietary intake had the potential to affect iodine intake such as; 
drinking more milk, being more aware of the nutritional requirements for pregnancy 
and using iodised salt.  Other reasons provided by subjects included eating more or 
less (generally), different cravings, feeling full quickly, more nausea, end of religious 
fast, being on holidays or travelling.  
4.6.1 Comparisons with different subgroups 
Time differences between completion of FFQ1 and FFQ2 were explored, as well as 
differences in gestational stage at time of FFQ1. It should also be noted that four 
subjects in the retest group were provided with the KEMH iodine brochure after 
completion of their first questionnaire due to the questions they asked regarding iodine 
upon initial administration.  Two subjects stated that they thought their intake had 
changed upon administration of FFQ2 (eating more in general, eating more meat) and 
two stated that intake had not changed. As with time differences and gestational stage, 
ICC and kappa tests were run twice with this group, including and separately excluding 
all 4 subjects (see Table 4.17 and Table 4.18). 
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Table 4.16  Kappa statistic and percentage classification of subjects for FFQ1 and FFQ2 
Into same tertile, adjacent tertiles (1 and 2, 2 and 1, 2 and 3 or 3 and 2) and opposite tertiles (1 and 3 
or 3 and 1). 
 Kappa Same tertile 
(%) 
Adjacent 
tertile (%) 
Opposite  
Tertile (%) 
P Value 
Kappa 
Kappa-tertiles 
FFQ1 and 
FFQ2* 
0.48 65.2 31.9 2.9 <0.001 
Kappa-tertiles 
Bread and 
bread products   
FFQ1 and  
FFQ2* 
0.38 59.4 34.8 5.8 <0.001 
Kappa-tertiles 
Cow’s milk 
FFQ1 and  
FFQ2*  
0.58 72.5 24.6 2.9 <0.001 
*Marginal homogeneity p>0.05 
Table 4.17  Kappa statistic for FFQ1 and FFQ2  
Food iodine intake (tertiles), cow’s milk (tertiles) and bread and bread products (tertiles).   
Comparisons with different subgroups. 
 Kappa 
 
Intake 
change 
YES*a 
Intake 
change NO*a 
≤ 28 wks 
(inclusive) 
gestation*b 
> 29 wks 
gestation*c 
≤14 days*d >14 days*e Excluding 
n=4 
(pamphlet)*f 
Food iodine 
intake  
FFQ1 and 
FFQ2* 
0.48 0.45 0.50 0.54 0.40 0.37 0.51 0.49 
Bread and 
bread 
products  
FFQ1 and 
FFQ2* 
0.38 0.49 0.29 0.42 0.26 0.09 0.47 0.39 
Cow’s milk  
FFQ1 and 
FFQ2* 
0.58 0.65 0.52 0.58 0.60 0.71 0.53 0.62 
*Marginal homogeneity p>0.05 
aSubjects stated that their dietary intake had/had not changed since first administration of the FFQ 
(FFQ1) 
bSubjects who completed FFQ1 up to 28 weeks (inclusive) gestation 
cSubjects who completed FFQ1 from 29 weeks gestation 
d FFQ2 completed ≤14 days from FFQ1 
e FFQ2 completed >14 days from FFQ1  
f Analysis run excluding 4 subjects who received iodine brochure upon completion of FFQ1 
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Table 4.18  Kappa > 0.5 for food items for FFQ1 and FFQ2 
Categorised according to frequency of consumption (including bread and bread products). 
Comparisons with different subgroups. 
 Kappa 
 
Intake 
change 
YES*a 
Intake 
change NO*a 
≤ 28 wks 
(inclusive) 
gestation*b 
> 29 wks 
gestation*c 
≤14 days*d >14 days*e Excluding 
n=4 
(pamphlet)*f 
Kappa-
frequency 
Cow’s milk 
FFQ1 and 
FFQ2* 
0.52 0.66 0.41 0.56 0.49 0.62 0.49 0.54 
Kappa-
frequency 
Tofu 
FFQ1 and 
FFQ2* 
0.60 0.62 0.56 0.64 0.58 0.73 0.50 0.56 
Kappa-
frequency 
Shellfish 
FFQ1 and 
FFQ2* 
0.53 0.56 0.47 0.41 0.70 0.76 0.39 0.55 
Kappa-
frequency 
Sushi 
FFQ1 and 
FFQ2* 
0.50 0.43 0.56 0.46 0.51 0.70 0.41 0.49 
Kappa-
frequency 
Bread and 
bread 
products 
FFQ1 and 
FFQ2* 
0.23 0.32 0.24 0.27 0.20 N/A 0.38 0.26 
* Marginal homogeneity p>0.05  
a Subjects stated that their dietary intake had/had not changed since first administration of the FFQ 
(FFQ1) 
b Subjects who completed FFQ1 up to 28 weeks (inclusive) gestation 
c Subjects who completed FFQ1 from 29 weeks gestation 
d FFQ2 completed ≤14 days from FFQ1 
e FFQ2 completed >14 days from FFQ1  
f Analysis run excluding 4 subjects who received iodine brochure upon completion of FFQ1 
N/A Limited number of subjects in this category (n=16) completed FFQ2 ≤14 days from FFQ1 
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4.7 Development of a rapid screening tool 
The findings in Figure 4.9 were used to develop a rapid screening tool designed to 
assess the likelihood of pregnant women meeting the EAR for iodine.  Each question 
and result were independent of each other.  As can be seen in Figure 4.9 nearly all 
women (97%) who used an iodine-containing supplement (regardless of iodine 
content) (n=95) attained the EAR using total iodine data.  Women who were 
consuming iodised salt (n=160) had an 83% chance of meeting the EAR using dietary 
iodine data (based on findings that over half of the subjects used iodised salt in cooking 
daily). 
The last two components of the screening tool related to the likelihood of attaining the 
EAR for iodine if relying on food sources of iodine.  Women who consumed cow’s 
milk at least twice a day (minimum 1 cup per day) demonstrated a high likelihood of 
attainment (91%) of the EAR using food iodine data, reinforced by moderate to 
substantial agreement upon reliability testing (Section 4.6).  Those consuming bread 
or bread products at least twice a day (minimum 2 slices per day) were assessed to 
have a slightly lower chance of meeting the EAR using food iodine data (83%), with 
reliability testing demonstrating fair agreement. 
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Figure 4.9  Decision tree used to develop a rapid screening tool 
(based on subjects achieving EAR (%) for major contributors to iodine intake) 
“Do you have thyroid disease?” 
Discuss iodine requirement with  
your Doctor 
NO 
Total iodine group (n=95) 
YES 
“Do you use a pregnancy supplement 
(containing iodine) daily?” 
97% likelihood of achieving EAR  
(n=95) 
NO 
Dietary iodine group (n=160) 
YES 
“Do you use iodised salt daily?” 
83% likelihood of achieving EAR 
(n=160) 
NO 
Food iodine group (n=423) 
YES 
“Do you consume cow’s milk at least 
twice a day? (Min. 1 cup per day)” 
91% likelihood of achieving EAR 
(n=159) 
NO 
Food iodine group (n=423) 
YES 
“Do you consume bread or bread 
products (shop bought/non-organic) at 
least twice a day? (Min. 2 slices per day)” 
83% likelihood of achieving EAR  
(n=93) 
NO YES 
Commence a daily pregnancy 
supplement containing 150 ug iodine 
or discuss your requirements with a 
Dietitian 
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4.8 Summary  
Estimated iodine intake: 
 Median iodine intakes calculated using the dietary iodine data and the total iodine 
method met the EAR for pregnancy, whilst median intake of the food iodine data 
was slightly less than the EAR. 
 Cow’s milk contributed approximately 38-41% of dietary iodine intake, followed 
by bread and bread products (fortified with iodine) (18-20%) and iodised salt (10-
16%). 
 Over one-third of the subjects did not meet the EAR (calculated using dietary 
iodine data), whilst more than half did not achieve the EAR (calculated using the 
food iodine data).  
 Higher frequency of consumption of cow’s milk (at least twice a day) was 
significantly associated with achieving the EAR from both dietary iodine and food 
iodine.  
 Higher frequency of consumption of bread and bread products (fortified with 
iodine) (at least twice a day) was significantly associated with achieving the EAR 
from both dietary iodine and food iodine.    
Iodised salt use: 
 Approximately 45% of subjects used iodised salt (after excluding women who did 
not know whether they used iodised salt or not). 
 Education level was significantly associated with iodised salt use.  Proportionally 
more women who had tertiary or professional qualifications reported using iodised 
salt compared to those in the other education categories. 
 Ethnic combination group was significantly associated with iodised salt use.  
Proportionally more women from Asian/African/Other ethnic backgrounds 
reported using iodised salt, followed by women from New Zealand/Polynesian 
backgrounds.  Australian/Australian Aboriginal/TSI women reported the lowest 
iodised salt usage.  
 Iodised salt use was significantly associated with achieving the EAR. 
 
 125 
Iodine-containing supplement use 
 Approximately one-quarter of subjects used an iodine-containing supplement in 
the year prior to pregnancy. 
 Age was significantly associated with iodine-containing supplement use in the year 
prior to pregnancy.  A higher proportion of women in the highest age category used 
an iodine-containing supplement prior to pregnancy compared to women in the 
middle and lowest age category.  
 Gestational stage was significantly associated with iodine-containing supplement 
use in the year prior to pregnancy.  A higher proportion of women in the earlier 
stage of pregnancy reported using an iodine-containing supplement prior to 
pregnancy compared to women in the later stage of pregnancy. 
 Income was significantly associated with iodine-containing supplement use in the 
year prior to pregnancy.  A higher proportion of women in the highest income 
category used an iodine-containing supplement prior to pregnancy compared to 
women in the middle and lower income category.   
 Two-thirds of subjects used an iodine-containing supplement during pregnancy 
with the majority of subjects (97%) who consumed quantifiable iodine 
supplements (n=95) achieving the EAR for pregnant women. 
 Gestational stage was significantly associated with iodine-containing supplement 
use during pregnancy.  A higher proportion of women who completed the 
questionnaire at or before 28 weeks gestation used iodine-containing supplements 
compared to women who were in the later stage of pregnancy (29 weeks or more). 
 Gravidity was also significantly associated with iodine-containing supplement use 
during pregnancy.  A higher proportion of women who were pregnant for the first 
time used iodine-containing supplements compared to those who had been 
pregnant previously.  
Knowledge and beliefs 
 Knowledge regarding food sources of iodine and health problems associated with 
a lack of iodine in the diet was low compared to other issues. 
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 There was a significant association between education level and knowledge 
regarding food sources of iodine.  Proportionally more women who had secondary 
school qualifications only selected “I do not know” while the lowest proportion 
was found in the highest education category. The greatest proportion of women 
from the highest education category correctly selected seafood as a good source of 
iodine. 
 Education was significantly associated with the knowledge of health problems 
potentially related to a lack of iodine in the diet.  Proportionally more women who 
had secondary school qualifications only selected “I do not know” while women 
from the highest education category represented the lowest proportion.  
Conversely, the greatest proportion of women from the highest education category 
correctly selected goitre and mental retardation.   
 Age was significantly associated with the correct selection of goitre and mental 
retardation with the greatest proportion of women from the highest age category 
(35-44 years) correctly choosing these conditions. 
 Ethnicity was significantly associated with knowledge regarding health problems 
related to inadequate iodine intakes.  A greater proportion of women within the 
Asian/African/Other ethnic combination group correctly selected goitre and 
mental retardation, with proportions of less than 10% coming from those in each 
of the other ethnic combination groups.  Proportionally more women from the New 
Zealand/Polynesian ethnic combination group selected “I do not know” in relation 
to health problems, followed by those from the Australian/Australian 
Aboriginal/TSI group while women from the Asian/African/Other ethnic 
combination group represented a considerably lower proportion. 
 Gestational stage was significantly associated with the correct selection of goitre 
as a health problem.  A higher proportion of women in the earlier stage of 
pregnancy correctly selected goitre.  
 Approximately 45-55% of women across all categories relating to their belief that 
their diet met their iodine needs whilst pregnant reported using iodised salt. 
Women who were confident that their diet provided enough iodine for their needs 
were more likely to use iodised salt compared to those who did not know what 
iodine was. 
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 Approximately 60-75% of women across all categories relating to their belief that 
their diet met their iodine needs whilst pregnant reported using iodine-containing 
supplements. Women who did not think that their diet provided enough iodine for 
their needs were more likely to use iodine-containing supplements compared to 
those who did not know what iodine was. 
 The most popular sources of dietary information were a doctor, followed by a 
midwife and the internet. 
 Women received less information on iodine and other diet-related topics compared 
to folate and iron, with more women indicating they could not receive enough 
information on iodine than for any of the other dietary topics. 
Reliability and rapid screening tool 
 The FFQ demonstrated moderate reliability, allowing for the development of a 
rapid iodine screening tool that incorporated iodine-containing supplement use, 
iodised salt use, consumption of cow’s milk and bread or bread products to 
determine the percentage likelihood of subjects meeting the EAR from total iodine, 
dietary iodine and food iodine, respectively. 
 Women answering “yes” to the use of a pregnancy multivitamin (containing 
iodine) or the cow’s milk consumption question were highly likely to achieve the 
EAR (97% likelihood using total iodine data) and (91% likelihood using food 
iodine data), respectively. 
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CHAPTER 5 : DISCUSSION 
This study was designed to investigate the dietary iodine intake (including iodised salt 
and iodine-containing supplement use) of pregnant women attending KEMH, Western 
Australia’s only women’s and neonatal hospital, as well as to determine their 
knowledge and beliefs on iodine-related topics.  The secondary aims were to assess 
the reliability of an existing tool used to rank dietary iodine intake in pregnant women 
in order to identify the potential of developing a rapid iodine screening tool to 
determine the women whose individual usual intake are not likely to meet the EAR for 
iodine. 
This is the first study to investigate iodine knowledge, beliefs and practices of pregnant 
women in WA.  The literature over the last 15 years reveals that there is a lack of data 
regarding iodine status, iodine intake or the more recent interests of iodine, iodine-
containing supplement use and iodine nutrition knowledge and beliefs of pregnant 
women in WA. 
5.1 Estimated iodine intake 
The median iodine intake values calculated for dietary iodine (iodine from food + 
iodised salt) and for the total iodine data (iodine from food + iodised salt + iodine-
containing supplements) met the EAR for pregnancy (196 ug/day and 358 ug/day), 
respectively, whilst median intake relating to the food iodine data was slightly less 
than the EAR at 148 ug/day. These findings are consistent with two of the more 
recently published studies with Condo et al. (2015) (SA) reporting similar estimated 
iodine intake values for food iodine data (borderline sufficient/sufficient) and Lucas et 
al. (2014) (NSW) reporting a median iodine intake value that exceeded the EAR for 
dietary iodine data and total iodine intake data.  Brough et al. (2015) (NZ), Charlton 
et al. (2013) (NSW) and Mallard and Houghton (2014) (NZ) also report estimated 
population iodine intake values above the EAR post-fortification of bread and bread 
products, whereas pre-fortification studies estimating iodine intake indicated 
insufficiency. 
 130 
Whilst not a focus of this study, it is noteworthy that three of the 95 women whose 
estimated total iodine intake (range 1142-1384 ug/day) exceeded the UL for iodine 
(1100 ug/day) set by the NHMRC (2006b).  These women used iodised salt (estimated 
iodine content approximately 800 ug/day with the majority added to cooking) iodine-
containing supplements (iodine content of supplements approximately 220 ug/day), in 
addition to consuming cow’s milk daily, with two women using bread and bread 
products at least twice a day.  Iodised salt was clearly contributing the most toward 
excessive iodine intakes in these subjects, highlighting a potential issue with women 
using the equivalent of 1 tsp of iodised salt at least twice a day (in addition to daily 
iodine-containing supplements).  Overestimation of the amount of salt used by these 
women is a possibility given the limitations of estimating iodine contribution from 
iodised salt (Section 2.7).  It has also been assumed that iodine-containing supplements 
are taken every day.   
Comparisons between estimates of intake are complicated by different dietary 
assessment methods, sample sizes, research methodologies, sample demographics, 
timing of study (pre- or post-fortification), and associated dietary habits, however the 
trend of iodine intakes approaching and achieving the EAR in study populations in 
WA, SA, NSW and NZ is promising on a population level.   
The food items contributing the most to iodine intake of subjects using iodine (ug) 
from iodised salt (Section 4.3.1) were calculated using estimate 1 (calculated in 
FoodWorks (based on the subject’s estimation of iodised salt)), estimate 2 (calculated 
by correcting (halving) iodised salt used in cooking for primigravid women (assuming 
the cooking was for two people-subject and partner)) and estimate 3 (calculated using 
an adjusted standard figure of 48 ug (approximately equivalent to 1 g of iodised salt)), 
the latter method has been used in other studies (Charlton et al. 2013; Mallard and 
Houghton 2014).  The top three sources of iodine in the study population (n=425) were 
cow’s milk, bread and bread products (fortified with iodine) and iodised salt, 
contributing 38-41%, 18-20% and 10-16%, respectively (Table 4.5). 
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These results concur with findings from the 2003 cohort of the ALSWH study 
indicating that milk/dairy products and bread and bread products (adjusted for iodine 
fortification) were major contributors to dietary iodine intake in 665 pregnant women 
(Mackerras et al. 2011).  The 1995 NNS provided evidence that dairy products 
contributed significantly to overall iodine intake in Australia on a larger scale (Food 
Standards Australia New Zealand 2008a), however it was around this time that iodine-
containing sterilising agents used in milk production were being replaced by non-
iodine containing agents, rendering dairy products as less reliable sources of iodine.  
In addition, the 1995 NNS was conducted prior to fortification of bread and bread 
products with iodine, discretionary iodised salt data was reported to be incomplete and 
only a small number of pregnant women were sampled.   
The percentage contribution of iodised salt to dietary iodine intake in this study (10-
16%) is higher than those reported by Lucas et al. (2014) and Charlton et al. (2013) 
(10 and 4.5-8%), respectively.  Comparisons are limited as both studies used a 
maximum cut-off of 1g of iodised salt per day, differences are compounded further by 
the problems that exist for quantifying iodised salt intake (Section 2.7). 
Since bread fortification, studies conducted in Australia and NZ confirm that milk and 
dairy products together with bread, bread products (iodine fortified) or breads and 
cereals are significant contributors to overall iodine intake (Charlton et al. 2013; Lucas 
et al. 2014; Martin, Savige, and Mitchell 2014; Rahman et al. 2011).  Direct 
comparisons of percentage contribution of these major food sources could not be 
made, as specific categories of foods were not the same as those in the current study. 
All studies (including this research) indicate low intakes of fish and other seafood 
(Charlton et al. 2013; Lucas et al. 2014; Martin, Savige, and Mitchell 2014; Nguyen 
et al. 2010; Pettigrew-Porter et al. 2011; Rahman et al. 2011), a trend that has 
repercussions not only on iodine intakes but also on other important dietary 
constituents such as omega-3 fatty acids and vitamin D. 
5.2 Data collection tool and assessment of dietary iodine intake 
This study utilised a 68-item questionnaire comprising of a 41-item iodine-specific 
FFQ (adapted from a tool validated by Tan et al. (2013) in the elderly) (Section 3.4). 
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Food frequency questionnaires are a well-accepted method of dietary data collection 
(long-term) allowing for the investigation into food and nutrient intake, behaviours 
and habits as well as eating patterns (Subar et al. 2015).  This particular FFQ recorded 
subjects’ self-reported dietary intake over the last two months which lent itself to 
capturing more “usual” estimated iodine intake data, thus reducing random error in a 
population where nausea and taste changes vary from one day to the next. The FFQ 
was a practical assessment and ranking tool of low subject burden and also provided a 
means of investigating consumption patterns of food items (e.g. once a day, once a 
week, never) as well as collecting some data on alcohol (beer) intake in this study 
sample. 
Attempts were made to minimise systematic error associated with the collection of 
dietary intake data including; the use of a FFQ based on a previously validated tool 
demonstrating moderate test-retest reliability.  This was the largest study out of all 
Australian studies in the literature review that had investigated iodine knowledge, 
beliefs and iodine intake.  Furthermore, a standardised approach to data entry in 
Foodworks was carried out by TH, together with the assessment of the reproducibility 
of the FFQ upon repeat administration.  In addition to this, TH was available to answer 
questions and to provide photographs of food items to assist with questionnaire 
completion during the data collection phase. 
Methods used to determine estimated iodine intake in Australian and NZ studies varied 
with most using FFQs (Charlton et al. 2013; Lucas et al. 2014; Pettigrew-Porter et al. 
2011), one study used a FFQ and a 4-day weighed food record (Condo et al. 2015), 
with Mallard and Houghton (2014) assigning 60 ug/day from food as a baseline 
assignment for all subjects and 48 ug iodine from iodised salt for those who used 
iodised salt.  Two studies used a method of extrapolation from urinary iodine excretion 
to estimate dietary iodine intake (Blumenthal, Byth, and Eastman 2012; Brough et al. 
2015).  These methods have associated limitations and these will be discussed further 
in Section 5.9. 
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5.3 Iodised salt use 
Approximately 45% of subjects used iodised salt (after excluding women who did not 
know whether they used iodised salt or not).  More than half of the iodised salt users 
added it in cooking at least once a day (62%) and approximately 40% used iodised salt 
at the table at least once a day (Table 4.9).  Gathering and comparing data regarding 
iodised salt use from the literature proved difficult as not all information was related 
to daily use or distinguished between iodised salt used in cooking or at the table.  Most 
of the Australian and New Zealand studies that reported any iodised salt use described 
ranges between approximately 20% to 50% (Blumenthal, Byth, and Eastman 2012; 
Brough et al. 2015; Charlton et al. 2012; Charlton et al. 2010; Charlton et al. 2013; 
Condo et al. 2015; El-mani, Charlton, et al. 2014; Lucas et al. 2014; Martin, Savige, 
and Mitchell 2014; Nguyen et al. 2010; Pettigrew-Porter et al. 2011; Rahman et al. 
2011).  The results from this study are consistent with these findings. 
Education level and knowledge regarding iodine were significantly associated with 
iodised salt use in the subjects who knew whether they used iodised salt or did not use 
iodised salt (excluding those who did not know what type of salt they used).  A higher 
proportion of women who had tertiary or professional qualifications reported using 
iodised salt.  Although the numbers are low, subjects who did not know what iodine 
was (n=36) in response to the woman’s belief that her diet provided enough iodine for 
her body’s needs when pregnant) were less likely to be using iodised salt (73.5%). 
The subjects in this study were sampled from a public hospital whereas a number of 
other Australian studies have recruited from private hospitals or both private and 
public hospital sites.  The mean age of subjects in this study was 29.4 (5.5) years with 
over half (60%) in the 25-34 age category.   More than a third were primigravid and 
over half were ≥ 29 weeks gestation.  Of those who responded to the question on 
earnings, more than half (54%) earned less than $50 000 in the previous 12 months.   
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Combination of ethnic groups was significantly associated with iodised salt use in the 
subjects who knew what type of salt they used.  Women in the Asian/African/Other 
ethnic combination group were more likely to use iodised salt (59.1%) followed by 
46.7% of women from New Zealand/Polynesian backgrounds.  Women from the 
Australian/Australian Aboriginal/TSI grouping (Australian Aboriginal (n=6), TSI 
(n=0) used iodised salt and represented the lowest proportion of iodised salt use out of 
all groups (35.2%).   
The representation of women of diverse ethnic backgrounds in this study has 
demonstrated differing dietary practices and knowledge relating to iodine.  Given that 
USI exists in many areas of Asia, Africa and “Other” regions such as India, it is 
possible that habitual use and/or greater awareness of women from these ethnic groups 
explained the higher rates of consumption.   
5.4 Iodine-containing supplement use 
In 2010 the NHMRC released a national recommendation stating that all women who 
are considering pregnancy, who are pregnant or breastfeeding take a daily iodine 
supplement of 150 ug (National Health and Medical Research Council 2010).  Despite 
this, the present study demonstrated a distinct difference in iodine-containing 
supplement use prior to pregnancy and during pregnancy. 
Approximately one-quarter of subjects who answered the question used an iodine-
containing supplement in the year prior to pregnancy versus more than half who 
indicated using iodine-containing supplements during pregnancy (Figure 4.2). 
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Age, income and gestational stage were significantly associated with iodine-
containing supplement use in the year prior to pregnancy.  Results indicated that the 
proportionate use of iodine containing supplements prior to pregnancy increased with 
the age category of the subjects. Whilst results indicate that more than half of those 
who used iodine-containing supplements in the year prior to pregnancy were from the 
lowest income category, a greater proportion of women from the highest income 
category (52.6%, n=10) used these supplements.  As discussed further in Section 5.9, 
only the subject’s income over the last 12 months was requested, potentially 
underestimating household income or earning potential of the subject (if currently on 
a career break).  In addition, age and income are related and therefore may have led to 
confounding.  A higher proportion of women who were 28 weeks gestation or less at 
the time of completing the questionnaire reported using iodine-containing supplements 
compared to those who undertook the questionnaire from 29 weeks.  
Three assumptions can be made based on this data; 1) that women in the youngest age 
category may not have been planning to become pregnant and therefore were not 
taking an iodine-containing supplement or 2) were not aware of the recommendation 
to use these supplements (if planning to become pregnant or during pregnancy) or 3) 
iodine-containing supplement use was higher pre-pregnancy in those who were more 
likely to be able to afford these supplements.  Memory recall over time may have 
affected the women’s ability to retrospectively report their use of supplements used as 
their pregnancy progressed, potentially explaining the reason for the significant 
decrease of reported iodine-containing supplement use prior to pregnancy in women 
completing the questionnaire in the later stage of pregnancy (29 weeks or more).   
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In contrast, age and income were not significantly associated with iodine-containing 
supplement use during pregnancy.  Gestational stage and gravidity were significantly 
associated with iodine-containing supplement use with a higher proportion of women 
who completed the questionnaire at or before 28 weeks gestation reporting use of 
iodine-containing supplements compared to those who undertook the questionnaire 
from 29 weeks.  This trend of non-compliance with iodine supplement use in the later 
stage of pregnancy may be similar to factors identified in a United Kingdom study on 
folic acid supplementation use (Barbour et al. 2012) and include; forgetting to take the 
supplement, morning sickness, less perceived risk due to previous normal pregnancy 
(or in this case, possibly once assured that pregnancy is progressing without 
complications), other health priorities and doubt relating to benefits of 
supplementation.   
A greater proportion of primigravid women reported iodine-containing supplement use 
compared to those who had been pregnant previously (73.8% and 60.6%), 
respectively.  The lower use of these supplements by women who had been pregnant 
before was likely to have been due to less perceived risk (in those who had experienced 
a previous normal pregnancy).  It was also found that women who did not know what 
iodine was were significantly less likely to be using iodine-containing supplements 
compared to women in the same category who were using them. 
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Previous studies conducted in Australia and NZ have reported similar factors 
associated with iodine-containing supplement use.  Charlton et al. (2010) provided 
evidence for higher iodine supplement use in those who were pregnant for the first 
time, and Martin, Savige, and Mitchell (2014) similarly identified that women who did 
not think their diet contained enough iodine were more likely to take iodine-containing 
supplements than women who did not know or who thought a healthy diet was 
adequate.  Mallard and Houghton (2014) reported that women who were less likely to 
take supplements as recommended were those who were the least advantaged (i.e. from 
lower income and education groups) although the results from the current study did 
not concur with the latter findings in those who used iodine-containing supplements 
prior to or during pregnancy.  In contrast to the current study, El-mani, Charlton, et al. 
(2014) indicated higher percentage use of iodine (and folate) supplements in pregnant 
women from the highest income category and based on a related theme, Bower et al. 
(1997) reported that pregnant women with less education were less likely to take folate 
supplements prior to, and in early pregnancy compared to women with a tertiary 
education.   
Differences in findings may have been due, in part, to the difference in overall sample 
sizes and locations within Australia and New Zealand. The proportion of multigravid 
women in the WA study was more than that of the Gippsland study (62%, n=262 
versus 42%, n=83, respectively) with the current study indicating that amongst this 
group fewer women used iodine-containing supplements (compared to primigravid 
iodine-containing supplement users). Furthermore, varying results between studies 
may also have been due to the complexities related to the measurement of 
socioeconomic status, including the overlap between occupation, income and 
education (Adler et al. 1994). The use of individual income has limitations (Section 
5.9), nonetheless, it was worth exploring this SES variable (in addition to education 
level) in this diverse study population. 
The confirmed findings from this study are valuable as they highlight subgroups of the 
population at a higher risk of inadequate iodine intakes (e.g. younger women, those 
with less education and those from lower income groups).  The fact that there was less 
supplement use from 29 weeks pregnancy than before in the present study raises 
concerns regarding continued supplement use during breastfeeding. 
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The prevalence of iodine-containing supplement use during pregnancy in the present 
study (66%) falls within the range found in post-fortification studies in NSW, Vic, SA 
and NZ (50-75%), adding to the body of evidence that iodine-containing supplement 
use post-fortification in 2009 is greater than pre-fortification (less than 50%).  As 
mentioned previously, this trend, for the most part, is likely due to the reformulation 
of pregnancy multivitamins (over the last five or six years) to align with 
recommendations regarding iodine-containing supplement use of national and 
international health organisations such as NHMRC (2010), NZ MoH (2010) and ATA 
(2006).  Interestingly, the dietary supplement with the highest percentage use in this 
study was Elevit (43.4%) with each dose containing 220 ug iodine which is greater 
than the recommended amount (150 ug). 
5.5 Reliability and development of a rapid screening tool 
Overall, the FFQ demonstrated moderate test-retest reliability based on repeat 
administration of the FFQ (for 69 subjects).  The development of a rapid iodine 
screening tool incorporated key components found in this study (iodine-containing 
supplement use, iodised salt use, frequency of consumption of cow’s milk and bread 
or bread products fortified with iodine) to determine the percentage likelihood of 
subjects meeting the EAR for each component (Figure 4.9). 
The initial question in the screening tool acknowledges the requirement for women 
with thyroid disease or a history of thyroid disease to seek individual medical advice.  
The remaining 4-items relate to oral consumption with yes and no options for each.  
Women who answer two or more of the shaded “no” sections should consider taking 
an iodine-containing supplement (150 ug/day) or should discuss their individual 
requirements with a dietitian (as it may be possible to increase dietary intake to meet 
requirements without the need for iodine-containing supplements in this population). 
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Ninety-seven percent of women who reported using (quantifiable) iodine-containing 
supplements in this study (n=95) achieved the EAR based on the total iodine data (food 
+ iodised salt + iodine from supplement).  The percentage is likely to have been higher 
however the assumption was made that two out of the three women who did not meet 
the EAR only consumed one capsule (not two, as per manufacturer’s instructions) of 
their pregnancy (iodine-containing) supplement per day.  One woman only reported 
consuming her pregnancy supplement (iodine-containing) three times a week (Section 
4.2.2).  All of these women were not iodised salt users, nor did they consume cow’s 
milk daily. 
Following on from this, iodised salt use was significantly associated with meeting the 
EAR with women who used iodised salt having an 83% chance of meeting the EAR 
based on dietary iodine data (food + iodised salt). 
An essential question for those not consuming iodine-containing pregnancy 
multivitamins or iodised salt was related to the consumption of cow’s milk at least 
twice a day.  This component demonstrated a high percentage likelihood of achieving 
the EAR (91%) using food iodine data, was significant and demonstrated moderate to 
substantial agreement upon reliability testing (Section 4.6). 
Following on from this, the consumption of bread and bread products at least twice a 
day was also significantly associated with achieving the EAR with those who 
consumed a minimum of 2 slices of bread per day having an 83% likelihood of meeting 
the EAR based on food iodine data.  Reliability assessment indicated fair agreement 
for this item. 
There is scope for the trialling and subsequent validation of this newly developed 5-
item screening tool in pregnant women in WA (Figure 4.9).  Whilst there is no “gold-
standard” to apply, it is likely that a combination of validation methods such as; 
weighed food records, UIE, UIC and thyroid function tests as used by Condo et al 
(2015) in their study (described below) on a larger sample size will enhance the 
usability of this tool and provide further data on this unique population. 
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Findings from other Australian and NZ studies identify similar key components and 
associations. To the author’s knowledge only one other study in the Australian 
literature has validated a 44-item iodine-specific FFQ specifically in pregnant women 
(Condo et al. 2015) (SA) (using 4-day weighed food records, UIE, 24-h UIC, spot UIC 
and thyroid function tests) and have proposed its use as an iodine screening tool for 
pregnant women.  However, factors such as the exclusion of iodine contribution from 
iodised salt and a final sample size of less than 100 subjects limits the applicability of 
the final results.  It was also difficult to determine from the study if women from 
different ethnic backgrounds and NESB were excluded therefore limiting 
generalisability of the findings towards culturally and ethnically diverse populations if 
so. 
5.6 Knowledge, beliefs and sources of iodine information 
The study results indicate that the subjects’ knowledge regarding iodine nutrition was 
limited, confirming the findings of previous literature on this topic (Brough et al. 2015; 
Charlton et al. 2012; Charlton et al. 2010; Charlton et al. 2013; El-mani, Charlton, et 
al. 2014; Lucas et al. 2014; Martin, Savige, and Mitchell 2014). 
Less than half of the subjects in this study were able to correctly identify a good food 
source of iodine, salt being the most frequently selected option (46.9%).  Given that 
nearly one-third of all women used iodised salt, it was assumed that those who selected 
this option were referring to iodised salt being a good source of iodine.  Less than 5% 
of all subjects identified bread as the mandatory fortification vehicle whilst 
approximately one-quarter of women incorrectly identified food items such as meat 
and vegetables as good sources of iodine and a quarter chose the option “I do not 
know”. 
Over half of the women selected “I do not know” in response to a list of health 
problems that may or may not be associated with not having enough iodine in the diet 
with less than 20 and 10% of subjects correctly choosing goitre and mental retardation, 
respectively. 
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As explained in Section 4.5.3, subjects who did not know what iodine was (in response 
to the woman’s belief that her diet provided enough iodine for her body’s needs when 
pregnant) reported the lowest proportion of iodised salt and iodine-containing 
supplement use amongst respondents, providing some justification for increased 
iodine awareness/education strategies in areas where iodine deficiency is prevalent.   
Interestingly, women who felt confident that their diet provided enough iodine were 
more likely to be using iodised salt however those who did not think that their diet 
provided enough iodine were more likely to be using iodine-containing supplements.  
This may reflect that those who were using iodised salt had made a conscious decision 
to use it and felt confident that this improved their diet whereas women using iodine-
containing supplements may have been unaware of the recommendations to use them 
and/or were unsure as to whether their supplement contained iodine.  There is also the 
possibility that these women perceived their diets (food only) to be inadequate and 
were deliberately using iodine-containing supplements (or pregnancy supplements) to 
increase iodine intake (or overall dietary adequacy). 
In the current study education and age were significantly associated with knowledge 
regarding iodine.  A greater proportion of women who had secondary school 
qualifications only selected “I do not know” for questions relating to good food 
sources of iodine and health problems.  Women from the highest education group were 
more likely to correctly select goitre and mental retardation as health problems related 
to inadequate iodine intake (Table 4.12) and a higher proportion of women from this 
education group correctly chose seafood as a good food source.  El-mani, Charlton, et 
al. (2014) also found a significant relationship between higher education levels and 
better knowledge regarding health problems associated with a lack of iodine in the 
diet.  There was a significant association between age and the correct selection of the 
health problems goitre and mental retardation, with the highest proportion of women 
who chose these conditions being from the highest age group.   
Younger age and less education have also been associated with other pregnancy-
related health behaviours in Australian women such as smoking (Mohsin and Bauman 
2005) and high-risk alcohol consumption after the first trimester (Cameron et al. 2013).  
This reinforces the need for targeted strategies to raise awareness and provide support 
for young pregnant women and those with lower education levels.   
 142 
To the author’s knowledge, this is the first time that iodine knowledge has been 
investigated in terms of ethnic differences, yielding important results.  Combinations 
of ethnic groups was significantly associated with the selection of “I do not know” 
relating to health problems with greater proportions of women from the New 
Zealand/Polynesian and Australian/Australian Aboriginal/TSI ethnic combination 
groups selecting this option compared to those of Asian/African/Other backgrounds.  
Although the numbers were lower, a similar trend in relation to knowledge was shown 
with a higher proportion of women from the Asian/African/Other ethnic combination 
group correctly choosing goitre and mental retardation compared to women from the 
other two groupings (Table 4.12).  As mentioned in relation to iodised salt use (Section 
5.3) and equally as relevant here, it is possible that women from the 
Asian/African/Other combination group may have greater awareness due to USI in 
areas of Asia, Africa and “Other” regions such as India.  This in turn would influence 
dietary habits, practices, patterns and knowledge. 
A significantly higher proportion of women in the earlier stage of pregnancy correctly 
identified goitre as a health problem.  This may have been related to age, education 
level and/or ethnic combination group, given the findings above.  
A greater proportion of women who had been pregnant previously achieved the EAR 
from food alone compared to women who were pregnant for the first time.  The reasons 
for this significant finding are unclear. One possibility could be that women who have 
been pregnant before may have incidentally gained more knowledge on healthy eating 
and pregnancy through previous antenatal care and/or mothers’ groups and this has 
had a positive influence on iodine intake.   
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Given that cow’s milk has been identified in this study as the single most important 
food contributor to iodine intake it was interesting to note that only 17.4% of subjects 
identified it as a good source of iodine, with approximately one-quarter of participants 
in NSW studies by Charlton et al. (2012); (2010) and Lucas et al. (2014) identifying 
the same.  Similarly, lower percentages of women in the present study identified bread 
as a good source of iodine (18, 27 and 26%, respectively vs 16%).  It is difficult to 
suggest a reason for this difference in knowledge of good food sources between the 
two states as it may simply reflect sample size differences (with the WA study sample 
being approximately three times the size of the NSW studies) or varied sample 
demographics. In addition to this, these findings suggest there may be less antenatal 
education provided on iodine in WA, however comparison with Charlton et al. (2013) 
(NSW) findings does not support this suggestion.  The percentage of women attending 
a public antenatal clinic in Wollongong in 2008 and 2011 who reported that had 
received enough dietary information on iodine to make informed decisions was lower 
than the findings from this WA study (17, 34 and 48%), respectively. 
Women in the present study received less information on iodine and other diet-related 
topics compared to folate and iron, with more women indicating they could not receive 
enough information on iodine than for any of the other dietary topics (Figure 4.8), this 
trend was also reported in NSW (Charlton et al. 2012; Charlton et al. 2013).  Findings 
reveal that GPs and midwives were identified as the most popular sources of dietary 
information (followed by the internet) and therefore play an important role in 
providing this information.  Similarly Charlton et al. (2012) report healthcare 
professionals, followed by the internet as the most common sources of dietary 
information. 
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5.7 Impact of pregnancy on food choices 
Pregnancy is a time when many women experience taste changes, taste aversions and 
nausea.  In addition to this women are advised to adapt food choices to minimise the 
risk of listeria infection, to minimise intake of fish that accumulate methylmercury and 
to abstain from alcohol consumption (National Health and Medical Research Council 
2013).  Over 60% of women in this study reported having eliminated food/foods during 
pregnancy with more than 50% (combined) no longer consuming deli meat, pre-
prepared and reheated food and unpasteurised dairy/soft cheeses.  This appears to be 
in keeping with a high percentage of women who felt they could access information 
on listeria topics. 
It is difficult to ascertain from the data the reason why approximately 8% of women 
were no longer consuming fish, shellfish (seafood) (not raw) (Table 4.13).  However, 
it is likely that the following factors have influenced the decreased consumption of this 
rich source of iodine; 1) taste changes, aversions and nausea, 2) confusion regarding 
mercury recommendations and fish intake, 3) women being focused (and potentially 
confused) about foods to avoid to minimise listeria infections.  To illustrate the last 
point, results from focus groups conducted on WA women of child-bearing age to 
identify barriers to good nutrient intakes during pregnancy indicated that listeria was 
the most commonly discussed nutrition-related theme with the potential to have 
implications on food choices and therefore nutrient intake (Begley 2002). 
There appears to be a clear case for improved education strategies on mercury and 
avoidance of listeria infection.  Whether the form of such education requires review is 
worth considering in light of a recent article that investigated the complexities 
surrounding the uptake of health and nutrition-related practices of NSW mothers 
(Maher and Lowe 2015).  An important finding of relevance to this study was the 
identification by mothers of the challenges related to following all of the recommended 
guidelines, as well as the difficulties of translating and implementing these 
recommendations in their day-to-day lives (Maher and Lowe 2015). 
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5.8 Strengths of this study 
The doubling of sample size over the previous Australian studies that assessed iodine 
intake together with knowledge, attitudes and beliefs assisted with minimising 
sampling errors and increased the statistical power of other analysis. 
Women from across the state were included in this study including women from 
varying cultural backgrounds and NESB (n=7).  Representation of these women was 
appropriate given the cultural diversity of the WA population.  Their inclusion has led 
to interesting findings suggesting that women from Asian/African/Other ethnic 
combination groups have better knowledge regarding potential health effects of 
inadequate iodine and are more frequent users of iodised salt, therefore may be less 
likely to have inadequate iodine intakes  This study did not measure urinary iodine but 
such measures by Hamrosi, Wallace, and Riley (2005) on three different ethnic groups 
in Melbourne indicated that UIC for Caucasian women was significantly lower than 
Indian/Sri Lankan women and Vietnamese women.  Indeed, it is likely that different 
education strategies are required for Australian women of Caucasian background and 
Aboriginal or TSI backgrounds and for Polynesian women. 
The age of women in this study could be considered reasonably representative of 
national figures for women who had given birth in 2013 (29.4 versus 30.1 years, 
respectively).  Primigravid women in this study were under-represented (38%) 
compared to 43.7% of women, nationally, who had given birth to their first baby in 
2013.  These differences could have been due, in part, to vastly different sample sizes 
(n=425 versus n= 304777) (Australian Institute of Health and Welfare 2013).  
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The FFQ used in this study enabled investigation into dietary habits and patterns, 
knowledge and beliefs.  The addition of the options “I do not know what iodine is” in 
relation to the questions “Do you feel that your own diet provides enough iodine for 
your body’s needs (i.e. when you are pregnant)” and “… (when you are not 
pregnant?)” was used to encourage accurate reporting relating to these questions, 
allowing subjects to feel that not knowing the answer was acceptable (Krosnick and 
Presser 2010).  Furthermore, these options allowed exploration of factors related to 
knowledge, or lack thereof.  This research provided evidence that women who selected 
“I do not know what iodine is” were less likely to use iodine-containing supplements 
and iodised salt, linking a lack of knowledge to their non-use. 
5.9 Limitations of this study 
The present cross-sectional study was based on a convenience sample of pregnant 
women at one public hospital site which limits the generalisability of the findings.  In 
addition to this, one data collection day every week coincided with a Childbirth and 
Mental Illness clinic and therefore women with serious mental illness were likely to 
have been over-represented.  Postcode information was not obtained from study 
subjects.  Inclusion in future studies would prove useful for distinguishing between 
urban and rural responses. 
Australian Aboriginal and TSI pregnant women comprised approximately 2.4% of the 
study population which is lower than the state and national percentage of Australian 
Aboriginal and TSI women reported to have given birth in 2013 (5.1% and 4.1%, 
respectively) (Australian Institute of Health and Welfare 2015). The small number of 
women this equates to (n=10) also limits the applicability and generalisability of these 
findings.   
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According to 2013 National Perinatal data 69% of women giving birth in Australia in 
2013 were born in Australia (Australian Institute of Health and Welfare 2015) 
compared to 50% in this study sample (excluding Australian Aboriginal and TSI 
women).  Nationally, 3.1% of women giving birth in 2013 were born in New Zealand 
(Australian Institute of Health and Welfare 2013).  Thus the demographic profile of 
this study suggests an over-representation of these women in the study population with 
approximately 7% (n=30) of subjects including NZ and/or Maori backgrounds in their 
ethnic group description (Appendix E).  It was difficult to ascertain WA information 
for the representation of the African/Asian/Other ethnic combination group due to the 
broad description of this category.  In addition, the question “What ethnic group do 
you belong to?” could have been interpreted as country of birth or ancestry, further 
adding to the difficulty of determining representativeness of the sample. 
The item relating to income is likely to have underestimated associations due to 
requesting the earnings of the subject only.  Information on household income over 
the last 12 months would have given more of a complete picture on earnings and would 
have been more relevant given that some women from the highest education group in 
this population may have had career breaks due to undertaking unpaid work within the 
household, placing them in the lowest income category on their income alone.  
Changes should be made to the questionnaire in future to allow the determination of 
household income.  An attempt was made to determine patterns relating to income and 
education however the aforementioned trend was not apparent in this study.  The 
greatest proportion of those who correctly identified with these selections were in the 
highest education category.   
As with any research that involves measuring self-reported dietary intake data, 
consideration needs to be given to the likelihood of measurement error.  It is well-
known that pregnant women experience taste changes, aversions and often nausea 
throughout pregnancy and attempts were made to identify inconsistent dietary intake 
in women who repeated the FFQ.  Upon second administration of the FFQ subjects 
were asked to specify if their diet had changed since first administration and to state a 
reason.  This allowed for reliability data to be looked at separately for these women. 
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Seasonal changes over the duration of the data collection period (December to July) 
may have affected dietary consumption patterns, a possibility that exists in many 
studies conducted across seasons.  In the present study, if women completed the FFQ 
in late autumn when Perth’s weather becomes considerably cooler, and with >14 days 
between administrations, seasonal changes may have influenced dietary intake.  
Separate reliability assessments were also conducted to determine differences related 
to time-frame between administration of the FFQ (≤14 days or >14 days between 
questionnaire completion), stage of pregnancy (≤28 weeks gestation and ≥29 weeks 
gestation) and the women who received written information on iodine after completing 
FFQ1. 
The limitations associated with the use of food composition databases to determine 
dietary iodine intake are important to note.  These databases only provide an estimated 
iodine value and are often based on an average figure determined via analysis, imputed 
data and/or borrowed data from a wide variety of food types or single foods that are 
grown and stored in different conditions and seasons (Sobolewski, Cunningham, and 
Mackerras 2010). The iodine content of soil varies across Australia therefore assigning 
one iodine value to a specific food that could have a substantial range in iodine content 
is problematic, especially given that WA is recognised for having nutrient-rich soil 
(Australian Bureau of Statistics 2013b) it may be possible that the iodine content of 
our local produce falls at the upper end of the iodine values assigned in food 
composition databases. 
As described in Section 2.7 accurate estimation of dietary consumption is influenced 
by subject recall of foods, self-report bias, misinterpretation of quantities and lack of 
motivation to complete the FFQ (Babor 1987).  In addition, the estimation of iodine 
contribution from iodised salt has been problematic in all studies that have attempted 
to do this.  As a consequence, percentage iodine contribution from iodised salt in this 
study is presented as a range (based on three calculations).  Whilst not ideal it is 
believed that providing a range based on three calculations is more likely to cover the 
true contribution than using one standard value.  Further adjustments to account for 
cooking losses and women/partners/family members cooking multiple meals should 
be considered in future studies.  Questions to address these issues need to be added to 
the FFQ to be answered by those who added iodised salt during cooking.   
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In addition to this, it is also important to acknowledge that the iodine levels of cow’s 
milk (the most important contributor to food iodine intake in this population) is likely 
to be highly variable because of soil differences (milk sourced for the Perth market 
comes from WA and other states) and several different processing plants with different 
cleaning procedures (Section 2.7).  Thus for all of the reasons discussed above, the 
values for dietary iodine intake presented here are at best estimated intakes.  In the 
absence of urinary data, the FFQ has proven useful in categorising subjects into levels 
of intake suggesting likelihood of achieving the EAR, in ranking subjects into tertiles 
to assess the reliability of the FFQ and in determining key foods contributing to iodine 
intake.  
There are conflicting reports on the contribution of tap water to iodine intake (Charlton 
et al. 2013; Food Standards Australia New Zealand 2008a; Rahman et al. 2010).  Tap 
water was not an item in the FFQ and should be included in future studies.  It is highly 
likely, however, that regional and seasonal variations in tap water source(s) and the 
use of rain water on some rural or remote properties in this vast state could make for 
inaccurate estimations and conclusions. It would be ideal to use iodine content data 
from a number of statewide locations and water sources in the future if including tap 
(and possibly rain water) as an item in FFQs.  It is difficult to ascertain whether the 
FFQ over or underestimated iodine intake in this population as there were no 
comparison methods such as food records or biochemical indices. Estimated iodine 
intakes would have been higher if tap water was included in the FFQ, however 
estimated iodine intakes relating to iodised salt use would have been lower if losses of 
iodine through cooking and division of dishes to produce multiple meals had been 
undertaken.  
The assumption that women who selected the option “Yes, regularly (more than once 
a week” used an iodine-containing supplement daily is a limitation of this study.  The 
author acknowledges that the results presented represent a best-case scenario and 
adapting the wording of such a question in the future to specify “daily use” would be 
useful.  It is worth noting that studies that have attempted to measure and verify 
pill/supplement usage via pill counts report limitations in these alternative methods 
such as subjects saving unused supplements and/or discarding unused supplements 
prior to collection due to social desirability (Jasti et al. 2005).   
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It is possible that the number of women who correctly selected iodised salt as a good 
source of iodine has been overestimated based on the assumption that subjects who 
selected “salt” for question 13 were referring to iodised salt.  This is a limitation of the 
questionnaire, however, iodised salt is readily available on supermarket shelves in 
Western Australia and nearly one-third of all women reported using iodised salt 
therefore were likely to be aware that salt can be iodised. It would be useful to 
investigate an alternative approach in stating this option more clearly in future studies. 
Using the term “iodised salt” is problematic due to the option itself revealing the 
correct answer, thereby giving a false representation of the subjects’ knowledge on the 
topic.  
This research did not measure biomarkers such as UIC, a measure commonly used to 
determine iodine status of groups of pregnant women. Future studies could be 
strengthened by including a range of biomarkers such as UIC, UIE and thyroid 
hormones to offset limitations related to the use of UIC alone (Sections 2.4.1 and 
2.9.1).    
5.10  Summary 
The median iodine intake values calculated for dietary iodine (iodine from food + 
iodised salt) and for the total iodine data (iodine from food + iodised salt + iodine-
containing supplements) met the EAR for pregnancy (196 ug/day and 358 ug/day), 
respectively, indicating that the majority of the subjects had sufficient iodine intakes. 
The median iodine intake relating to the food iodine data was slightly less than the 
EAR at 148 ug/day.  These findings are consistent with two of the more recently 
published studies with Condo et al. (2015) (SA) reporting similar estimated iodine 
intake values for food iodine data (borderline sufficient/sufficient) and Lucas et al. 
(2014) (NSW) reporting a median iodine intake value that met the EAR for dietary 
iodine data and total iodine intake data.  Brough et al. (2015) (NZ), Charlton et al. 
(2013) (NSW) and Mallard and Houghton (2014) (NZ) also report estimated 
population iodine intake values that met the EAR post-fortification of bread and bread 
products, whereas pre-fortification studies estimating iodine intake indicated 
insufficiency. 
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Over one-third of women were using iodised salt, whilst two-thirds were using iodine-
containing supplements, the latter being similar to other post-fortification studies 
conducted in Australia and NZ.  Cow’s milk, bread and bread products and iodised 
salt are major contributors to dietary iodine intake in this population.  Results also 
suggest that iodine knowledge is limited, furthermore, sociodemographic factors 
involved with iodine knowledge, intake and practices are complex. 
Whilst not a focus of this study, it is noteworthy that three of the 95 women whose 
total iodine intake was estimated (range 1142-1384 ug/day) appeared to have exceeded 
the UL for iodine (1100 ug/day) set by the NHMRC (2006b).  These women used 
iodised salt (estimated iodine content approximately 800 ug/day) and iodine-
containing supplements (iodine content of supplements approximately 220 ug/day), in 
addition to consuming cow’s milk daily, with two women using bread and bread 
products at least twice a day.  Iodised salt was clearly contributing the most toward 
excessive iodine intakes in these subjects, highlighting a potential issue with women 
using the equivalent of 1 tsp of iodised salt at least twice a day (in addition to daily 
iodine-containing supplements containing iodine at levels higher than that 
recommended). 
Approximately 97% and 92% of the subjects who consumed quantifiable iodine 
supplements (n=95) achieved the EAR and RDI for pregnant women, respectively 
(Figure 4.4) (Table 4.4).  Over one-third (39.3%) of the subjects in the dietary iodine 
group did not meet the EAR, whilst more than half (53.4%) did not achieve the EAR 
in the food iodine group. 
This study was conducted on a convenience sample of pregnant women attending one 
hospital in Perth, thus generalisability of the findings is limited.  Attempts to minimise 
measurement error associated with self-report dietary intake data were made including 
the adaptation of a previously validated tool and by assessing the reliability of the 
current tool.  In addition, daily iodine intakes are reported as estimated values.  To 
recognise this fact, the reliability assessment investigated the ranking ability of the 
questionnaire (tertiles) as well as estimated iodine values. 
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CHAPTER 6 : CONCLUSIONS AND RECOMMENDATIONS 
This was the first WA study to investigate iodine knowledge, beliefs and practices of 
pregnant women attending the state’s only tertiary women’s and neonatal hospital 
(KEMH), thereby providing initial data on pregnant women residing in the largest state 
of Australia. 
Based on the median iodine intake (calculated from self-reported dietary intake data) 
it is apparent that in 2012-2013 the population in this study achieved the EAR for 
pregnancy when iodised salt and iodine from supplements (for consumers of iodised 
salt and/or iodine-containing supplements) together with iodine from food was 
accounted for.  Thus indicating that the majority of participants had sufficient iodine 
intakes.  Furthermore, the median iodine intake based on food iodine alone was only 
slightly less than the EAR.  This corresponds to Australian Bureau of Statistics (ABS) 
data indicating that WA adults and school children had the highest MUIC out of all 
Australian states and territories (Australian Bureau of Statistics 2013a). 
There will always be subgroups within any pregnant population that have a higher risk 
of inadequate iodine intake and this study identified associations through dietary intake 
and demographic data.  In the absence of urinary excretion data approximately 39% of 
subjects did not appear to meet the EAR (using estimated dietary iodine data) and 
therefore were unlikely to be meeting their requirement for iodine.  Further exploration 
indicated four key components significantly associated with subjects attainment of the 
EAR: 
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1. Iodine-containing supplement use (resulting in an overall 97% likelihood of 
achieving the EAR) was lower in the 12 months prior to becoming pregnant 
(24.4%) compared to use during pregnancy (65.7%).  Notably, younger women 
were less likely to take iodine-containing supplements prior to pregnancy and a 
lower proportion of women from the lowest income categories were using these 
supplements prior to pregnancy.  Proportionally less women in the later stage of 
pregnancy (from 29 weeks) reported using iodine-containing supplements prior to 
pregnancy compared to those in the earlier stage of pregnancy.  A lower proportion 
of multigravid women and of those in later pregnancy (from 29 weeks) used iodine-
containing supplement during their pregnancy.  Women who did not know what 
iodine was were less likely to use these supplements during their pregnancy. 
2. Iodised salt use (resulting in an overall 83% likelihood of achieving the EAR) was 
proportionally less in women whose highest level of education was secondary, 
diploma or a trade/technical certificate compared to those with tertiary or 
professional qualifications and in women of Australian/Australian Aboriginal/TSI. 
3. Cow’s milk consumption was a major contributor to iodine intake in the study 
population despite being identified as a good source of iodine by less than one-
quarter of subjects. Women who consumed cow’s milk at least twice a day had a 
91% chance of achieving the EAR. 
4. Bread and bread products (fortified with iodine) were the second top contributor 
to iodine intake, again, subject knowledge of this item being a good source of 
iodine was low.  The findings indicated that women who consumed these products 
at least twice a day had an 83% chance of achieving the EAR. 
This information, together with reliability testing supported the development of a 
decision tree (Figure 4.9), leading to the development of a potential rapid iodine 
screening tool to identify women at risk of inadequate iodine intakes. 
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Subject knowledge regarding iodine topics was limited reflected in the findings that 
less women in this study indicated that they could receive enough information on the 
topic of iodine than on any other dietary topics.  Conversely, a high percentage of 
women felt they could obtain enough information on listeria, however assessment of 
foods avoided during pregnancy raised concerns regarding confusion on this topic.  
This ultimately has flow-on effects to fish and seafood consumption and therefore 
iodine intake. 
Whilst nation-wide recommendations exist for the use of iodine-containing 
supplements in pregnant women, the results from this study provide initial evidence 
that this may not be the case for WA pregnant women in general.  This research, in 
particular, begins to challenge the notion of blanket iodine supplementation 
recommendation in a state that traditionally and recently has reported optimal iodine 
status of the adult population and SAC. 
This study highlights areas for further investigation and several recommendations are 
proposed: 
1. Assessment of the iodine status of WA pregnant women using biochemical 
measures such as UIC, UIE and thyroid hormones. 
2. Use of the rapid screening tool on a larger, randomised sample of WA pregnant 
women (in both private and public antenatal settings) including validation against 
biochemical markers such as UIC, UIE and thyroid hormones. 
3. Consider using the screening tool (once validated) with subgroups identified in this 
study as being at risk of not meeting the EAR for iodine (e.g. younger women, 
those with less education and those from lower income groups).  
4. Promotion of dairy products and bread and bread products (fortified with iodine) 
to all pregnant women. 
5. Clarification and promotion of safe fish and seafood intake to all pregnant women. 
6. Prioritising and targeting education for subgroups identified in this study (e.g. 
younger women, those with less education and those from lower income groups).  
Given the findings from this research, women who do not consume bread or bread 
products (fortified with iodine) at least twice a day or those who do not consume 
cow’s milk at least twice a day are at risk of inadequate iodine intakes if they are 
not using iodine-containing supplements or iodised salt. 
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7. Australian women of Caucasian background and Aboriginal or TSI backgrounds 
and Polynesian backgrounds may require different education strategies to improve 
iodine knowledge. 
8. Strategies to increase the awareness on the importance of adequate iodine during 
pregnancy in health professionals are required, especially for doctors and 
midwives (identified as the top sources of information). 
9. Promotion of reputable websites for dietary information on iodine. 
10. Promotion of dietitians (as university trained nutrition experts) to provide tailored 
dietary advice on meeting iodine requirements. 
11. Monitoring of pregnant women who are at risk of exceeding the UL for iodine 
needs to be considered in WA, especially women using more than 1 teaspoon of 
iodised salt and iodine containing supplements daily, in addition to consuming 
cow’s milk and bread and bread products daily.  Alternatively, discouraging the 
over-consumption of iodised salt and encouraging manufacturers of pregnancy 
supplements to add the recommended amount of iodine to supplements (150 ug) 
(range in this study was 38 ug to 500 ug iodine) should be considered as two 
options to limit women exceeding the UL. 
In conclusion, this research indicates that the majority (65.7%) of women reported 
taking iodine-containing supplements (iodine range 38-500 ug) during pregnancy, and 
that taking an iodine-containing supplement was associated with a high likelihood of 
achieving the EAR (96.8%).  This estimate is based on the assumption that iodine-
containing supplements were taken every day. The population sampled here was a 
convenience sample rather than a truly representative sample (Section 5.9) and the 
subgroup for which data on total iodine (food, +/- iodised salt and supplements) was 
comprised of 95 subjects, thus it cannot be stated with certainty that this high level of 
likelihood of attaining the EAR can be applied to all the pregnant women who take 
iodine-containing supplements in WA. Nonetheless, 91.6% achieved the RDI which 
suggests that most pregnant women in this population are able to meet their 
requirements by taking an iodine-containing supplement.  
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The current study highlights that more than five years after the release of the NHMRC 
recommendation, at least one-quarter of this particular population were not using 
iodine-containing supplements.  Interestingly, 43% of women were able to achieve the 
RDI without supplementation. Given that the RDI is the amount of iodine required to 
cover the needs of 97-98% of the needs of healthy pregnant women, this indicates a 
high likelihood of these women all meeting their individual requirement.  However, 
the dietary hallmarks of these women were the daily use of iodised salt and the 
consumption of cow’s milk and/or bread products at least twice a day.  Thus the 
NHMRC recommendation for all pregnant women to take an iodine-containing 
supplement during pregnancy may not apply to all pregnant women in WA, but this 
needs to be balanced with the NHMRC suggested dietary target (sodium) to reduce 
chronic disease of 1600 mg (National Health and Medical Research Council and New 
Zealand Ministry of Health 2006a).   
The investigation into an alternative approach such as a rapid screening tool to identify 
women at risk of inadequate iodine intakes is substantiated.  Blanket recommendations 
regarding iodine supplementation may avoid confusion in the target population 
however it is also known that there are subgroups in the population who are less likely 
to use iodine-containing supplements.  The need for such a screening tool may be of 
more use in the subgroups identified in this and similar studies (e.g. younger women, 
those with less education and those from lower income groups).   
The future successful validation of the rapid screening tool detailed in this study is 
likely to enhance the ability of healthcare professionals to identify pregnant women at 
risk of inadequate iodine intakes.  There are restricted opportunities for these groups 
to see an antenatal health professional in the early stages of pregnancy thus exposure 
to the screening tool may need to be through avenues such as doctor and hospital 
clinics, popular pregnancy websites and pharmacies.  
An important next step in extending the investigation into the iodine status of pregnant 
women in WA would be to assess the median urinary iodine level of a sample of these 
women and to determine the sensitivity and specificity of the rapid screening tool.  
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APPENDIX D : STATISTICAL TESTS TO DETERMINE 
RELIABILITY FOR CATEGORICAL DATA. 
Variable Statistical test Application 
Food iodine intake (tertiles) 
FFQ1 & FFQ2 
1. Kappa and percentage 
agreement 
1. To investigate ranking 
ability of FFQ upon repeat 
administration 
Absolute iodine contribution-
cow’s milk (tertiles) 
FFQ1 & FFQ2 
1. Kappa and percentage 
agreement 
2. Wilcoxon signed rank test 
3. Marginal homogeneity 
1. To investigate ranking 
ability of FFQ upon repeat 
administration 
2. To determine if differences 
in medians of FFQ1 and FFQ2 
were statistically significant 
3. To examine if changes 
between FFQ1 and FFQ2 
were statistically significant 
Absolute iodine contribution-
bread and bread products 
(tertiles) 
FFQ1 & FFQ2 
1. Kappa and percentage 
agreement 
2. Wilcoxon signed rank test 
3. Marginal homogeneity 
1. To investigate ranking 
ability of FFQ upon repeat 
administration 
2. To determine if differences 
in medians of FFQ1 and FFQ2 
were statistically significant 
3. To examine if changes 
between FFQ1 and FFQ2 
were statistically significant 
Frequency of consumption 
(8 categories) – selected food 
items* 
FFQ1 & FFQ2 
1. Kappa and percentage 
agreement 
2. Wilcoxon signed rank test 
3. Marginal homogeneity 
1. To investigate ranking 
ability of FFQ upon repeat 
administration 
2. To determine if differences 
in medians of FFQ1 and FFQ2 
were statistically significant 
3. To examine if changes 
between FFQ1 and FFQ2 
were statistically significant 
* Food items with Kappa value >0.5 + bread and bread products 
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APPENDIX E : ORIGINAL ETHNIC GROUP RESPONSES 
 Ethnic Group Frequency 
(n) 
Percent 
(%) 
 Australian 207 48.8 
 Australian Aboriginal 10 2.4 
 Indian 27 6.4 
 Chinese 14 3.3 
 British 25 5.9 
 Persian 2 .5 
 Filipino 8 1.9 
 African 16 3.8 
 Canadian 3 .7 
 Sri Lankan 2 .5 
 Bangladeshi 1 .2 
 New Zealand European 1 .2 
 Thai 2 .5 
 Libyan 2 .5 
 Greek 1 .2 
 Arabic 2 .5 
 Maori NZ 12 2.8 
 Vietnamese 4 .9 
 Other 1 .2 
 Serbian 1 .2 
 Afghani 1 .2 
 Iraqi 1 .2 
 Maori/English 1 .2 
 NZ/Samoan 2 .5 
 Australian/British 4 .9 
 American 1 .2 
 Mongolian 1 .2 
 Malay 1 .2 
 Egyptian 1 .2 
 South African 5 1.2 
 NZ 14 3.3 
 Australian/Indian/British 1 .2 
 Polish 2 .5 
 Pakistani 3 .7 
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 Ethnic Group Frequency 
(n) 
Percent 
(%) 
 Middle Eastern 2 .5 
 Irish 6 1.4 
 Samoan 2 .5 
 Australian Aboriginal/British 1 .2 
 Fijian 1 .2 
 South American/Chilean 1 .2 
 Swiss 1 .2 
 Italian 3 .7 
 Bosnian 1 .2 
 Indonesian 2 .5 
 Papua New Guinean 1 .2 
 Korean 2 .5 
 Latin/Brazilian 2 .5 
 Japanese 2 .5 
 Indian/British 1 .2 
 Albanian 1 .2 
 Algerian 1 .2 
 Dutch 3 .7 
 Latina 1 .2 
 Thai 1 .2 
 Turkish 1 .2 
 Nepalese 1 .2 
 Australian/German 1 .2 
 Bhutanese 1 .2 
 Sudanese 1 .2 
 Malay/English 1 .2 
 Dutch/German/Irish 1 .2 
 Iranian 1 .2 
 Asian 1 .2 
 Lebanese 1 .2 
 Total 424 100.0 
Missing  1  
Total  425  
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APPENDIX F : SELECTED CROSS TABULATIONS  
AND CHI SQUARE TESTS 
F.1 Iodine in supplement taken before 
becoming pregnant  * Age 
Categorical .................................. 212 
F.2 Iodine in supplement taken before 
becoming pregnant  * Weeks 
pregnant recoded into BINARY . 214 
F.3 Iodine in supplement taken before 
becoming pregnant  * Income 3 
categories minus no response ..... 215 
F.4 Iodine in supplement taken since 
becoming pregnant  * Weeks 
pregnant recoded into BINARY . 217 
F.5 Iodine in supplement taken since 
becoming pregnant  * Is this your 
first pregnancy? .......................... 219 
F.6 Iodine in supplement taken since 
becoming pregnant  * Education 
categorical ................................... 221 
F.7 Iodine in supplement taken before 
becoming pregnant  * Education 
categorical ................................... 223 
F.8 FFQ1 Does or does not meet EAR 
Diet only  * Is this your first 
pregnancy? .................................. 225 
F.9 FFQ1 Does or does not meet EAR 
Diet only  * How often in the last 2 
months have you had cow's 
milk? ........................................... 227 
F.10 Total diet intake + salt categorical  * 
How often in the last 2 months have 
you had cow's milk? ................... 230 
F.11 FFQ1 Does or does not meet EAR 
Diet only  * How often in the last 2 
months have you had bread and 
bread products eg rolls, pita breads, 
pizza bases, bagels, English muffins, 
sticky buns? ................................ 232 
F.12 Total diet intake + salt categorical  * 
How often in the last 2 months have 
you had bread and bread products eg 
rolls, pita breads, pizza bases, 
bagels, English muffins, sticky 
buns? ........................................... 233 
F.13 Total diet intake + salt categorical  * 
Iodised salt use BINARY minus I do 
not know ......................................235 
F.14 Iodised salt use BINARY minus I do 
not know  * Education categorical 
Crosstabulation ............................237 
F.15 Iodised salt use BINARY minus I do 
not know  * NEW Ethnicity 3 
cat ................................................239 
F.16 Food source of I I do not know  * 
Education categorical ..................241 
F.17 Food source of I Seafood  * 
Education categorical ..................243 
F.18 Health problem Goitre  * Age 
Categorical ..................................245 
F.19 Health problem I do not know  * 
Education categorical ..................247 
F.20 Health problem Goitre  * Education 
categorical ...................................249 
F.21 Health problem Mental retardation  
* Education categorical ...............251 
F.22 Health problem I do not know  * 
NEW Ethnicity 3 cat ...................253 
F.23 Health problem Goitre  * NEW 
Ethnicity 3 cat .............................255 
F.24 Health problem Mental retardation  
* NEW Ethnicity 3 cat ................257 
F.25 Health problem Goitre  * Weeks 
pregnant recoded into BINARY..259 
F.26 Iodine in supplement taken since 
becoming pregnant  * Do you feel 
that your diet provides enough 
iodine when you are pregnant? ...261 
F.27 Iodised salt use BINARY minus I do 
not know  * Do you feel that your 
diet provides enough iodine when 
you are pregnant? ........................263 
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F.1 Iodine in supplement taken before becoming pregnant  
* Age Categorical 
Cross Tabulation 
 
 213 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 10.855a 2 .004 
Likelihood Ratio 10.850 2 .004 
Linear-by-Linear 
Association 
10.701 1 .001 
N of Valid Cases 415   
a 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 19.42. 
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F.2 Iodine in supplement taken before becoming pregnant  
* Weeks pregnant recoded into BINARY 
Cross Tabulation 
 
 215 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 5.376a 1 .020   
Continuity Correctionb 4.855 1 .028   
Likelihood Ratio 5.328 1 .021   
Fisher's Exact Test    .022 .014 
Linear-by-Linear 
Association 
5.363 1 .021   
N of Valid Cases 418     
a 0 cells (0.0%) have expected count less than 5. The minimum expected count is 42.95. 
b Computed only for a 2x2 table 
 216 
F.3 Iodine in supplement taken before becoming pregnant  
* Income 3 categories minus no response 
Cross Tabulation 
 
 217 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 6.923a 2 .031 
Likelihood Ratio 6.139 2 .046 
Linear-by-Linear 
Association 
3.830 1 .050 
N of Valid Cases 339   
a 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 5.10. 
 218 
F.4 Iodine in supplement taken since becoming pregnant  
* Weeks pregnant recoded into BINARY 
Cross Tabulation 
 
 219 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 11.279a 1 .001   
Continuity Correctionb 10.586 1 .001   
Likelihood Ratio 11.495 1 .001   
Fisher's Exact Test    .001 .001 
Linear-by-Linear 
Association 
11.251 1 .001   
N of Valid Cases 414     
a 0 cells (0.0%) have expected count less than 5. The minimum expected count is 60.02. 
b Computed only for a 2x2 table 
 220 
F.5 Iodine in supplement taken since becoming pregnant  
* Is this your first pregnancy? 
Cross Tabulation 
 
 221 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.498a 1 .006   
Continuity Correctionb 6.928 1 .008   
Likelihood Ratio 7.646 1 .006   
Fisher's Exact Test    .008 .004 
Linear-by-Linear 
Association 
7.480 1 .006   
N of Valid Cases 414     
a 0 cells (0.0%) have expected count less than 5. The minimum expected count is 54.88. 
b Computed only for a 2x2 table 
 222 
F.6 Iodine in supplement taken since becoming pregnant  
* Education categorical 
Cross Tabulation 
 
 223 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 5.509a 2 .064 
Likelihood Ratio 5.480 2 .065 
Linear-by-Linear 
Association 
5.439 1 .020 
N of Valid Cases 409   
a 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 34.33. 
 224 
F.7 Iodine in supplement taken before becoming pregnant  
* Education categorical 
Cross Tabulation 
 
 225 
Chi-Square Tests 
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 3.368a 2 .186 
Likelihood Ratio 3.348 2 .187 
Linear-by-Linear 
Association 
2.359 1 .125 
N of Valid Cases 414   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 25.13. 
 226 
F.8 FFQ1 Does or does not meet EAR Diet only  
* Is this your first pregnancy? 
Cross Tabulation 
 
 227 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 6.695a 1 .010   
Continuity Correctionb 6.188 1 .013   
Likelihood Ratio 6.736 1 .009   
Fisher's Exact Test    .012 .006 
Linear-by-Linear 
Association 
6.680 1 .010   
N of Valid Cases 425     
a 0 cells (0.0%) have expected count less than 5. The minimum expected count is 75.94. 
b Computed only for a 2x2 table 
 228 
F.9 FFQ1 Does or does not meet EAR Diet only  
* How often in the last 2 months have you had cow's milk? 
Cross Tabulation 
 
 229 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 205.865a 7 .000 
Likelihood Ratio 232.249 7 .000 
Linear-by-Linear 
Association 
91.959 1 .000 
N of Valid Cases 423   
a 2 cells (12.5%) have expected count less than 5. The minimum 
expected count is 2.34. 
 230 
F.10 Total diet intake + salt categorical  
* How often in the last 2 months have you had cow's milk? 
Cross Tabulation 
 
 231 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 118.005a 7 .000 
Likelihood Ratio 132.767 7 .000 
Linear-by-Linear 
Association 
83.428 1 .000 
N of Valid Cases 423   
a 3 cells (18.8%) have expected count less than 5. The minimum 
expected count is 1.95. 
 232 
F.11 FFQ1 Does or does not meet EAR Diet only  
* How often in the last 2 months have you had bread and bread products 
eg rolls, pita breads, pizza bases, bagels, English muffins, sticky buns? 
Cross Tabulation 
 
 233 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 86.967a 7 .000 
Likelihood Ratio 95.015 7 .000 
Linear-by-Linear 
Association 
43.179 1 .000 
N of Valid Cases 423   
a 4 cells (25.0%) have expected count less than 5. The minimum 
expected count is 1.87. 
 234 
F.12 Total diet intake + salt categorical  
* How often in the last 2 months have you had bread and bread products 
eg rolls, pita breads, pizza bases, bagels, English muffins, sticky buns? 
Cross Tabulation 
 
 235 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 66.007a 7 .000 
Likelihood Ratio 73.814 7 .000 
Linear-by-Linear 
Association 
35.510 1 .000 
N of Valid Cases 423   
a 4 cells (25.0%) have expected count less than 5. The minimum 
expected count is 1.58. 
 236 
F.13 Total diet intake + salt categorical  
* Iodised salt use BINARY minus I do not know 
Cross Tabulation 
 
 237 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 47.089a 1 .000   
Continuity Correctionb 45.584 1 .000   
Likelihood Ratio 49.385 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
46.956 1 .000   
N of Valid Cases 355     
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 59.04. 
b Computed only for a 2x2 table 
 238 
F.14 Iodised salt use BINARY minus I do not know  
* Education categorical Crosstabulation 
Cross Tabulation 
 
 239 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 7.522a 2 .023 
Likelihood Ratio 7.530 2 .023 
Linear-by-Linear 
Association 
6.440 1 .011 
N of Valid Cases 352   
a 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 39.75. 
 240 
F.15 Iodised salt use BINARY minus I do not know  
* NEW Ethnicity 3 cat 
Cross Tabulation 
 
 241 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance  
(2-sided) 
Pearson Chi-Square 18.056a 2 .000 
Likelihood Ratio 18.153 2 .000 
Linear-by-Linear 
Association 
18.002 1 .000 
N of Valid Cases 355   
a 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 13.52. 
 242 
F.16 Food source of I I do not know  
* Education categorical 
Cross Tabulation 
 
 243 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 9.188a 2 .010 
Likelihood Ratio 9.435 2 .009 
Linear-by-Linear 
Association 
7.315 1 .007 
N of Valid Cases 420   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 28.01. 
 244 
F.17 Food source of I Seafood  
* Education categorical 
Cross Tabulation 
 
 245 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 13.380a 2 .001 
Likelihood Ratio 13.669 2 .001 
Linear-by-Linear 
Association 
13.308 1 .000 
N of Valid Cases 420   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 37.10. 
 246 
F.18 Health problem Goitre  
* Age Categorical 
Cross Tabulation 
 
 247 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 6.017a 2 .049 
Likelihood Ratio 5.552 2 .062 
Linear-by-Linear 
Association 
4.775 1 .029 
N of Valid Cases 422   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 12.89. 
 248 
F.19 Health problem I do not know  
* Education categorical 
Cross Tabulation 
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Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 12.022a 2 .002 
Likelihood Ratio 12.073 2 .002 
Linear-by-Linear 
Association 
11.442 1 .001 
N of Valid Cases 420   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 48.20. 
 250 
F.20 Health problem Goitre  
* Education categorical 
Cross Tabulation 
 
 251 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 32.308a 2 .000 
Likelihood Ratio 34.132 2 .000 
Linear-by-Linear 
Association 
31.095 1 .000 
N of Valid Cases 420   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 17.67. 
 252 
F.21 Health problem Mental retardation  
* Education categorical 
Cross Tabulation 
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Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 7.603a 2 .022 
Likelihood Ratio 7.862 2 .020 
Linear-by-Linear 
Association 
7.453 1 .006 
N of Valid Cases 420   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 9.34. 
 254 
F.22 Health problem I do not know  
* NEW Ethnicity 3 cat 
Cross Tabulation 
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Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 9.732a 2 .008 
Likelihood Ratio 9.745 2 .008 
Linear-by-Linear 
Association 
8.237 1 .004 
N of Valid Cases 424   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 15.02. 
 256 
F.23 Health problem Goitre  
* NEW Ethnicity 3 cat 
Cross Tabulation 
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Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 30.801a 2 .000 
Likelihood Ratio 30.302 2 .000 
Linear-by-Linear 
Association 
28.661 1 .000 
N of Valid Cases 424   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 5.53. 
 258 
F.24 Health problem Mental retardation  
* NEW Ethnicity 3 cat 
Cross Tabulation 
 
 259 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 7.048a 2 .029 
Likelihood Ratio 7.141 2 .028 
Linear-by-Linear 
Association 
5.346 1 .021 
N of Valid Cases 424   
a 1 cells (16.7%) have expected count less than 5. The minimum 
expected count is 2.88. 
 260 
F.25 Health problem Goitre  
* Weeks pregnant recoded into BINARY 
Cross Tabulation 
 
 261 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 6.828a 1 .009   
Continuity Correctionb 6.158 1 .013   
Likelihood Ratio 6.747 1 .009   
Fisher's Exact Test    .012 .007 
Linear-by-Linear 
Association 
6.812 1 .009   
N of Valid Cases 425     
a 0 cells (.0%) have expected count less than 5. The minimum expected count is 30.07. 
b Computed only for a 2x2 table 
 262 
F.26 Iodine in supplement taken since becoming pregnant  
* Do you feel that your diet provides enough iodine when you are 
pregnant? 
Cross Tabulation 
 
 263 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 16.817a 3 .001 
Likelihood Ratio 16.021 3 .001 
Linear-by-Linear 
Association 
3.392 1 .066 
N of Valid Cases 410   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 9.90. 
 264 
F.27 Iodised salt use BINARY minus I do not know  
* Do you feel that your diet provides enough iodine when you are 
pregnant? 
Cross Tabulation 
 
 265 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance 
(2-sided) 
Pearson Chi-Square 7.955a 3 .047 
Likelihood Ratio 8.192 3 .042 
Linear-by-Linear 
Association 
4.049 1 .044 
N of Valid Cases 351   
a 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 13.14. 
 
